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ABSTRACT 
Tissue engineering is a new concept emerged as an alternative approach to 
tissue and organ reconstruction. It differs from organ transplantation by 
regenerating patient’s own tissue and organs avoiding the biocompatibility and 
low biofunctionality problems as well as severe immune rejection; which are the 
main problems of organ transplantation. Tissue engineering methods generally 
require the use of three main components: a porous scaffold that serves as a 
matrix, cells and growth factors. The architecture of the tissue engineered 
scaffold is an important factor to take into consideration that can modulate 
biological response and the clinical success of the scaffold.  
Fiber-based scaffolds can provide large surface area and highly 
interconnective porous structure for cell attachment and ingrowth as well as 
variety of geometric possibilities that can be regulated depending on the 
application.  
In the works presented in this thesis, we developed different fiber based 
structures based on two natural origin polymers, chitosan and starch, for use in 
tissue engineering.  
In Chapter III, chitosan fibers and fiber mesh scaffolds were produced by 
means of wet spinning technique. The tensile strength of produced fibers was 
around 205 MPa and Ca-P layer formation could be observed on their surfaces 
after 14 days of immersion in simulated body fluid (SBF). In Chapter IV, these 
fibers were then used in further studies for the reinforcement of the structure of a 
composite material which was consisting of microporous coralline origin 
hydroxyapatite microgranules, chitosan membranes and chitosan fibers. This 
composite architecture showed 88% (w/w) swelling in one hour and preserved its 
complex structure upon long-term incubation. Chitosan fiber meshes were 
obtained by moulding a predetermined amount of wet-spun fibers. After 7 days of 
culture, it was found that they were able to support osteoblast-like cell 
attachment and proliferation. A bone-like apatite layer was obtained on these 
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scaffolds by means of using a simple biomimetic coating process. The apatite 
formation was determined by different techniques, including SEM, FTIR-ATR, 
EDS, XRD. The influence of biomimetic coating on osteoblast cell behaviour was 
also examined by culturing SaOs-2 cells onto scaffolds. The cell population and 
ALP enzyme activity were found to be higher in the biomimetic coated scaffolds 
than those in uncoated scaffolds. Furthermore, cell presented more spread and 
flat morphology when they were seeded on biomimetic coated scaffolds. 
Regarding starch-based fiber structures, wet spinning was used in 
Chapter VI as an alternative method to melt spinning for production of 
starch/polycaprolactone fiber mesh scaffolds. This method seemed to be a very 
reproducible way of obtaining the fiber mesh scaffolds, typically with 77% 
porosity and mean pore size 250µm. The specific surface of the scaffolds was 
measured around 29 mm2/mm3, which was very similar to natural bone. The 
surfaces of the scaffolds were then treated with plasma under Ar atmosphere. 
Although both treated and untreated scaffolds exhibited ability for osteoblast-like 
cell attachment and proliferation, DNA content and ALP enzyme activity were 
higher in plasma treated scaffolds. 
Finally, and as a new approach to mimic the natural extracellular matrix 
(ECM), nano- and micro-fiber combined scaffolds from starch/polycaprolactone 
blend were designed by means of two step methodology. Electrospinning was 
used to obtain nanofibers on melt-spun micro-fiber meshes. With regard to the 
cell culture studies with osteoblast-like cells and rat bone marrow stromal cells, 
these new architectures showed excellent cell support ability and very promising 
properties to make them a proper tissue engineering scaffold.   
 In summary, results from these works showed that the designed fiber-
based structures from natural origin polymers could successfully serve as a 
scaffold for tissue engineering. 
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RESUMO  
Engenharia de tecidos é um conceito novo que emergiu como uma abordagem 
alternativa para a reconstrução de tecidos e órgãos. Difere da transplantação de 
órgãos na medida em que gera os tecidos e órgãos do próprio doente 
melhorando desta forma a biocompatibilidade e funcionalidade, assim como 
reduzindo o risco de rejeição pelo sistema imunitário, que são os principais 
problemas associados à transplantação de órgãos. Geralmente os métodos de 
engenharia de tecidos requerem o uso de três componentes principais: um 
suporte poroso que serve de matriz, células e factores de crescimento. A 
arquitectura do suporte é um aspecto importante a ter em consideração que 
pode modular a resposta biológica e o sucesso clínico do mesmo a longo prazo. 
Suportes à base de fibras podem dar origem a uma grande área superficial e a 
uma estrutura porosa interconectada para a adesão migração celulares, assim 
como uma variedade de possibilidades geométricas que podem ser adaptadas 
dependendo da aplicação. 
No trabalho apresentado nesta tese foram desenvolvidas, para uso em 
engenharia de tecidos, diferentes estruturas à base de fibras produzidas a partir 
de dois polímeros de origem natural, sendo estes o quitosano e o amido. Fibras 
de quitosano e suportes à base de fibras foram produzidos pela técnica de “wet 
spinning”. A resistência à tracção das fibras produzidas foi em média 204.9 MPa 
e a formação da camada Ca-P foi observada nas suas superfícies após 14 dias 
de imersão em “simulated body fluid” (SBF). Estas fibras foram usadas em 
estudos posteriores para o reforço da estrutura do material compósito, que 
consiste em microgrânulos de hidroxiapatite de origem coralina microporosa, 
membranas e fibras de quitosano. Esta arquitectura compósita apresentou 88% 
(p/p) de inchamento ao fim de uma hora e manteve a sua estrutura complexa em 
incubações prolongadas. Suportes à base de fibras de quitosano foram obtidos 
moldando uma quantidade pré-determinada de fibras produzidas por “wet-
spinning”. Após 7 dias de cultura, verificou-se que eram capazes de suportar a 
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adesão e proliferação de osteoblastos. Uma camada de apatite idêntica ao osso 
foi obtida nestes suportes através de um processo simples de revestimento 
biomimético. A formação de apatite foi determinada por diferentes técnicas, tais 
como: SEM, FTIR-ATR, EDS e XRD. A influência do revestimento biomimético 
foi também examinada na actividade celular dos osteoblastos, cultivando células 
SaOs-2 nos suportes. Observou-se que a população celular e a actividade da 
enzima ALP é maior nos suportes com revestimento biomimético do que nos 
suportes sem revestimento. Além disso, células semeadas nos suportes com 
revestimento biomimético apresentam-se mais espalhadas e com uma 
morfologia plana. 
Relativamente às estruturas de fibras à base de amido, a técnica de “wet 
spinning” é utilizada como uma alternativa à técnica de “melt spinning” para 
produção de suportes à base de fibras de amido/policaprolactona. Este método 
permite obter de uma forma reprodutível suportes à base de fibras com 77% de 
porosidade e tamanho médio de poro de 250 µm. A superfície específica dos 
suportes é de aproximadamente 29 mm2/mm3, que é em muito semelhante ao 
osso natural. As superfícies dos suportes foram então tratadas com plasma em 
atmosfera árgon. Embora ambos os suportes tratados e não tratados por plasma 
tenham exibido capacidade para adesão e proliferação dos osteoblastos, o 
conteúdo de DNA e a actividade da enzima ALP foram maiores em suportes 
tratados.  
Numa nova abordagem para mimetizar a matriz extracelular natural (ECM), 
foram concebidos, por uma metodologia em duas etapas, suportes combinados 
de nano- e micro-fibras a partir de uma mistura de amido/policaprolactona.  A 
técnica de “electrospinning” é utilizada para produzir nano-fibras no topo de 
malhas de micro-fibras sendo estas obtidas por “melt-spun”. No que diz respeito 
a estudos de culturas celulares com osteoblastos e células da medula óssea de 
rato, estas novas arquitecturas mostraram uma excelente capacidade de suporte 
celular como uma estrutura de engenharia de tecidos. 
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Em resumo, os resultados destes trabalhos demonstraram que as estruturas à 
base de fibras, concebidas a partir de polímeros naturais, podem servir com 
êxito como suporte para engenharia de tecidos.   
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CHAPTER I 
GENERAL INTRODUCTION 
BIODEGRADABLE POLYMERİC FIBER STRUCTURES IN TISSUE 
ENGINEERING 
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Abstract 
Tissue engineering offers a promising new approach to create biological alternatives 
to repair or restore function of damaged or diseased tissues. In order to obtain three-
dimensional tissue constructs, stem/progenitor cells must be combined with a highly 
porous three-dimensional scaffold. However, so far, many of the structures purposed 
for tissue engineering can not meet all the criteria required by an adequate scaffold 
due to the lack of mechanical strength and interconnectivity as well as poor surface 
characteristics. Fiber-based structures represent a wide range of morphological and 
geometric possibilities that can be tailored for each specific tissue engineering 
application. The present article overviews the research data in tissue engineering 
therapies based on the use of biodegradable fiber architectures as a scaffold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3
1. Definition 
Fibers are the fundamental units of textile and fabrics. They can be directly supplied 
from nature or produced from synthetic polymers. Both natural and synthetic fibers 
and fiber-based structures, so-called biotextiles, have been widely used for 
biomedical applications.  
 “Biotextiles” has been defined as a “structure composed of textile fibers and 
designed for used in a specific biological environment (e.g. surgical implant), where 
its performance depends on its interactions with cells and biological fluids as 
measured in terms of its biocompatibility and biostability” [1].   
Polymeric fibers that are used in medicine can be manufactured by three main 
techniques; melt spinning [2], dry spinning and wet spinning [3].  All those techniques 
are based on an extrusion of a polymer melt or solution. The final properties of the 
produced fibers can be controlled by using different finishing methods for instance 
stretching [4] or drying treatments with different solvents [5]. Besides those main 
techniques, some special methods such as electrospinning [6], gel spinning [7] were 
also used in fiber processing. As we will discuss below, due to the structural 
similarity of electrospun polymeric mats to the natural extracellular matrix, the 
electrospinning process has attracted a great deal of attention in scaffold processing 
for tissue engineering [8]. In a brief, this process is based on the generation of an 
electrical field between a polymeric solution (or a polymer melt) placed in a capillary 
tube with a pipette or needle of small diameter and a metal collector. When the 
electrical field reaches its critical value, repulsive electrostatic force overcomes the 
surface tension of the polymer solution and a charged jet is produced. This charged 
polymeric jet then undergoes a stretching process which is accompanied by the 
rapid solvent evaporation and results the formation of long and thin nano fibers. 
Electrospinning have been used to fabricate nanofibrous structures from a number of 
both natural synthetic polymers, such as collagen[9], chitosan [10] , chitin[11] , silk 
fibroin[12], hyaluronic acid [13] and poly(DL-lactide-co-glycolide) [14], poly(L-lactide) 
[15], and polycaprolactone [16], among many others. Within last few years, these 
nanofibrous structures have been used as a scaffold in many different tissue 
engineering applications.   
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2. Fiber Structures 
Fibers can be manufactured as monofilaments or multifilaments, they find, for 
instance, application as a suture in surgery. Sutures are the oldest and simplest 
example of the textiles used in medicine. They are made of both biodegradable and 
non-degradable polymers, either natural or synthetic origin.  Dexon® (polyglycolide; 
multifilament), Dexon Plus® (polyglycolide, braided), Vicryl® (poly[glycolide-L-
lactide]; multifilament), Maxon® (poly[glycolide-co-trimethylene carbonate]; 
monofilament), Biosyn® (poly[glycolide-co-L-lactide-co-trimethylene carbonate]), and 
PDS® (poly-p-dioxanone; monofilament) are the some examples for commercially 
available biodegradable sutures [17, 18].  
For more complex applications, fibers can also be formed in 3D structures 
such as knitted, braided, woven, and non-woven. The orientation of fibers into these 
structures may range from highly regular to completely random. The final structure of 
the fibers affects the behaviors of the fibers when they are applied. For example, 
woven structures show more stable and porous structure than the other fiber 
structures. As a disadvantage, they can be unraveled at the edges when they cut 
squarely or obliquely for implantation. However, knitted structures have inherent 
ability to resist unraveling when they cut. Moreover, they are very flexible and 
porous. But sometimes their flexibility is reduced when the additional yarns are used 
to interlock the loops in order to obtain more stable structures. Additionally, 
difficulties of reducing their high porosity below a certain value are another clear 
disadvantage for some applications. Braided structures are mostly used as a suture. 
They can be designed using several different patterns, either with or without core. 
The spaces between the yarns, which cross each other, make them porous and help 
the fluid flow during the healing process. Non-woven structures may have a wide 
range of porosity. Their isotropic structure provides good mechanical and thermal 
stability. They can easily compress and expand. These advantages make them a 
suitable material for many tissue engineering applications.    
3. Applications in Tissue Engineering 
Tissue engineering offers a promising new approach to create biological alternatives 
for regenerating different tissues. It involves typically the use of  stem/progenitor 
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cells seeded in a scaffold which can guide the cell growth and tissue formation in 
three dimensions. Several requirements must be considered in the design of tissue 
engineering scaffolds, including high porosity, large surface area, adequate pore 
size, and uniformly distributed interconnected porous structures throughout the 
matrix [19-21].  
Biodegradable polymeric fiber structures can provide a large surface area, 
and a relatively large porosity which can be optimized for specific applications. 
Besides these, many tissues, such as nerve, muscle, tendon, ligament, blood vessel, 
bone, and teeth, have tubular or fibrous bundle architectures and anisotropic 
properties. Therefore, fiber-based structures find a number of applications in tissue 
engineering, including soft tissue repair, vascular prostheses, bone and cartilage 
scaffolds, nerve guides, among others. On the other hand, many parameters must 
be considered in the design of fiber architectures, such as optimal fiber diameter and 
linear density, overall porosity and pore size distribution, influence of fiber orientation 
on cellular response and influence of degradation on the properties of the structures. 
3.1. Soft Tissue Engineering 
Skin Replacement 
Skin is a complex organ and mainly consisting of a superficial and an inner layer 
which are called epidermis and dermis, respectively. It is well known that most 
wounds can heal naturally. However, the replacement becomes a serious problem 
when it is irreversibly damaged by burns, trauma or disease. The most common 
approach for skin replacement is the use of autografts or allografts [22-24]. But they 
have many limitations including the creation of a donor site, risk of infection and slow 
healing. Over the past two decades, tissue engineering approach have been studied 
to construct a three dimensional skin architecture using a temporary scaffold 
combined with fibroblast, keratinocytes and endothelial cells [25, 26].   
Biodegradable fiber-based structures have been proposed to use for healing 
or dermal or epidermal injuries. The most successful fiber-based dermal equivalents 
are the commercialized products Dermagraft® and Dermagraft-TC®. Dermagraft® is 
a structure consisting of fibroblasts, extracellular matrix and a biodegradable fiber 
mesh [27]. In this product, polyglactin (PLGA) mesh is used as a scaffold for 
fibroblasts. The fibroblast proliferated into the scaffolds secrete human dermal 
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collagen, matrix proteins, growth factors and cytokines and create a dermal 
substitute. It has been already applied clinically to the patients with diabetic foot 
ulcers. It was found that healing was faster and better in patients with Dermagraft® 
treatment compared to the control patients (debridement and moist wound healing) 
[28, 29]. Dermograft-TC® is a Silastic covered form of Dermagraft®  and act as a 
non-biodegradable form due to that covering. It has been also apporoved by FDA to 
use as a dermal substitute. More recently, the PLGA knitted mesh has been 
combined with collagen microsponges for three-dimensional culturing of skin 
fibroblast [30]. In this new hybrid approach, the PLGA knitted mesh serves as a 
scaffold to support the forming tissue while collagen microsponges help the new and 
homogenous dermal tissue formation.    
Besides those commercialized synthetic fiber structures, natural fibers, such 
as chitin, chitosan, alginate and a benzyl ester of hyaluronic acid (Hyaff 11®), are 
also proposed for wound healing due to their wound healing ability [31].  For 
instance, Hirano et al. [32] developed a new biocompatible dressing material made 
of wet spun chitin-acid gylcosaminoglycan fibers that released a portion of the 
glycosaminoglycan in the body. Softness and easy handling of these fibers could be 
useful to heal epidermal tissue injuries. 
Engineering of dermal tissue with using a non-woven scaffolds based on a 
benzyl ester of hyaloronic acid has been studied by many researchers [29, 33-35]. In 
order to obtain a nonwoven mesh structure hyaluronan benzyl ester thread is 
produced by phase separation extrusion technology, then cut, carded and needle-
punched. For instance, Tonello et al. [34] studied the co-culturing of fibroblast and 
endothelial cells into a hyaluronan-based fiber mesh to create microcappillary like 
structures in a dermal graft. Such structure could benefit the healing of deeper 
lesions where the tissue vascularization is clearly needed.  
Electrospun nanofibrous mats have been also investigated as novel wound 
dressing material. Nanofiber matrices show high oxygen permeability due to their 
high surface area (ranging 5-100m2/g) which also allows fluid accumulation at the 
wound site. On the other hand, their pore size is small enough to prevent bacterial 
penetration and making them a promis1ing candidate for wound dressing. For 
instance, Katti et al. [36] used electrospining method to produce antibiotic loaded 
Poly(lactide-co-glycolide) nanofibrous membranes for wound healing. Collagen-
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based electrospun mats were also studied for using in tissue engineering 
applications including wound healing [37]. 
Vascular Grafts 
Biomedical textiles can find an application in the cardiovascular area namely as 
vascular grafts. In order to mimic the soft and flexible structure of natural blood 
vessels, they have been used in woven, knitted, or microporous tubular structures. 
Early attempts to develop a vascular graft focused on the use of bypass grafts made 
of nondegradable or degradable synthetic materials. Most used non-biodegradable 
synthetic polymeric fiber structures for this purpose are Dacron® and Teflon® [38-
40]. Later, fiber structures made of biodegradable polymers were applied as a 
temporary scaffold for the regeneration of blood vessels. The first proposed totally 
biodegradable vascular graft was Polyglactin 910 knitted mesh (Vicryl® ) in 1979. 
The woven PGA structures have been also evaluated in a rabbit model, as a 
vascular graft [41].  
After many studies based on directly implantation of biodegradable grafts, 
tissue engineering approaches have been started to be applied to the cardiovascular 
system for namely in the development of a blood vessel substitute. For example, Kim 
et al. [42] studied the use of nonwoven PGA matrices, which were coated with PLLA 
in order to eliminate stability lack of PGA mesh, to design tissue engineering 
constructs. The smooth muscle cells (SMCs) seeded onto these matrices has 
showed high cellular viability and produced high amount of extracellular matrix 
proteins. Others have attempted to utilize surface hydrolyzed nonwoven PGA 
scaffolds for culturing smooth muscle cells [43].  In another study, Shum-Tim et 
al.[44] created a new vascular graft combined of nonwoven PGA mesh and 
biodegradable polyhydroxyalkanoate (PHA) as a inner and outer layer, respectively. 
After one week of culturing a mixed cell population of endothelial cells, smooth 
muscle cells and fibroblasts in these tubular structures, the final construct have been 
implanted into a lamb. It has been observed that these tissue engineered constructs 
could resemble the native aorta and be used as vascular substitutes. In a later study 
, tubular scaffolds have been designed from nonwoven PGA fabrics which were 
coated with a poly(L-lactide-co-caprolactone) (50/50) porous membrane. The 
autografts made of these scaffolds and mixed cells have shown no occlusion or 
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aneurismal formation when they were implanted in dogs. Moreover, a line of 
endothelial cells has been observed at the luminal surface of each autograft. More 
recently, these scaffolds with bone marrow cells have been successfully implanted 
into patients [45].    
In order to mimic natural structure of blood vessels, Xu et al. [46] suggested 
the use of aligned nanofibrous poly(L-lactide-co-ε-caprolactone) scaffolds produced 
by electrospinning, and proposedf these systems to use for blood vessel 
engineering. They have reported that nanofibers could provide aligned attachment 
migration of smooth muscle cells along the axis of nanofibers In addition, it has been 
also found that distribution and organization of smooth muscle cytoskeleton proteins 
inside SMCs were parallel to the direction of the nanofibers.   
Prosthetic heart valves 
The other application of biodegradable polymeric fibers in the cardiovascular field is 
on the tissue engineered of heart valves. The clinically used prosthetic heart valves 
include xenograft valve, mechanical valve and homograft valve. But there are 
limitations as to the long term benefits of these valve prostheses such as poor 
durability, foreign body reaction, infection, anticoagulation problem or donor scarcity. 
Recently, many studies have been undertaken to determine if tissue engineering 
principles could be used to develop valve tissue substitutes. Seeding of human 
fibroblasts, endothelial cells or marrow stromal cells on biodegradable fiber mesh is 
a new approach for the creation of human autologous tissue engineered heart 
valves. Poylglycolide (PGA) non-woven scaffolds are the most widely used materials 
for this purpose [47-49]. In order to improve cell attachment and proliferation, PGA 
and PLA non-woven fiber mesh structures have been coated with poly-4-
hydroxybutyrate and their performance have been tested under dynamical conditions 
[50].  
Stents 
Biodegradable fiber structures have also been proposed for using as a stent [51-54]. 
A stent is a expandable mesh tube which mechanically supports vessels against 
elastic recoil and reduces the restenosis rate in percutanous coronary interventions 
[52]. Biodegradable stents are only used when a temporary airway stenting is 
 9
needed. For instance, Paclitaxel loaded melt extruded poly-L-lactide fibers have 
been tried as a temporary stent [52].  Furthermore, Saito et al. [54] studied a 
biodegradable knitted stent made by poly-L-lactide in rabbit airways. The results 
have showed that the knitted tubular PLLA stents could be used like commercially 
available silicone stents.  Nuutinen et al. [51] developed a biodegradable stent from 
PLLA fibers using a braiding technique. These stents showed the similar radial 
pressure stiffness as compared to commercial metallic stents. They have also 
studied the mechanical properties and in vitro degradation of biodegradable knitted 
stents made of polylactide, poly(L-lactide-co-DL-lactide) and pol(L-lactide-co-
glycolide) fibers [53]. It has been shown that different chemical composition of these 
fiber structures provided for different degradation rates which can be tailored for 
specific applications.  
Nerve Tissue Regeneration  
The nervous system is a complex, sophisticated system that regulates and 
coordinates body activities. It has two major divisions: central nervous system (CNS) 
and peripheral nervous system (PNS). The central nervous system consists of the 
brain and the spinal cord, while the peripheral nervous involves all the nerves that 
branch off from the spinal cord to the extremities. Neurons in central nervous system 
have different characteristics and cannot regenerate by themselves. Therefore, 
restoring their function is a major challenge in neurology. Recently, engineering of 
neural tissue by means of using scaffolds with or without cells become an alternative 
to traditional transplantation methods. For example, Yang et al.[15] developed highly 
porous and fibrous PLLA scaffolds prepared by liquid-liquid phase separation 
methods to be used on nerve tissue engineering. These nanofibrous scaffolds 
showed an ability to support nerve stem cell differentiation and neurite outgrowth.   
In peripheral nervous system, injuries generally affect axons and can be 
regenerated by a variety of methods, depending on how far the stumps are apart 
from each other. To avoid the problems of the autografts and allografts, artificial 
nerve guidance channels have been developed. A nerve guide can be defined as a 
conduit that bridges the gap between the nerve stumps and directs and supports 
nerve regeneration. Most of nerve guides reported in literature have a rigid solid 
structure. Recently, nerve guides based on biodegradable fibers have been studied. 
 10
For instance, Bini et al. [55] fabricated a nerve guide from microbraided poly(L-lctide-
co-glycolide) fibers, which allowed for a good nutrient transfer due to its microbraided 
structure. They observed a successful regeneration in rats after one month of 
implantation. Later, they used the same approach to produce microbraided chitosan 
conduits [56]. However, chitosan based conduits did not show the same success as 
poly(L-lactide-co-glycolide) conduits due to the swelling characteristic of chitosan. A 
nerve guide from poly(L-lactide-co-glycolide) was also fabricated by using a 
electrospinning method [57].    
A nerve guide made of collagen filaments has been proposed as an 
alternative to the tube type nerve conduits [58]. The collagen conduits consisting of 
two thousand collagen filaments showed better regeneration than the collagen tubes 
(as a control) in regeneration of rat static nerve. In another study, synthetic 
biodegradable fibers made of poly-L-lactide have been examined using dorsal root 
ganglia in vitro [59]. PLLA filaments oriented the growth of Schwann cells and 
neuritis along the longitudinal axis of the filament. In addition, it has been observed 
better neurite growth when the filaments were coated with laminin [59]. Steuer et al. 
[60] also studied in vitro axonal outgrowth using polylactide filaments coated with rat 
Schwann cells.  They demonstrated that axonal outgrowth on polylactide sheets 
coated with Schwann cells (+SC) was 15-fold better than that on sheets without 
Schwann cells (−SC). 
As another engineering approach, Cheng et al. [61] have also reported a 
successful axonal regeneration in rats as a result of implantation of a construct 
consisting of Schwann cells seeded on polyglactin 910 fiber scaffolds and 
biomembrane.   
3.2. Hard Tissue Engineering 
Articular Cartilage 
Articular cartilage of the knee is a highly specialized connective tissue responsible 
for cushioning and lubricating. It is an avascular, anueral, alymphatic tissue and 
contains only one cell type, chondrocytes. Due to this avascular and low cellular 
nature, self-healing capacity of articular cartilage is very limited. Various techniques 
for repairing cartilage defects have been developed, including abrasion [62], drilling 
[63], microfracture [64], osteochondral grafting [65] and transplantation of tissue 
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engineering constructs [66-68]. Many different types of polymeric matrices 
with/without cells have been tested in vitro, as well as in experimental animals, and 
in human patients for their ability to promote articular cartilage repair. Recent trends 
are toward to use of fiber based structures for engineering of articular cartilage. Most 
used biodegradable fiber structures are made by poly-α-hydroxy acids and 
hyaluronic acid. In embryonic tissue, hyaluronan is the main component of 
extracellular matrix and plays an important role in chondrogenic condensation during 
limb formation [69]. It has been shown that HA can affect the differentiation of 
chondrocytes [70]. However, HA can not form easily without any modification and 
usually can be modified by means of esterification. As it was previously described, 
Hyaff® is a derivative of HA and is being investigated as a scaffold for articular 
cartilage repair. For example, Brun et al. [71] have compared Hyaff® 7 and Hyaff® 
11 nonwoven meshes which have the same fiber thickness, 20µm, but different in 
vitro and in vivo degradation rates. Chicken embryo chondrocytes seeded in both 
structures maintained their phenotype and secrete ECM for up to 3 weeks of in vitro 
culture. On the other hand, Hyaff®11 nonwoven scaffolds with a slower degradation 
rate promoted a higher cell proliferation rate. They latter reported on the use of 
Hyaff® 11 non-woven scaffolds as a support for mesenchymal progenitor cells which 
produced the main extracellular matrix molecules, accompanied by an occasional 
synthesis of mature type II collagen [72]. Moreover, when those structures were 
implanted in the rabbit knees, with or without cells, there was no inflammatory 
response and they degraded within 4 months after implantation. Other studies with 
human chondrocytes and mesenchymal stromal cells also confirmed that Hyaff® 11 
nonwoven meshes could promote the growth and differentiation of chondrocyte and 
production of collagen type II, aggrecan and downregulate the production of collagen 
type I [73-75].  
Poly-α-hydroxy acid based fibrous matrices have been widely investigated to 
serve as cartilage grafts. For instance, Freed et al. [76-79]have performed several 
studies where they used PGA fiber meshes and freshly isolated chondrocytes to 
investigate the influence of scaffold properties as well as seeding and culture 
methods on the development of cartilage constructions. Ma et al. [80] have also 
investigated ways to engineer the cartilage tissue by seeding articular chondrocytes 
onto polyglycolic acid non-woven scaffolds. They reported that after the aggregate 
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modulus of the engineered cartilage reached 179+9 kPa after 20 weeks of in vitro 
cultivation, which was 40% that of natural articular cartilage.  
In order to provide the ability of the cells to suspend and making it possible to 
distribute cells within the polymeric mesh, synthetic non woven mesh structures have 
been combined with some natural derived materials such as alginate, collagen, and 
fibrin. Using this approach, Ameer at al. [81] have prepared a composite, which was 
composed by a polyglycolide non-woven mesh coated by fibrin gel, for use them in 
meniscal surgery. At 4 weeks in culture, glycosaminoglycan (GAG) content in fibrin 
coated PGA mesh scaffolds has been found to be better than the uncoated PGA 
mesh scaffolds. In another similar study, PLGA meshes with two different 
compositions which are slower resorbing 47.5/52.5 PGA-PLA and faster resorbing 
90/10 PGA-PLA have been combined with chondrocyte suspended alginate gel and 
tested in vitro and in vivo. Both types of coated copolymer pads have shown uniform 
cell distribution and same performance regarding expression of aggrecan, type I 
collagen and type II collagen [82]. However, the construct consisting of 47.5/52.5 
PGA-PLA, alginate and chondrocytes have exhibit a better performance when they 
have been implanted to osteochondral defects of rabbits. It has been also shown that 
alginate stimulates the chondrogenic phenotype of the transplanted chondrocytes 
and prevents cells from floating out of the defects. Other researchers have used type 
I collagen for chondrocyte encapsulation and tried to combine this gel with a 
nonwoven polylactide (PLLA) scaffolds [83]. This method allowed for encapsulating a 
high number of chondrocytes into the scaffolds, quite homogeneously.            
More recently, collagen type I has been also used to create a web-like structures 
within the PLGA knitted meshes in order in order to achieve a uniform cell 
distribution [84]. The bovine chondrocytes seeded on these scaffolds have shown a 
homogenous distribution, maintained their phenotype and regenerated cartilaginous 
matrix filling the void spaces in the scaffolds. To obtain thicker scaffolds, the cell/ 
composite constructs have been laminated or rolled after 1 day of culture and 
implanted subcutaneously in the dorsum of athymic nude mice. In vivo results have 
demonstrated the formation of articular cartilage after 12 weeks of implantation. 
These new approaches have promised to generate structurally regular cartilage.    
The use of biorectors is a great challenge to obtain a homogenous 
scaffold/cell construct for cartilage and bone regeneration. Such systems can 
provide a good nutrient transfer throughout the porosity of the scaffolds which results 
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in a better cell migration and production of extracellular matrix at interior part of the 
scaffolds. These systems have been successfully applied for creating a tissue 
engineered cartilage construct by using fiber based scaffolds. Davisson  et al. [85] 
have been reported the positive effect of perfusion on cell content and extracellular 
matrix production of bovine articular cartilage cultured polyglycolic acid scaffolds. 
The synthesis of sulphated glycosaminoglycan has been found to be 40% higher 
when compared with static conditions. Griffon et al. [86] compared two different 
dynamic culturing techniques for culturing porcine chondrocytes on a scaffold 
composed of polyglycolic acid mesh or chitosan sponge. A better and uniform cell 
attachment has been found where PGA scaffolds used in the vacuum-reactor 
system.  
Finally, within the last few years, biodegradable non-woven nanofibers, which 
are produced by electrospinning, have been started be to used as scaffolds for 
regeneration of cartilage. 3D matrix made of polycaprolactone nanofibers with 
diameter of 700 nm have been proposed as a scaffold for cartilage tissue 
engineering [87]. The primary chondrocytes that were seeded onto these scaffolds 
proliferated and efficiently maintained their differentiated phenotype, as indicated by 
the expression of cartilage-associated genes. In a latter study [88], the same authors 
demonstrated that PCL nanofibrous scaffolds could significantly enhanced the 
chondrogenic differentiation of human mesenchymal stem cells (MSC) compared to 
the cell pellet culture system, which is a widely used culture protocol for studying 
chondrogenesis of MSC. Collagen based nanofibrous scaffolds have been also 
purposed for cartilage tissue engineering. It is well known that collagen is a naturally 
occurring polymer and one of the major components of extracellular matrix of animal 
tissues. It is found in ECM as fibrillar form with a diameter of 50-300nm. It has been 
shown that collagen type II could be electrospun in a nonwoven mats with a fiber 
diameter between 110nm-1.8µm and use as a scaffold for chondrocyte seeding [89].  
Bone  
Bone is a complex, dynamic and highly vascular tissue with a large amount of 
extracellular matrix and limited cell population. As in all tissue engineering fields, 
many researches [90-94] have been carried out to recreate complexity, stability, and 
biologic function of bone tissue. The most common strategy for engineering of bone 
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is to use a scaffold combined with osteoblast or the cells that can 
mature/differentiate into osteoblasts and regulating factors that promote cell 
attachment, differentiation and mineralized bone formation [95]. The requirements for 
the design and production of an ideal scaffold for bone regeneration are very 
complex and not yet fully understood. It is generally agreed that it must be a 
biocompatible, porous (more than 90% and pore sizes between 100-350µm), 
interconnected, and permeable structure to in order permit the ingress of cells and 
nutrients. Clearly, the structures designed with biodegradable fibers can meet all 
these criteria and serve as a scaffold for the engineering of bone. Many different 
fiber-based polymeric matrices have been tested with different cell types to create a 
bone construct. For instance, bone marrow cells seeded in a nonwoven HA 
polymeric scaffold (Hyaff 11) in a mineralizing medium, and basic fibroblast growth 
factor (bFGF) have shown mineralization through the expression of the markers Ca, 
alkaline phosphatese, osteopontin, bone sialprotein and collagen I [96, 97]. Recently, 
Mikos and co-workers [90, 98] have been reported a study where they used 
biodegradable fiber mesh scaffolds to create bone substitutes in dynamic culture 
conditions. In this study, rat bone marrow cells were seeded onto nonwoven poly(L-
lactic acid) scaffolds which was with a thickness of 1.7mm, a volumetric porosity of 
99% and a fiber diameter of 17mm [90]. These constructs have been cultured either 
in a flow perfusion biorector or under static conditions. It has been found that 
nonwoven PLLA scaffolds could support the attachment, growth and differentiation of 
rat bone marrow cells. Moreover, it has been reported that flow perfusion could 
accelerate calcified matrix deposition and provide a homogenous cell distribution 
though the interior part of the scaffold. Gomes, Reis et al. [98] used the same 
approach to culture rat bone marrow cells in starch-based fiber mesh scaffolds. They 
have observed an increased osteogenic differentiation of bone marrow stromal cells 
when they culture on starch-based fiber mesh scaffolds under dynamic conditions. 
They also reported that fiber-based structures were more advantageous than 
extruded porous structures due to their highly interconnected structure which 
provides a homogenous tissue formation.         
Also in our group, we developed chitosan based non-woven structures as 
bone tissue engineering scaffolds, using a traditional wet spinning technique [99]. 
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We demonstrated that chitosan non-woven scaffolds had an ability to support 
osteoblast cell attachment. 
 As a new trend in the tissue engineering field, nanofibrous scaffolds 
produced by electrospining process have been also suggested for bone tissue 
engineering. For example, non-woven polycaprolactone nanofibrous scaffolds have 
been tested with mesenchymal stem cells derived from the bone marrow of neonatal 
rats under dynamic culture conditions [16]. After 4 weeks of culture, it has been 
found that at least the surfaces of the cell-polymer constructs were covered with cell 
multilayers. Additionally, it has been shown that these structures could support 
mineralization and production of type I collagen under dynamic culture conditions. 
However, colonization by cells of 3D electrospun scaffolds is a major problem due to 
the pore size of the scaffolds which is typically less than average cell size.   Li et al. 
[100] have presented the next step in such nanofibrous PCL scaffolds by culturing 
human mesenchymal stem cells that can differentiate adipogenic, chondrogenic, and 
osteogenic lineage in the same matrix. This very promosing result underscores the 
potential of using both stem cell and nanofibers in bone tissue engineering. More 
recently, Jin et al [101] used the electrospinning technique to produce nanofibrous 
fiber mats with average fiber diameter 700±50nm from silk fibroin with PEO. In vitro 
culture studies with human bone marrow stromal cells have shown that these 
matrices, especially after PEO extraction, could support initial cell attachment and 
ingrowth. 
Tuzlakoglu, Reis et al. [102] have suggested a new approach to design a 
structure which combines polymeric micro and nanofibers in the same construct.  
This novel structure is aimed to serve as a scaffold and mimic the physical structure 
of ECM for bone tissue regeneration, but simultaneously still providing the macro 
support that cells do require. Nano and micro fiber combined scaffolds have been 
originally produced from starch based biomaterials by means of a fiber bonding and 
a electrospinning, two step methodology. The cell culture studies with SaOs-2 
human osteoblast-like cell line and rat bone marrow stromal cells demonstrated that 
presence of nanofibers influenced cell shape and cytoskeletal organization of the 
cells on the nano/micro combined scaffolds as well as cell viability and ALP activity.       
Besides the use of polymeric fiber structures as a scaffold, they also find an 
application for a special kind of bone regeneration in dentistry, as a membrane for 
guided tissue regeneration (GTR). These barrier membranes prevent epithelial 
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migration and promote the regeneration of new connective tissue attachment. 
Vicryl® periodontal mesh and Gore Resolut® (composed by polyglycolide fiber and 
trimethylene carbonate) are successfully used for this application [103, 104]. A PLA 
coated knitted PGA mesh was developed and suggested for using as a barrier 
membrane in GTR [105]. Another GTR membrane composed of polycaprolactone 
and calcium carbonate has been developed by Fujihara et al. [106], using again a 
electrospining process. 
Anterior Cruciate Ligament 
Ligaments are bands or sheets of fibrous connective tissue between two or more 
bones, being responsible for providing the motion and stability of joints and 
transmitting the tensile loads in the musculoskeletal system. Ligaments are mainly 
consisting of collagen fibers which are formed into large bundles with specific 
orientation. The anterior cruciate ligament (ACL) connects the femur to the tibia and 
acts as a primary stabilizer of the knee motion. A rupture of the ACL can not heal 
and a surgically reconstruction is required to restore normal joint function. Tissue 
engineering offers a potential technique to design ligament replacement grafts by 
using a biodegradable scaffold with/without cells. An ideal scaffold for ACL must 
provide a high degree of mechanical strength initially and loose its strength by 
gradually degradation while a new tissue is remodelling. Due to the natural structure 
of ACL, collagen-based fiber scaffolds are widely used for ACL replacement [107, 
108]. The mechanical strength and the control of degradation rate of collagen 
scaffolds could be improved by crosslinking for instance with UV or carbodiimide 
(EDC) [108]. However, it has been shown that both crosslinking methods had 
different advantages on with regards to the final mechanical strength and the 
correspondent cell attachment.  Silk is another natural polymer that has been 
proposed for tissue engineering of anterior cruciate ligaments[109]. When they are 
properly prepared, silk fiber matrices, which have good mechanical properties as 
well as biocompatibility and slow degradation, can serve as a suitable matrices to 
support adult stem cell differentiation toward ligament lineages. Hyaluronic acid 
based fibers are another natural origin alternative for ACL replacement.  Cristino et 
al. [110]  have designed a prototype scaffold with a multilayered knitted cylindrical 
array of Hyaff 11 fibers oriented in two directions. They indicated that mesenchymal 
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stem cells grown on these scaffolds could express collagen type I, type III, laminin, 
fibronectin, and actin which are the characteristic markers for the ligament tissue.  
Alternative biodegradable materials in anterior cruciate ligament 
reconstructions are the synthetic polymers, namely polydioxanone, polylactide, 
polyglycolide and their copolymers. These materials have been purposed either as 
an implant for using directly or a scaffold for creating three-dimensional tissue 
engineering constructs. Based on the first approach, commercially available 
polydioxanone (PDS®) has been suggested for ACL replacement [111] . However, 
this material shows very fast degradation that can be a problem for this application. It 
has been reported that PDS loose the half of its tensile strength in about 4-6 weeks, 
whereas the process for replacements can take up to 12 months [112]. A similar 
problem has occurred when braided polyglycolide (Dexon®) ligaments were used for 
the replacement. For example, Cabaud et al. [113] used braided polyglycolide 
(Dexon®) ligaments, which showed 828N max. linear load at 22.6% strain, for the 
repair of ACL of dogs. Although they showed high initial strength, degradation time 
was not long enough to protect the repaired ligament. In a later study, Laitinen et al. 
[114] tested the mechanical properties of braided poly(L-lactide) implants in vitro and 
after subcutaneous implantation in rabbits. These implants have shown a better 
mechanical strength and slower degradation rate than PDS and PGA that would be 
advantageous for reconstruction of ACL. Within the last few years, biodegradable 
synthetic fibers have been formed into 3-D scaffolds for engineering of ACL. Cooper 
et al. have developed a new braiding procedure to create 3-D scaffolds with a 
desired pore diameter, porosity, mechanical properties and geometry from different 
polyesters, namely PLLA, PGA and PLAGA [115, 116]. Although PGA scaffolds have 
showed a highest tensile strength, they have supported lowest level of ACL cell 
attachment and growth compared to PLAGA and PLA due to their fast degradation 
time and released degradation product during cell culture. On the other hand, 
fibronectin coated PLLA scaffold have provide for a better cell viability than PGA and 
PLAGA and maintained their structural integrity and high mechanical properties over 
culturing period [115]. These results confirm that tissue engineering of ACL using 
fiber based scaffolds and ACL cells is a promising approach for ACL reconstruction.  
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4. Conclusions and Future Aspects 
Tissue engineering is a relatively new approach that purposes the regeneration of 
tissues by using stem/progenitor cells and scaffolds or artificial extracellular 
matrices. The design of an ideal scaffold still remains as a problem in most of the 
tissue engineering fields. Although it is specific for each tissue, it is generally agreed 
that biocompatibility, biodegradability, porosity and interconnectivity, as well as 
surface properties are main requirements for an ideal scaffold. Fiber-based 
architectures described in this review seem to be quite promising scaffolds in many 
different tissue engineering applications due to their highly porous and 
interconnected pore structures as well as mechanical strength and structural 
integrity, combined with a large surface area. However, there are still many issues to 
be addressed, including the choice of a proper material, the combination and 
diameter of fibers (distinct for different applications and cell sources), and scaffold 
geometry for each specific application.  
 
 
 
 
 
 
 
 
 
 
 
 
 19
References 
1. King, M.W., Designing fabrics for blood vessel replacement. Canadian Textile 
Journal, 1991. 108: p. 24-30. 
2. Fambri, L., Bragagna, S., and Migliaresi, C., Biodegradable fibers of poly-
L,DL-lactide 70/30 produced by melt spinning. Macromol. Symp., 2006. 234: 
p. 20-25. 
3. Ellis, M.J. and Chaudhuri, J.B., Poly(lactic-co-glycolic acid) hollow fibre 
membranes for use as a tissue engineering scaffold. Biotechnol. and Bioeng., 
2007. 96: p. 177-187. 
4. Solarski, S., Ferreira, M., and Devaux, E., Thermal and mechanical 
characteristics of polylactide filaments drawn at different temperatures. J. 
Textile Institute, 2007. 98(3). 
5. Knaul, J., et al., Improvements in the drying process for wet-spun chitosan 
fibers. J. Appl. Polymer Sci., 1998. 69: p. 1435-1444. 
6. Sell, S., et al., Extracellular matrix regenerated: Tissue engineering via 
electrospun biomimetic nanofibers. Polymer International, 2007. 56: p. 1349-
1360. 
7. Kim, S.-H., et al., Fabrication of a new tubular fibrous PLCL scaffold for 
vascular tissue engineering. J. Biomater. Sci.: Polym. Ed., 2006. 17: p. 1359-
1374. 
8. Ashammakhi, N., et al., Biodegradable nanomats produced by 
electrospinning: expanding multifunctionality and potential for tissue 
engineering. J. Nanosci. and Nanotech., 2007. 7: p. 862-882. 
9. Matthews, J.A., et al., Elelctrospining of collagen nanofibers. 
Biomacromolecules, 2002. 3: p. 232-238. 
10. Ohkawa, K., Cha, D., Kim, H., Nishida, A., Yamamoto, H., Electrospining of 
chitosan. Macromol. Rapid Commun., 2004. 25: p. 1600-1605. 
11. Min, B.M., et al., Chitin and chitosan nanofibers:electrospining of chitin and 
deacetylation of chitin nanofibers. Polymer, 2004. 45: p. 7137. 
12. Jin, H.J., et al., Electrospinning of bombyx mori silk with poly(ethylene oxide). 
Biomacromolecules, 2002. 3: p. 1233-1239. 
13. Um, I.C., et al., Electro-spinning and electro-blowing of hyaluronic acid. 
Biomacromol., 2004. 5: p. 1428-1436. 
 20
14. Li, W., et al., Electrospun nanofibrous structure:a novel scaffold for tissue 
engineering. J. Biomed. Mater. Res., 2002. 60: p. 613-621. 
15. Yang, F., et al., Fabrication of nano-structured porous PLLA sacffold intended 
for nerve tissue engineering. Biomaterials, 2004. 25: p. 1891-1900. 
16. Yoshimoto, H., et al., A biodegradable nanofiber scaffold by electrospining 
and its potential for bone tissue engineering. Biomaterials, 2003. 24: p. 2077-
2082. 
17. Bourne, R.B., et al., In-vivo comprasion for four absorable sutures:Vicryl, 
Dexon Plus, Maxon and PDS. Can. J. Surg., 1988. 31: p. 43-45. 
18. Hong, J.-T., et al., Biodegradable studies of poly(trimethylenecarbonate-
εcaprolactone)- block-poly(p-dioxanone), poly(dioxanone), and poly(glycolide-
ε- caprolactone) (monocryl®) monofilaments. J. Appl. Polymer Sci., 2006. 
102: p. 737-743. 
19. Mikos, A.G. and Temenoff, J.S., Formation of highly porous biodegradable 
scaffolds for tissue engineering. Electronic J. Biotechol., 2000. 3: p. 114-119. 
20. Gomes, M.E., Malafaya, P.B., and Reis, R.L., Fiber Bonding and Particle 
Aggregation as Promissing Methodologies For The Fabrication Of 
Biodegradable Scaffolds For Hard-Tissue Engineering, in Biodegradable 
Systems for Tissue in Engineering and Regenerative Medicine, R.L.R.a.J.S. 
Roman, Editor. 2004, CRC Press: Boca Raton. p. 53-65. 
21. Ikada, Y., Challenges in Tissue Engineering. J. R. Soc. Interface, 2006. 3: p. 
589-601. 
22. Gibbs, S., et al., Autologous full-thickness skin substitute for healing chronic 
wounds. British J. of Dermatology, 2006. 155: p. 267-274. 
23. Cuono, C., Langdon, R., and Mcguire, J., Use of cultured epidermal autografts 
and dermal allografts as skin replacement after burn injury. Lancet, 1986. 1: p. 
1123-1124. 
24. Leigh, I.M., et al., Treatment of chronic venous ulcers with sheets of cultured 
allogenic keratinocytes. 1987. 117: p. 591-597. 
25. Schulz, J.T., Tompkins, R.G., and Burke, J.F., Artificial skin. Annu. Rev. Med., 
2000. 51: p. 231-244. 
26. Bello, Y.M., Falabella, A.F., and Eaglstein, W.H., Tissue-engineered skin: 
Current status in wound healing. 2001. 2: p. 305-313. 
 21
27. Kirsner, S.K., Falanga, V., and Eaglstein, W.H., The development of 
bioengineered skin. Trends in Biotech., 1998. 16: p. 246-249. 
28. Edmons, M.E., Foster, A.V., and Mccolgan, M., "Dermagraft": a new treatment 
for diabetic foot ulcers. Diabet. Med., 1997. 14: p. 1010-1011. 
29. Zacchi, V., et al., In vitro tissue engineering of human skin-like tissue. J. 
Biomed. Mater. Res., 1998. 40: p. 187-194. 
30. Chen, G., et al., Culturing of skin fibroblasts in a thin PLGA-collagen hybrid 
mesh. Biomaterials, 2005. 26: p. 2559-2566. 
31. Miraftab, M., et al., Fibers for wound dressing based om mixed carbohyadrate 
polymer fibres. Carbohydrate Polym., 2003. 53: p. 225-231. 
32. Hirano, S., Zhang, M., and Nakagawa, M., Release of glycosaminoglycans in 
physiologival saline and water by wet-spun chitin acid glycosaminoglycan 
fibers. J. Biomed. Mater. Res., 2001. 56: p. 556-561. 
33. Gallasi, G., et al., In vitro reconstructed dermis implanted in human wounds: 
degradation studies of the HA-based supporting scaffold. Biomaterials, 2000. 
21: p. 2183-2191. 
34. Tonello, C., et al., In vitro reconstruction of human dermal equivalent enriched 
with endothelial cells. Biomaterials, 2003. 24: p. 1205-1211. 
35. Caravaggi, C., et al., HYAFF 11-based autologous dermal and epidermal 
grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a 
prospective, multicenter, controlled, randomized clinical trial. Diabetes Care, 
2003. 26: p. 2853-2859. 
36. Katti, D.A., et al., Bioresorbable nanofiber-based systems for wound healing 
and drug delivery:optimization of fabrication parameters. J. Biomed. Mater. 
Res.Part B: Appl. Biomater., 2004. 70B: p. 286-296. 
37. Huang, L., et al., Engineered collagen-PEO nanofibers and fabrics. J. 
Biomater. Sci.: Polym. Ed., 2001. 12: p. 979-995. 
38. Sipehia, R., et al., Enhanced attachment and growth of human endothelial 
cells derived from umbilical veins on ammonia plasma modified surfaces of 
PTFE and ePTFE synthetic vascular graft biomaterials. Biomat. Artif. Cells 
Immobil. Biotechnol., 1993. 21: p. 465-468. 
39. Vohra, R.K., et al., Fibronectin coating of expanded polytetrafluoroethylene 
(ePTFE) grafts and its role in endothelial seeding. Artif. Org., 1990. 14: p. 41-
45. 
 22
40. Schmidt, S.P., et al., Endothelial cell-seeded four-milimeter Dacron vascular 
grafts:effects of blood flow manipulation through the grafts. J. Vasc. Surg., 
1984. 1: p. 434-441. 
41. Greisler, H.P., et al., Arterial regenerative activity after prosthetic implantation. 
Arch. Surg., 1985. 120: p. 315-323. 
42. Kim, B. and Mooney, D.J., Engineering smooth muscle tissue with a 
predefined structure. J. Biomed. Mater. Res., 1998. 41: p. 322-332. 
43. Gao, J., Niklason, L., and Langer, R., Surface hydrolysis of poly(glycolic acid) 
meshes increases the seeding density of vascular smooth muscle cells. J. 
Biomed. Mater. Res., 1998. 42: p. 417-424. 
44. Shum-Tim, D., et al., Tissue engineering of autologous aorta using a new 
biodegradable polymer. Ann. Thorac. Surg., 1999. 68: p. 2298-2035. 
45. Matsumura, G., et al., Successful application of tissue engineered vascular 
autografts: clinical experience. Biomaterials, 2003. 24: p. 2303-2308. 
46. Xu, C.Y., et al., Aligned biodegradble nanofibrous structure: a potential for 
blood vessel engineering. Biomaterials, 2004. 25: p. 877-886. 
47. Zund, G., et al., Tissue engineering: A new approach in cardiovascular 
surgery; seeding of human fiibroblasts followed by endothelial cells on 
resorbable mesh. Eur. J. Cardiothorac. Surg., 1998. 13: p. 160-164. 
48. Zund, G., et al., The in vivo construction of a tissue engineered bioprosthetic 
heart valve. Eur. J. Cardiothorac. Surg., 1997. 11: p. 493-497. 
49. Hoerstrup, S.P., et al., Tissue engineering of functional trileaflet heart valves 
from humna marrow stromal cells. Circulation, 2002. 106: p. 1143-1149. 
50. Engelmayr, G.C., et al., A novel biorector for the dynamic flexural stimulation 
of tissue engineered heart valve biomaterials. Biomaterials, 2003. 24: p. 2523-
2532. 
51. Nuutinen, J.P., et al., Mechanical properties and in vitro degradation of 
bioabsorbable self-expanding braided stents. J. Biomater. Sci.: Polym. Ed., 
2003. 14: p. 255-266. 
52. Nguyen, K.T., et al., In vitro hemocompatability studies of drug-loaded poly-(L-
lactic acid) fibers. Biomaterials, 2003. 24: p. 5191-5201. 
53. Nuutinen, J.P., et al., Mechanical properties and in vitro degradation of 
bioresorbable knitted stents. J. Biomater. Sci.: Polym. Ed., 2002. 13: p. 1313-
1323. 
 23
54. Saito, Y., et al., New tubular bioabsorbable knitted airway 
stent:biocompatibility and mechanical strength. J. Thorac. Cardiovasc. Surg., 
2002. 123: p. 161-167. 
55. Bini, T.B., et al., Peripheral nerve regeneration by microbraided poly(L-lactide-
co-glycolide) biodegradable polymer fibers. J. Biomed. Mater. Res. PartA, 
2004. 68: p. 286-295. 
56. Bini, T.B., et al., Development of fibrous biodegradable polymer conduits for 
guided nerev regeneration. J. Mater. Sci.: Mater. Medic., 2005. 16: p. 367-
375. 
57. Bini, T.B., et al., Electrospun poly(L-lactide-co-glycolide) biodegradable 
polymer nanofibre tubes for pheripheral nerve regeneration. Nanotech., 2004. 
15: p. 1459-1464. 
58. Yoshii, S. and Oka, M., Peripheral nerve regeneration along collagen filament. 
Brain Res., 2001. 2001: p. 158-162. 
59. Rangappa, N., et al., Laminin-coated poly(L-lactide) filaments induce robust 
neurite growth while proving directional orientation. J. Biomed. Mater. Res., 
2000. 15: p. 625-630. 
60. Steuer, H., et al., Biohybride nerve guide for regeneration: degradable 
polylactide fibers coated with rat Schwann cells. Neurosci. Lett., 1999. 277: p. 
165-168. 
61. Cheng, B. and Chen, Z., Fabrication autologous tissue to engineering artificial 
nerve. 2002, 2002. 22: p. 133-137. 
62. Friedman, M.J., Berasi, C.C., and Fox, J.M., Preliminary results with abrasion 
arthroplasty in the osteoarthritic knee. Clin. Orthop., 1984. 4: p. 200-2005. 
63. Dzioba, R.B., The classsification and treatment of acute articular cartilage 
lesions. Arthroscopy, 1988. 4: p. 72-80. 
64. Blevins, F.T., Steadman, J.R., and Rodrigo, J.J., Treatment of articular 
cartilage defects in athletes: an analysis of functional outcome and lesion 
appearance. Orthopedics, 1998. 21: p. 761-768. 
65. Bobic, V., Autologous osteo-chondral garfts in the managment of articular 
cartilage lesions. Orthopedics, 1999. 28: p. 19-25. 
66. Vacanti, C.A., et al., Synthetic polymers seeded with chondrocytes provide a 
template for new cartilage formation. Plast. Reconstr. Surg., 1991. 88: p. 753–
759. 
 24
67. Zwingmann, J., et al., Chondrogenic differentiation of human articular 
chondrocytes differs in biodegradable PGA/PLA scaffolds. Tissue Eng., 2007. 
13: p. 2335-2343. 
68. Banu, N., et al., Biodegradable polymers in chondrogenesis of human 
articular chondrocytes. 2005. 8: p. 184-191. 
69. Solchaga, L.A., et al., Repair of osteochondral defects with hyaluronan- and 
polyester-based scaffolds. Osteoarthritis Cartilage, 2005. 13: p. 297-309. 
70. Cortivo, R., et al., Hyaluronic acid promotes chick embryo fibroblast and 
chondroblast expression. Cell. Biol. Int. Rep., 1990. 14: p. 111-112. 
71. Brun, P., et al., Chondrocyte aggregation and reorganization into three-
dimensional scaffolds. J. Biomed. Mater. Res., 1999. 46: p. 337-346. 
72. Radice, M., et al., Hyaluronan-based biopolymers as delivery vehicles for 
bone-marrow-derived mesenchymal progenitors. J. Biomed. Mater. Res., 
2000. 50: p. 101-109. 
73. Grigolo, B., et al., Evidence for redifferantiation of human chondrocytes grown 
on a hyluronan-based biomaterail (HYAFF 11): molecular, 
immunohistochemical and ultrastructural analyis. Biomaterials, 2002. 23: p. 
1187-1195. 
74. Lisignolim, G., et al., Cellular and molecular events during chondrogenesis of 
human mesenchymal stromal cells grown in a three-dimensional hyaluronan 
based scaffold. Biomaterials, 2005. 26: p. 5677-5686. 
75. Aigner, J., et al., Cartilage tissue engineering with novel nonwoven structures 
biomaterial based on hyaluronic acid benzyl ester. J. Biomed. Mater. Res., 
1998. 42: p. 172-181. 
76. Blunk, T., et al., Differential effects of growth factors on tissue engineered 
cartilage. Tissue Eng., 2002. 8: p. 73-84. 
77. Freed, L.E., et al., Tissue engineering of cartilage in space. Proc. Natl. Acad. 
Sci. USA 94, 1997. 94: p. 13885-1389. 
78. Vunjak-Novakovic, G., et al., Bioreactor cultivation conditions modulate the 
composition and mechanical properties of tissue-engineered cartilage. J. 
Orthop. Res., 1999. 17: p. 130-138. 
79. Obradovic, B., et al., Integration of engineered cartilage. J. Orthop. Res., 
2001. 19: p. 1089-1097. 
 25
80. Ma, P.X., et al., Development of biomechanical properties and morphogenesis 
of in vitro tissue engineered cartilage. J. Biomed. Mater. Res., 1995. 29: p. 
1587-1595. 
81. Ameer, G.A., Mahmood, T.A., and Langer, R.A., A biodegradable composite 
scaffold for cell transplantation. J. Orthop. Res., 2002. 20: p. 16-19. 
82. Cohen, S.B., et al., The use of absorbable co-polymer pads with alginate and 
cells for articular cartilage repair in rabbits. Biomaterials, 2003. 24: p. 2653-
2660. 
83. Ushida, T., et al., Three-dimensional seeding pf chondrocytes encapsulated in 
collagen gel into PLLA scaffolds. Cell Transplantation, 2002. 11: p. 489-494. 
84. Chen, G., et al., The use of a novel PLGA fiber/collagen composite web as a 
sacffold for engineering of articular cartilage with adjustable thickness. 2003: 
p. 1170-1180. 
85. Davisson, T., Sah, R.L., and Ratcliffe, A., Perfusion increases cell content and 
matrix sythesis in chondrocyte three-dimensional culture. Tissue Eng., 2002. 
8: p. 807-816. 
86. Griffon, D.J., et al., Evaulation of vacuum and dynamic cell seeding of 
polyglycolic acid and chitosan scaffolds for cartilage engineering. Am. J. of 
Vet. Res., 2005. 66: p. 599-605. 
87. Li, W.J., et al., Biological response of chondrocytes cultured in three-
dimensional nanofibrous poly(e-caprolactone) scaffolds. J. Biomed. Mater. 
Res., 2003. 67A: p. 1105-1114. 
88. Li, W.J., et al., A three-dimensional nanofibrous scaffold for cartilage tissue 
engineering using mesenchymal stem cells. Biomaterials, 2005. 26: p. 599-
609. 
89. Matthews, J.A., et al., Electrospining of collagen type II: A feasibility study. J. 
Bioact. Compat. Polym., 2003. 18: p. 125-134. 
90. Sikavitsas, V., et al., Flow perfusion enhances the calcified matrix deposition 
of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. 
Annal. Biomed. Eng., 2005. 33: p. 63-70. 
91. Salgado, A.J., et al., In vivo response to starch-based scaffolds designed for 
bone tissue engineering applications. 2007. 80: p. 983-989. 
92. Morgan, S.M., Tilley, S., Perera, S., Ellis, M.J., Kanczler, J., Chaudhuri, J.B., 
Oreffo, R.O.C., Expansion of human bone marrow stromal cells on poly-(dl-
 26
lactide-co-glycolide) (PDLLGA) hollow fibres designed for use in skeletal 
tissue engineering. Biomaterials, 2007. 28: p. 5332-5343. 
93. Jiang, T., Abdel-Fattah, W.I., and Laurencin, C.T., In vitro evaluation of 
chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds for bone 
tissue engineering. Biomaterials, 2006. 27: p. 4894-4903. 
94. Tuzlakoglu, K. and L., R.R., Formation of bone-like apatite layer on chitosan 
fiber mesh scaffolds by a biomimetic spraying process. J. Mater. Sci.: Mater. 
Med., 2007. 18: p. 1279-1286. 
95. Liu, X. and Ma, P.X., Polymeric scaffolds for bone tissue engineering. Annal. 
Biomed. Eng., 2004. 32: p. 477-486. 
96. Lisignolim, G., et al., Basic fibroblast growth factor enhances in vitro 
mineralization of rat bone marrow stromal cells grown on non-woven 
hyaluronic acid based polymer scaffold. Biomaterials, 2001. 22: p. 2095-2105. 
97. Lisignolim, G., et al., Osteogenesis of large segmental radius defects 
enhanced by basic fibroblast growth factor activated bone marrow stromal 
cells grown on non-woven hyaluronic acid-based polymer scaffold. 2002, 
2003. 23: p. 1043-1051. 
98. Gomes, M.E., et al., Effect of flow perfusion on the osteogenic differantiation 
of bone marrow stromal cells cultured on starch-based three-dimensional 
scaffolds. J. Biomed. Mater. Res. PartA, 2003. 67A: p. 87-95. 
99. Tuzlakoglu, K., et al., Production and characterization of chitosan fibers and 
3-D fiber mesh scaffolds for tissue engineering applications. Macromol. 
Biosci., 2004. 4: p. 811-819. 
100. Li, W.J., et al., Multilineage differantiation of human mesenchymal stem cell in 
a three-dimensional nanofibrous scaffold. Biomaterials, 2005. 26: p. 5158-
5166. 
101. Jin, H.J., et al., Human bone marrow stromal cell responses on electrospun 
silk fibroin mats. Biomaterials, 2004. 25: p. 1039-1047. 
102. Tuzlakoglu, K., et al., Nano- and micro-fiber combined scaffolds: A new 
architecture for bone tissue engineering. J. Mater. Sci.: Mater. Med., 2005. 16: 
p. 1099-1104. 
103. Taddei, P., Monti, P., and Simoni, R., Vibrational and thermal study on the in 
vitro and in vivo degradation of a bioresobable periodontal membrane: Vicryl 
periodontal (polyglactin 90). J. Mater. Sci.: Mater. Med., 2002. 13: p. 59-64. 
 27
104. Soncini, M., et al., Experimental procedure for the evaluation of the 
mechanical properties of the surrounding dental implants. Biomaterials, 2002. 
23: p. 9-17. 
105. Park, Y.J., et al., Porous poly(L-lactide) memranes for guided tissue 
regeneration and controlled drug delivery:membrane fabrication and 
characterization. J. Control Rel., 1997. 43: p. 151-160. 
106. Fujihara, K., Kotaki, M., and Ramakrishna, S., Guided bone regeneration 
membrane made of polycaprolactone/calcium carbonate composite nano-
fibers. Biomaterials, 2005. 26: p. 4139-4147. 
107. Chvapil, M., et al., Collagen fibers as a temporary scaffold for replacement of 
ACL in goats. J. Biomed. Mater. Res., 1993. 27: p. 313-325. 
108. Caruso, A.B. and Dunn, M.G., Changes in mechanical properties and 
cellularity during long-term culture of collagen fiber ACL reconstruction 
scaffolds. J. Biomed. Mater. Res., 2005(73A): p. 388-397. 
109. Altman, G.H., et al., Silk matrix for tissue engineered anterior cruciate 
ligaments. Biomaterials, 2002. 23: p. 4131-4141. 
110. Cristino, S., et al., Analysis of mesenchymal stem dimensional HYAFF 11 (R)-
based cells grown on a prototype ligament scaffold. J. Biomed. Mater. Res., 
2005. 73A: p. 275-283. 
111. Puddu G, C.M., Cerullo G, Franco V, Gianni E, Anterior cruciate ligament 
reconstruction and augmentation with PDS graft. Clin. Sports Med., 1993. 12: 
p. 13-24. 
112. Buma, P., et al., Augmentation in anterior cruciate ligament reconstruction-a 
histological and biomedical study on goats. Int. Orthoped., 2004. 28: p. 91-96. 
113. Cabaud, H.E., Feagin, J.A., and Rodkey, W.G., Acute anterior cruciate 
ligament injury and repair reinforced with a biodegradabel intraarticular 
ligament: experimental studies. Am. J. Sports Med., 1982. 10: p. 259-264. 
114. Laitinen, O., et al., Mechanical properties of biodegradable ligament 
augmentation device of poly(L-lactide) in vitro and in vivo. Biomaterials, 1992. 
13: p. 1012-1016. 
115. Lu, H.H., et al., Anterior cruciate ligament regeneration using braided 
biodegradable scaffolds: in vitro optimization studies. Biomaterials, 2005. 26: 
p. 4805-4816. 
 28
116. Cooper, J.A., et al., Fiber-based tissue-engineered scaffold for ligament 
replacement: design considerations and in vitro evaluation. Biomaterials, 
2005. 26: p. 1523-1532. 
 
 
Polymer granules
extruder
filter
spinneret
Cooling 
by air stream
Initial take-up rolls
drawing
bobins
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               No amount of experimentation can ever prove me right;  
               a single experiment can prove me wrong.  
                                                                                    Albert Einstein 
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I. Materials: 
The materials used in the studies described in the present thesis were the 
following: 
A. Chitosan 
The chitosan used in the studies of the present thesis was a medium molecular 
weight with a deacetylation degree of 87%. It was obtained from Aldrich 
Chemical Co. 
Chitosan is a deacetylated derivative of chitin which is the second most 
abundant natural biopolymer after cellulose, being commonly found in shells of 
marine crustaceans and cell walls of fungi [1]. It is a linear polysaccharide, 
composed of glucosamine and N-acetyl glucosamine linked in a β(1-4) manner. 
(Figure 1). 
 
 
 
 
 
Figure 1. Chemical structure of chitosan  
The degree of deacetylation of chitosan refers to the ratio between 
glucosamine and N-acetyl glucosamine.  Depending on the source and 
preparation procedure, its molecular weight may range from 300 to over 
1000kDa with the degree of deacetylation from 30% to 95%. Chitosan is typically 
not soluble in aqueous solutions above pH 7. However, chitosan solutions can be 
obtained in dilute acids which protonates amino groups on glucosamine, 
rendering the polymer positively charged. Above the pH 6.2, the chitosan solution 
shows a gel-like precipitation due to the neutralization of free amine groups and 
the consequent removal of repulsive interchain electrostatic forces which allows 
for hydrogen bonding and hydrophobic interaction between chains. This 
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behaviour of the chitosan allows for the wet spinning (which is based on 
solution/precipitation) of the polymer  
B. Starch/Polycaprolactone Blend 
In the present studies, a starch/polycaprolactone (30/70 wt/wt) blend was used 
for the production of the fibers.  
Starch is a natural polymer which occurs widely in plants such as corn, 
potato and rice. It consists of two types of molecules, amylose and amylopectin 
(Figure 2). Amylose is a linear polymer and makes up about 20% wt of the 
starch. The other component, amylopectin, has a branched structure and made 
up about 80% of the starch. The relative proportions of amylose to amylopectin 
depend on the source of the starch [2].  
   
 
 
 
 
  
 
 
Figure 2. Chemical structure of starch.  
Starch is an inexpensive, totally biodegradable polymer found in a wide 
variety of environments and used in many industrial applications, mainly as a raw 
material for packaging. However, starch itself has poor mechanical properties 
and it is difficult to process. Moreover, pure starch articles and even those 
derived from the so-called thermoplastic starch (starch with disrupted granular 
structure), are usually brittle and moisture sensitive, thus strongly limiting their 
potential fields of application. To overcome this problem, starch can be blended 
with different polyesters such as polycaprolactone, polylactide, etc [3, 4]. 
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In the present studies, the synthetic part of the used blend was 
polycaprolactone which is a biodegradable polyester synthesized by a ring 
opening polymerization of a cylic lactone monomer (i.e. ε-caprolactone) (Figure 
3).  
 
 
 
 
Figure 3. Chemical structure of polycaprolactone.  
It is a hydrophobic and a semicrystalline polymer with a glass transition 
temperature about -60°C. High permeability of polycaprolactone to various 
substances makes it capable for long-term implantable drug delivery 
applications. However, it shows slower in vivo degradation than poly(α-hydroxy 
acids). It has been reported that the biodegradation rate of PCL can significantly 
increase in the presence of starch [5]. 
C. Bioglass® 
Bioglass® with a particle size of 5µm was supplied by US Biomaterials Corp. 
(Florida, USA), being used in biomimetic coating studies as a nucleation-inducing 
agent.  
II. Production Methods 
A. Wet Spinning 
Wet spinning is the oldest method of fiber spinning. This process is based on 
solution/precipitation. Basically, the polymer is dissolved in a suitable solvent. 
After passing through the spinneret, the solution enters into a coagulation bath. 
Either the bath reacts chemically to coagulate the polymer, or it draws out the 
solvent from the polymer stream so that the filament can harden. In most cases, 
the second liquid is aqueous. A main difference between wet spinning and either 
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melt or dry spinning is that one is spinning into a fluid with a much higher 
viscosity. Due to this higher viscosity, higher shearing stress occurs on fiber 
surfaces which introduce very high tension into the filaments. Figure 4 shows the 
schematic presentation of the production of wet spun fibers in large scale. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Schematic diagram of wet-spinning process. 
The extrusion may be out directly into the coagulating liquid or through a 
small air-gap. In the second case it is known as dry-jet wet spinning or air-gap 
wet spinning.   
Wet spinning method is mostly used to produce fibers from natural 
polymers, such as chitin and chitosan fibers which can not be formed by either 
melt or dry spinning methods. The strong inter-chain forces as derived from the 
hydroxyl, acetamido and amino groups, raise the melting point of chitin and 
chitosan to well above their thermal degradation temperatures. Therefore, melt 
spinning is typically not possible for chitin and chitosan. Besides that, these two 
natural polymers can only be dissolved in polar solvents which have high boiling 
points. As a consequence, dry spinning is also not practical for producing chitin 
and chitosan fibers.  
In the studies described in present thesis, the wet spinning technique was 
used to produce chitosan fibers and fiber mesh scaffolds, as well as SPCL fiber 
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mesh scaffolds. Figure 5 shows the schematic representation of the production of 
chitosan fibers and fiber mesh scaffolds.  
 
 
 
 
 
 
 
 
 
Figure 5. Shematic representation of the production of chitosan fibers and fiber 
mesh scaffolds.  
Briefly, chitosan was dissolved in aq. 2% (v/v) acetic acid solution in 5% 
(w/v) concentration at room temperature overnight. Methanol was added to dilute 
the viscous solution for easy injection until reaching 3% (w/v) final concentration. 
Glycerol was used as a plasticizer (2.5% (w/w)). After filtration with a cloth filter, 
the solution was placed in an ultrasonic bath to remove the air bubbles. The clear 
solution was injected into a coagulation bath (30% 1N Na2SO4, 10% 1N NaOH 
and distilled water) by using a syringe pump (Word Precision Instruments, UK). 
The formed fibers were kept in this coagulation medium for one day and then 
washed several times with distilled water. In the case of chitosan fibers, they 
were suspended in an aq. 30% methanol for 4-5h and subsequently in aq. 50% 
methanol overnight. The filaments are then the wounded onto a cylindrical mould 
and dried at room temperature. In order to obtain fiber meshes, the suspended 
fibers were treated with aq. 50% methanol and 100% methanol for 1 and 3 h 
respectively. The fibers were then put in a plastic cylindrical mould and dried at 
60°C overnight.  
The fiber mesh scaffolds from SPCL were also prepared by wet spinning 
technique. In this case, the polymer solution with a high viscosity (40% (w/v)) 
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was prepared by dissolving SPCL in chloroform. The homogenous polymer 
solution was subsequently extruded into the coagulation bath containing 
methanol. The high viscosity of the polymer solution and high extrusion rate were 
chosen to provide the fall of the polymer solution stream to the bottom of the 
bath. This approach allowed to form 3-D scaffolds in the bottom of the 
coagulation bath by means of a random movement. The scaffolds were kept in 
the bath until coagulation is completed and dried at room temperature to remove 
the remaining solvents 
B. Electrospinning 
Electrospinning is another fiber processing method which allows to obtain 
submicron size fibers (below 3nm) from a polymer solution or melt. This process 
is based on an electrostatic potential (typically up to 30kV) that is applied 
between a spinneret and a collector [6]. Both the spinneret and the collector must 
be electrically conductive and separated at a distance of around 10-25cm. In a 
typical electrospinning process, a fluid is slowly pumped through the spinneret. 
This fluid is usually a solution, whereby the solvent can evaporate during the 
spinning process. The spinning of the polymeric melt is more complicated due to 
the fast solidification process under a dynamic spinning condition at high 
temperatures and usually does not allow for the forming of uniform submicron-
sized fibers. The electrical charge is subjected to the spinneret tip that contains 
the fluid droplet held by its own surface tension. As the intensity of electrical 
charge increases, the polymer droplet becomes as a conical shape, known as 
the Taylor cone [7]. When the surface tension of the fluid can be overcome, the 
droplet becomes unstable and charged jet fluid is ejected from the tip. This 
charged jet then goes to a stretching process that leads the formation of nano-
size fiber by evaporation of the solvent. In the case of polymer melt the 
discharged jet solidifies during the travel in the air.  The final fiber diameter 
depends on various parameters, including applied voltage, the distance between 
the tip and the collector, used solvent, concentration of the polymer solution, etc 
[8]  
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In the present thesis, electrospinning was used for the development of 
nano- and micro-fiber combined scaffolds as described in detail in Chapter VI. In 
brief, the polymeric solution with a concentration of 10% was prepared by 
dissolving starch/polycaprolactone (SPCL, 30/70) in a solvent system consisting 
of chloroform and dimethylformamide (DMF) with a ratio of 7/3, respectively. 
Dimethylformamide was used to enhance the conductivity of the polymer solution 
for this process. Electrospinning apparatus used in the study is presented 
schematically in Figure 6. 
 
 
 
 
 
 
 
Figure 6. Experimental set-up for electrospinning of SPCL nano-fibers onto SPCL 
micro-fiber meshes. 
The polymer solution was vertically placed in a simple capillary tube. 
SPCL scaffolds produced by fiber bonding method were put onto a special 
design metal collector which is movable through the electrospun polymeric jets. 
The distance between the tip of capillary and collector was adjusted to 10 cm. A 
high voltage of 15kV was applied by a high voltage supplier (Gamma High 
Voltage, USA) for 10s. The time was selected by considering the proportion 
between the spinning time and the amount of electrospun nano-fibers. The final 
constructs were allowed to dry overnight at room temperature. 
C. In vitro Bioactivity Testing and Biomimetic Coatings 
C. 1. In vitro Bioactivity 
In vivo bioactivity of a material can be predicted by assessing the bone-like 
apatite formation on its surface in simulated body fluid (SBF) in vitro. The 
 37
bioactivity test for the chitosan fibers was carried out with the use of standard in 
vitro procedure described by Kokubo et al. [9]. The ion concentrations of SBF 
solution used in this study were similar to human blood plasma as presented in 
Table 1.  
 
Table 1. Ion concentrations of human blood plasma and SBF. 
Solution                                           Concentrations (mM) 
                              Na+      K+      Ca +     Mg2+      Cl-      HCO3-     HPO42-     SO42- 
Human plasma     142       5        2.5       1.5        103         27         1.0           0.5 
SBF (1.0x)            142       5        2.5       1.5        142.8     4.2         1.0           0.5 
 
In order to perform the bioactivity test, chitosan fibers were immersed in 
SBF solution and incubated at 37°C during 30 days. The fibers were removed 
and washed carefully with distilled water at different time intervals (3, 7, 14, 30 
days). They were then dried at room temperature before analysis.  
C. 2. Biomimetic Coating 
When a material is not bioactive or showing delayed bioactivity, a biomimetic 
coating approach can be used to obtain a bone-like apatite layer on its surface 
before in vivo implantation. Different functional groups can be introduced on to 
the materials surfaces, such as Si-OH, Ti-OH and carboxyl or carboxylate [10]. In 
the present thesis, Bioglass® was used to introduce functional Si-OH groups on 
the chitosan fiber mesh scaffolds.  
Regarding the biomimetic coating experiments, an innovative and simple 
Bioglass® spraying method was developed in order to obtain Ca-P layers on the 
scaffolds. The spraying approach was chosen to have a homogenous distribution 
of the Bioglass® particles on the complex fiber mesh structure. Figure 7 presents 
schematically the experimental procedure followed in this study. In brief, the 
Bioglass® particles were suspended in ultra-pure water and the suspension was 
placed into a simple container with a spray. The chitosan scaffolds were wet with 
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this suspension in all sides and dried under air flow before immersion in SBF(x) 
solution in polyethylene tubes at 37°C. The solution and the tubes were renewed 
the following day. After 7 days of immersion, the samples were removed from the 
solution, washed several times with distilled water and dried at room temperature 
before analysis.  
 
 
 
 
 
Figure 7. Schematic representation of a novel biomimetic coating process using 
Bioglass/water suspension. 
 
The mechanism of Ca-P formation by this method is given in Figure 8.  
 
 
 
 
Figure 8. The mechanism of Ca-P formation on chitosan fiber meshes immersed 
in SBF solution after Bioglass spraying. 
D. Plasma Treatment 
Plasma treatment, using different inert gases or monomers, is one of the most 
commonly used techniques for surface modification of the materials. As it is 
discussed in Chapter V, Ar plasma treatment was applied to wet-spun SPCL fiber 
mesh scaffolds to enhance the cell attachment and proliferation capability on 
them. The plasma reactor (Gala Instrument GmbH, Germany) used in this study 
allows for a fully automated process and has a control reactor with a chamber 
CaO-SiO2 
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size of 15 cm diameter and 31 cm length (5L). The scaffolds were hanged onto a 
metal wire with a distance of 1cm between them and then placed into the 
chamber. The air present in the system was first displaced with argon, by 
flushing argon through the reactor. The outlet was then closed, and the reactor 
was filled with argon with a controlled pressure of 0.18 mbar. The power of the 
plasma was set at 30W and the scaffolds were exposed to plasma for 15 min. In 
the end of this period, they were kept at ambient conditions before using in 
further studies. 
III. Characterization Methods for the Developed Structures: 
A. Morphology  
Morphologies of the scaffolds developed in the studies were analyzed under an 
optical microscope and a scanning electron microscope (SEM). In order to 
examine the nanofiber amount and distribution on the developed nano- and 
micro-fiber combined scaffolds, both sides of the samples were observed under 
an optical microscope (Olympus, MIC-D). Light transmission microscopy images 
were taken for HA/chitosan multichannel structures in order to see the placement 
of the components within the structure. SEM (Leica Cambridge S360 
microscope) was used for all developed scaffolds to analyze the overall structure 
as well as the surfaces. All the samples were sputtered coated with gold and the 
analysis were performed at an accelerating voltage 15 kV and magnifications 
between 15-5000 times. 
In the case of wet spun starch-based fiber meshes, a µCT imaging system 
(µCT40, Scanco Medical AG, Bassersdorf, Switzerland) with a nominal resolution 
of 12 µm was also used to determine the mean pore size, total porosity, surface-
to volume ratio, mean fiber diameter of the wet-spun SPCL fiber mesh scaffolds. 
The reconstructed images were filtered using a constrained 3D Gaussian filter to 
partially suppress noise in the volumes (σ = 1.2 voxel, support = 1 voxel), and 
binarized using a global threshold. Standard 3D morphometry as developed for 
trabecular bone was used to assess structural parameters for the scaffolds. Pore 
 40
size and fiber thickness were determined using the distance transformation 
method. In this method, each pore (fiber) is filled with a non-redundant set of 
maximal spheres. Mean pore (fiber) size was then calculated as the volume-
averaged diameter of all spheres making up the pore (fiber).  
B. Surface Analysis 
B. 1.  Energy Dispersive Spectroscopy (EDS):  
Energy Dispersive Spectroscopy (EDS) is an analytical technique that is used to 
identify the elemental composition of the specimen. It is based on utilization of x-
rays that are emitted from the specimen when bombarded by the electron beam 
of SEM. In the present thesis, EDS technique was employed to determine Ca 
and P elements on the surface of the samples after either bioactivity test or 
biomimetic coating. All the samples were coated with carbon by ion sputtering 
before analysis.  
B. 2.  Fourier Transform Infrared Attenuated Total Reflectance 
Spectroscopy (FTIR-ATR): 
Fourier transform infrared attenuated total reflectance spectroscopy (FTIR-ATR) 
was used to evaluate the presence of Ca-P bioactive layer on chitosan fiber 
mesh scaffolds after biomimetic coating. FTIR spectra were recorded at least at 
32 scans with a resolution of 2cm-1 in a FTIR spectrophotometer (Perkin Elmer 
System 1600) with an attenuated total reflectance device from SPECAC (MKII 
Golden Gate, diamond crystal, penetration depth 20µm, active area 0.8 mm2).  
B. 3.  Thin film X-Ray Diffraction (TF-XRD) 
X-ray diffraction technique (XRD) is used to provide information on structure, 
phases, crystal orientation and other structural parameters such as crystallinity, 
strain, and crystal defects for the crystalline materials. In this thesis, TF-XRD 
(Philips X'Pert MPD, The Netherlands) was utilized for identifiying the crystalline 
phases present, and characterizing the crystalline/amorphous nature of the 
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formed Ca-P layer on chitosan fiber mesh scaffolds after biomimetic coating. The 
data collection was performed by 2θ  scan method with 1º as incident beam 
angle using CuKα X-ray line and a scan speed of 0.05º/min in 2θ. 
B. 4. X-Ray Photoelectron Spectroscopy (XPS) 
XPS is used in major and minor elemental identification and chemical bonding 
information at the surface. It provides information about elemental composition of 
the surface approximately the top 100 Å. 
 In Chapter V, XPS analysis was performed to determine the chemical 
changes on the surface of SPCL wet-spun fiber mesh scaffolds after plasma 
treatment, using an 250 iXL ESCA instrument (VG Scientific) equipped with two 
X-Ray sources: a source with Al Ka1,2 monochromatized radiation at 1486.92 eV 
and another one (Dual) equipped with two anodes: Mg and Al. Further details of 
the analysis are discussed in Chapter V.  
C. Inductively Coupled Plasma- Optical Emission Spectroscopy (ICP-OES) 
One possible way to follow Ca-P layer formation during bioactivity test is to 
measure the changes in Ca and P ion concentration of SBF solution. In the case 
of bioactivity test for chitosan fibers, the immersion solutions were analyzed after 
each time interval by Inductively Coupled Plasma- Optical Emission 
Spectroscopy (ICP-OES, JY 70 plus, Jobin Yvon, France).   
D. Swelling test 
The swelling ratios of samples were determined in 0.154M NaCl aqueous 
isotonic saline solution (pH=7.4) at 37°C. The immersed samples were taken out 
from the solution at various time intervals, and wet weight of the samples were 
determined by blotting them with filter paper to remove the excess water on the 
surface  and then immediately weighing on an analytical balance. The 
experiment was continued until reaching of an equilibrium value. The equilibrium 
swelling percentage of samples was calculated as follows: 
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S%= (mw-mi)/mi x 100 
where S% is the percentage of swelling, mw  donates the swollen weight of the 
samples and mi is the initial weight of the sample. Five samples were used for 
each experiment and the average values were taken as the swelling percentage.  
E. Mechanical Analysis 
E. 1. Tensile test 
The stress-strain curve of developed chitosan fibers was recorded on a Universal 
Mechanical Testing machine (Lyloyd Instruments, LR %K Serensworth Fareham, 
England) at room temperature and under room humidity. The measurements 
were performed with a 500N load cell. The crosshead speed and the gauge 
length were set to be 20mm/min and 20mm, respectively. Average values of 
tensile strength and maximum strain were determined after repeating the test for 
five samples. 
E. 2. Dynamical Mechanical Analysis (DMA) 
Dynamical Mechanical Analysis (DMA) provides information about the stiffness 
and damping properties of the materials. DMA is the most sensitive technique for 
monitoring relaxation event as the mechanical properties change dramatically 
when relaxation behaviour is observed. 
In the present thesis, this technique was used to analyze short-time swelling, 
creep and rheological behaviour of chitosan fiber mesh scaffolds. All the 
experiments were carried out while the samples were in an isotonic saline 
solution in a DMA7e Perkin-Elmer apparatus, in compression mode, using 
parallel plates with 10mm diameter. The details for each kind of measurements 
are given in Chapter III. 
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IV. In Vitro Cytotoxicity and Cell Culture Studies 
A. Cell type 
A.1. Cell lines: Mouse lung fibroblast cell line (L929) and a human 
osteoblast-like cell line (SaoS-2) 
Cell lines can be easily maintained in culture and employed in the experiments 
which are conducted outside of the living system or the host body. In the present 
studies, mouse lung fibroblast cell line (L929) was selected for use in cytotoxicity 
tests. Cell culture studies on the developed scaffolds were performed by using a 
human osteoblast-like cell line (SaoS-2).   
A. 2.  Rat Bone Marrow Stromal Cells (isolation) 
Although the cell lines are quite useful to test the tissue engineering scaffolds in 
vitro, they have major limitations for the use in vivo. The use of primary cells 
appears to be a more realistic approach for tissue engineering.  
Based on this fact, rat bone marrow stromal cells were also used in some part of 
the cell culture studies. Rat bone marrow stromal cells were isolated from 4 
weeks-old male Wistar rats (Charles River, Spain). Surgical procedure was as 
follows: The rats were euthanized by placing them in a plastic bag in CO2  
atmosphere. Their femurs and tibia were excised under aseptic conditions and 
washed within α-MEM (Eagle, Sigma, St. Louis, MO) containing 10 times more 
amount of normal antibiotics concentrations. Soft tissues were removed from the 
bones and their epiphyses were cut off and the marrow residing in the midshaft 
was flushed out with 5ml of complete medium (α-MEM containing 10% foetal 
bovine serum (FBS, Biochrome), 50 µg/ml ascorbic acid (Sigma), 50 µg/ml 
gentamycin, 1% antibiotics, 100mM β-glycerolphosphate (Sigma) and 10-8 M 
dexamethasone (Sigma) using a syringe and collected in a 50 ml sterile 
centrifuge tube. Then, the cells were put in a culture flask and cultured at 37°C in 
a humidified atmosphere containing 5% CO2. These primary cultures were 
incubated for 2 days. After 2 days of incubation, hematopoietic and other 
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unattached cells were removed from the flasks by repeated washes with PBS 
and the complete medium of the flasks was renewed every other day until 
reaching confluency.     
B. Indirect Cytotoxicity Evaluation 
Cytotoxicity test is a first step towards screening the biocompatibility of a 
biomaterial. Indirect cytotoxicity tests are a rapid, standardized, sensitive, and 
inexpensive method to determine whether a material contains significant 
quantities of biologically harmful extracts. 
In the present thesis, a mouse lung fibroblast cell line (L929) was used in 
the cytotoxicity assessment to comply with the ISO/EN 10993-5 standard test 
method [11].  This standard test method is based on exposing the cells to the 
fluid extract of the test material and control materials. Ultra High Molecular 
Weight Polyethylene (UHMWPE) and latex rubber were used as negative and 
positive control, respectively. The extracts were obtained by placing the test and 
control materials (n=3) in cell culture medium (2.5cm2/ml or 0.2/ml) for 24 hours 
at 37°C under constant agitation.  In the end, the extract fluids were filtered 
(45µm of pore size). Each fluid extract obtained were then applied to cultured-cell 
monolayer, replacing the medium that had nourished the cells to that point, and 
incubated for 72h at 37°C in a humidified atmosphere containing 5% of CO2.  
Cells were then observed morphologically under a light microscope in response 
to the test and control materials’ extraction fluids. A score for confluency of the 
monolayer, degree of floating cells and change of cellular morphology was then 
calculated based on the values given in Table 1.  
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Cytotoxic Response Reactivity Pass/Fail 
0-1 None Pass 
1-3 Slight Pass 
3-5 Mild Retest 
5-7 Moderate Fail 
7-8 Severe Fail 
Table 2. Quantitative and qualitative scores used in the cytotoxicity tests. 
 
 
In the end of the test, cells were trypsinized and the percentage of growth 
inhibition was determined through trypan blue exclusion test. The final cytotoxic 
indexes of the samples were then obtained by combining all the scores. The 
scores used in the test are given in Table 3.  
 
Table 3. Different cytotoxicity indexes used to classify the reactivity of tested 
samples. 
 
 
 
 
 
 
 
 
 
 
Score 
Confluency  
(%) 
Floating cells 
(%) 
Change of cellular 
morphology 
Inhibition of cell 
growth 
 (%) 
0 100 0 No changes during test period 0-10 
1 90-100 0-5 Slight changes, few cells affected 10-30 
2 60-90 5-10 
Mild changes, some 
cells round/spindle 
shaped 
30-50 
3 30-60 10-20 
Moderate changes, 
many cells 
round/spindle 
50-70 
4 0-30 > 20 
Severe changes, 
about all cells show 
morphological 
changes 
70-100 
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C. Cell seeding and culture on the developed scaffolds  
In order for a scaffold to be considered successful, it should support to cells 
which are already seeded into the scaffolds prior the implantation, as well as the 
cells that might migrate into the scaffolds from the host.  
 To evaluate the cell supporting ability of the scaffolds developed in this 
thesis, a direct contact method was used. The parameters for the different 
scaffolds were given in Table 4. All the scaffolds were incubated with a culture 
medium without serum overnight prior to cell seeding. The determined number of 
cells was suspended in a low amount of culture medium (50-300µl) and the 
suspension was then dropped over the scaffolds carefully. After 1.5h incubation, 
1-3 ml (depending on the culture well used) of medium was added up to each 
well. All the experiments were performed at 37°C with 5% CO2 in humidified 
atmosphere with medium changes every 2-3 days.  
 
Table 4. The parameters used in cell culture experiments for different scaffolds. 
 
 
 
Scaffold Dimensions Cell type
Number of 
cells seeded 
per scaffold 
Culture Medium Culturing time intervals (days) 
SPCL 
 nano- and 
micro- fiber 
combined  
φ= 0.8cm, 
h= 1.5 mm 
 
 
SaOs-2 
 
 
 
 
 
RBMSc 
 
 
 
 
 
    3x105 
 
 
 
 
 
    3x105 
 
DMEM low glucose 
with 10% FBS, 
1%antibiotics/antimicotics 
 
α-MEM 
with 10% FBS, 
1%antibiotics/antimicotics 
10-8 dexamethasone, 
10mM βglycerophosphate 
 
7 and 14 
 
 
 
 
 
7 and 14 
 
 
 
Ca-P coated 
chitosan fiber 
meshes 
φ= 1 cm, 
h= 1 cm SaOs-2 2x10
6 
DMEM low glucose  
with 10% FBS, 
1%antibiotics/antimicotics 
14 and 21 
Wet-spun 
SPCL fiber 
meshes 
φ= 0.8 cm, 
h= 1mm  SaOs-2 3x 105 
DMEM low glucose  
with 10% FBS, 
1%antibiotics/antimicotics 
7 and 14 
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D. Characterization 
D. 1. Cell Morphology 
The morphology of the cells cultured on the developed scaffolds were examined 
with scanning electron microscopy (SEM, Leica Cambridge S360) at 15 V. After 
each time interval, cell/scaffold constructs were fixed with 2.5% glutaraldehyde 
for 30 min and washed excessively with PBS. They were then dehydrated 
through graded series of ethanol, dried and mounted onto brass stubs. Before 
the analysis, all the samples were sputtered coated with gold.    
D. 2. Cell viability and proliferation 
D. 2. 1. MTS 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymetyhoxyphenyl)-2(4-sulfophenyl)-
2H tetrazolium) is a substrate that is converted by NADPH or NADP produced by 
dehydrogenase enzymes in metabolically active cells to yield a brown formazan 
product . The intensity of the colour is directly related to the number of viable 
cells, and thus their proliferation in vitro. Cell viability on the scaffolds after 
different time intervals was determined by using Cell Titer 96® Aqueous One 
Solution Cell Proliferation Assay kit (Promega, USA). According to the standard 
procedure, the triplicates of the samples were washed with sterile PBS and 
placed in new culture wells. Fresh medium without phenol red and MTS reagent 
were added to each well in 5/1 ratio. The reaction was carried out by incubating 
the cell/scaffold constructs with this medium for 3h at 37°C in a humidified 
atmosphere containing 5% of CO2.  In the end of the reaction, 100 µl of incubated 
medium was transferred to 96-well plate and optical density was read at 490nm 
in a micro-plate reader (Synergy HT, Bio-tek). The results are expressed as the 
average absorbance of triplicate samples.     
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D. 2. 2. DNA 
DNA assay is one of the most used measurements to evaluate cell proliferation 
by quantifying DNA content of cells cultured on the scaffolds. In order to 
determine the cell proliferation on wet-spun SPCL fiber mesh scaffolds, 
PicoGreen dsDNA kit (Molecular Probes, USA) was used. PicoGreen dsDNA 
Quantitation Reagent is an ultra-sensitive fluorescent nucleic acid stain for 
quantitative analysis of double-stranded DNA (dsDNA) in solution. 
For the assay, the samples were prepared by rinsing with sterile PBS and 
incubated with sterile ultra pure water at 37°C for 1h. They were then frozen at -
80°C and thawed.  Before starting the assay, they were sonicated 15min in an 
ultrasonic bath. An aliquot of each sample was transferred to the 96-well plate. A 
certain ratio of Tris-EDTA buffer and PicoGreen reagent prepared in the same 
buffer was added to the each well. The fluorescence was read at 485nm and 
528nm excitation and emission, respectively. The DNA amount of each samples 
was then calculated using a standard curve.  
D. 3. ALP Enzyme Activity 
Alkaline phosphatase, an ectoenzyme produced by osteoblasts, is believed to 
involve in the degradation of inorganic pyrophosphate to provide a sufficient local 
concentration of phosphate or inorganic pyrophosphate for mineralization to 
proceed. Among the various biological functions of osteoblasts, secretion of 
alkaline phosphatase (ALP) is an important indicator determining the activity of 
the cells on a scaffold.  
In order to determine the extent of osteoblast phenotype expression, 
amount of alkaline phosphatase produced by the cells were determined. ALP 
activity of the cultured cells on the scaffolds was analyzed by either in weekly 
collected supernatant (culture medium) of the samples or lysed cells. In both 
experiments, the enzyme activity determination was based on the specific 
conversion of p-nytrophenyl phosphate (pNPP) into p-nytrophenol (pNP).   
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To determine the activity of the secreted enzyme in the culture medium, 
supernatants were collected at each time point and frozen at -80°C until further 
analysis. For the assay, the collected supernatant were thawed and mixed with 
substrate solution (0.2% w/v p-nytrophenyl phosphate (pnPP) in 1M 
diethanolamine HCl (pH=9.8)) at the ratio of 1/3. The enzyme reaction was 
carried out by incubation of the mixture at 37°C for 1h and then stopped by 
adding a solution containing 2M NaOH and 0.2mM EDTA in distilled water. The 
final mixture was vortexed and dispensed in a 96 well-plate. The absorbance of 
p-nytrophenol formed was measured at 405nm. A standard curve was made 
using pNP values ranging from 0-600µmol/ml. The results were expressed in 
µmol of pNP produced/ml/h. 
The ALP activity could also be measured in lysed cells. In this case, the 
determined enzyme is the one which is present in cells at the moment of the test. 
For this assay, scaffolds seeded with cells were washed three times with PBS 
and transferred into an eppendorf containing ultra pure water.Then, the samples 
were frozen and thawed, and sonicated for 15 min . The same reaction 
procedure was followed. Briefly,  an aliquot of 50 µL of each sample was added 
to 150 µL of p-nitrophenyl phosphate solution at room temperature in the well of 
a 96-well plate and incubated for 1h at 37 oC in the incubator. The absorbance of 
p-nytrophenol reduced in the presence of alkaline phosphatase was measured at 
405nm. Calibration curve of p-nitrophenol at 37oC is used to determine the 
enzyme activity in units of µmol substrate converted to product per hour.  
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The best scientist is open to experience and begins with 
romance - the idea that anything is possible.  
Ray Bradbury 
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Chapter III 
PRODUCTION AND CHARACTERIZATION OF CHITOSAN FIBERS AND 3-D 
FIBER MESH SCAFFOLDS FOR TISSUE ENGINEERING APPLICATIONS 
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Abstract 
This study reports on the production of chitosan fibers and 3-D fiber meshes for using 
as tissue engineering scaffolds. Both structures were produced by means of a wet 
spinning technique. Maximum strain at break, and tensile strength of developed 
fibers were found to be 8.5%, 204.9 MPa, respectively. After 14 days of immersion in 
simulated body fluid (SBF); scanning electron microscopy (SEM), energy dispersive 
spectroscopy (EDS), and inductively-coupled plasma emission (ICP) spectroscopy 
analyses showed that a bioactive Ca-P layer was formed on the surface of the fibers, 
meaning that they exhibit a bioactive behaviour. The samples showed around 120% 
max. swelling in physiological conditions.  
The pore sizes of 3-D chitosan fiber mesh scaffolds were observed to be in 
the range of 100-500µm by SEM. The equilibrium-swelling ratio of the developed 
scaffolds was found to be around 170% (w/w) in NaCl solution at 37°C. Besides that, 
the limit swelling strain was less than 30%, as obtained by mechanical spectroscopy 
measurements in the same conditions. The viscoelastic properties of the scaffolds 
were also evaluated by both creep and dynamic mechanical tests.  
By means of using short-term MEM extraction test both types of structures 
(fibers and scaffolds) were found to be non-cytotoxic to fibroblasts. Furthermore, 
osteoblasts directly cultured over chitosan fiber mesh scaffolds presented good 
morphology and no inhibition of cell proliferation could be observed.  
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1. Introduction 
Tissue engineering needs the development of better polymeric scaffolds, which 
among other characteristics should be biodegradable and biocompatible. The 
scaffolds can be applied simultaneously as a carrier matrix for bioactive agents and 
as a support to seed primary undifferentiated cells. A number of natural [1-3] and 
synthetic polymers are currently in use as tissue scaffolds [4]. Depending on the 
applications, scaffolds can be presented in different forms, such as for instances 
membranes, and several types of 3-D architectures. Within the last years, non-woven 
mesh-like scaffolds have been started to be used in tissue engineering applications 
due to their highly porous structures. Polyglycolide (PGA) [5, 6], 
polylactide/polyglycolide (PLA/PGA) [7], and chitosan meshes [8] have been used as 
a scaffold for different tissue engineering applications. 
Chitosan, a (1→4)-2-amino-2-deoxy-β-D–glucose, is derived from chitin, which 
is found in the exo-skeleton of shellfish like shrimp or crabs. Because of its stable, 
crystalline structure, chitosan is normally insoluble in aqueous solutions above pH 7. 
However, in dilute acids, the free amino groups are protonated and the molecule 
becomes fully soluble below pH 5 [3]. Viscous solutions can be formed into fibers in 
different coagulation solution with high pH, such as aq. NaOH [9], aq. KOH [10], aq. 
NaOH-40% methanol [11], and aq. NaOH-NaSO4 (or AcONa) mixture [12]. Chitosan 
fiber forming properties have been investigated by several researchers [13]. A 
number of methods have been tried in order to produce chitosan fibers with good 
mechanical properties [10, 14, 15].   
Chitosan is a well known natural polymer that is biodegradable, biocompatible 
and nontoxic [16]. It has been shown [3, 17] to aggressively bind to a variety of 
mammalian and microbial cells. Binding on cells and biodegradability of chitosan may 
lead to a variety of biomedical applications such as wound dressing [18], carriers for 
drug delivery systems [19, 20] and space filling implants [21, 22]. Recent studies of 
chitosan confirm the utility of chitosan for promoting the bone growth [23, 24]. 
Muzzarelli et al. [23] reported the formation of mineralized bone-like tissue in 
osseous defects in rats, sheep and dogs when using chitosan plugs. 
In the present study, chitosan fibers were produced for being used 
subsequently to process tissue engineering scaffolds. The developed scaffolds 
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should ideally combine an adequate porous structure with proper mechanical and 
degradation properties. Furthermore, this study aimed for the analysis of this 
materials cytotoxicity as a first screening of its biocompatibility by means of using 
mouse fibroblast (L929) and human osteoblast (SaOs-2) cell lines. 
2. Experimental 
2.1. Materials 
Medium molecular weight chitosan with an 85% degree of deacetylation was 
obtained from Sigma-Aldrich. All other chemicals were analytical grade and used as 
received. 
2.2. Methods 
2.2.1. Chitosan fiber preparation 
Chitosan fibers were produced by a wet spinning method as described elsewhere 
[12]. In a typical procedure; chitosan was dissolved in aq. 2% (v./v) acetic acid in 5% 
(w./v) concentration by stirring at room temperature overnight. The solution was 
diluted with methanol to reach 3% (w./v) final solution concentration. Glycerol at 2.5% 
wt/wt concentration was added into this solution as a plasticizer. The solution was 
filtered through a cloth filter and put in ultrasonic bath to remove the air bubbles. The 
solution was injected into a coagulation bath at 40°C containing a mixture of 30% 0.5 
M Na2SO4, 10% 1M NaOH and 60% distilled water. The fibers were kept in this 
coagulation medium for one day and washed several times with distilled water. They 
were then suspended in aq. 30% methanol for 4/5 h and then in aq. 50% methanol 
overnight. The chitosan filaments were wounded on the cylindrical support. The 
fibers were dried at room temperature/humidity conditions for one day. 
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2.2.2. Chitosan fiber meshes preparation 
A similar production method was used to produce 3-D chitosan fiber meshes. 
However, a different drying method and a thinner needle were used. After fibers were 
formed in coagulation medium at room temperature, they were kept in this solution 
overnight. The fibers were then washed several times with distilled water before 
being suspended in 50% methanol for 1h. Then they were suspended 100% 
methanol for 3h and put in the oven at 55°C for drying in a mould.  
2.3. Characterization 
2.3.1. Chitosan fiber 
Scanning Electron Microscopy 
The morphology of fibers was visualized by Scanning Electron Microscopy (SEM) in 
a Leica Cambridge S360 microscope. Samples were sputter coated with gold. 
Mechanical Properties 
Tensile tests were performed on a Universal Test Machine (Lyloyd Instruments, LR 
%K Serensworth Fareham, England), with a 500N load cell, using a cross-head 
speed of 20mm/min and a gauge length 20mm. Average values of tensile strength 
and maximum strain were determined after repeating the test five times. 
Swelling Tests  
Swelling behaviours of fibers have been investigated in 0.154M NaCl aqueous 
isotonic saline solution at pH=7.4. Fibers with different glycerol ratios were used, in 
order to observe the effect of glycerol on swelling ratio. The samples were immersed 
in the solution, taken out from it at various time intervals, and then weighted with an 
electronic balance. The experiment was continued until samples reach the 
equilibrium. Swelling degree was calculated according to the following equation: 
 
%S = (mw – mi) / mi x 100 
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where %S is the percentage of swelling, mw is the weight of the wet sample after 
immersion in the NaCl solution.  
Bioactivity Tests 
Chitosan fibers were immersed in 15 ml simulated body fluid (SBF) in a plastic bottle 
at 37°C. SBF solution was proposed initially by Kokubo et al [25], present an ionic 
composition similar to human blood plasma, and has been widely used [26, 27] to 
test the bioactivity of different materials in-vitro. After various periods of incubation (3, 
7, 14, 30 days) in SBF, samples were removed from the solution, washed carefully 
with water and dried at room temperature in a desiccator. The apatite formation on 
the fiber surface of a calcium-phosphate film was visualized by SEM (Leica 
Cambridge S360). EDS spectra were obtained after the observation. Changes in 
concentration of calcium and phosphorus of SBF solution due to soaking of fibers 
were measured using inductively-coupled plasma emission (ICP) spectroscopy. 
Cytotoxicity: Short Term MEM Extraction Test using Fibroblast Cells 
To establish the cytotoxic rate of leachables, a MEM Extract test, a cytotoxicity test 
laid down in European and International standards (ISO/EN 109935 Guidelines) was 
performed [28]. For this assay, a cell line of mouse lung fibroblasts (L929) was 
selected. Growth to confluency was performed in controlled atmosphere (37ºC, 5% 
CO2, 100% humidity) using Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma), 
supplemented with 10% Foetal Bovine Serum (FBS, Biochrome) and 1% 
antibiotic/antimicotic solution (Sigma). In order to achieve 80% of confluency, cells 
seeded in cell culture polystyrene plates (10 000 cells/cm2) were incubated for 24h. 
According to ISO/EN 109935 Guidelines, surface area of the different samples was 
determined and immersion in the correspondent cell culture media volume was 
performed (37ºC, 60 rpm). The same procedure was carried out for a negative 
control Ultra High Molecular Weight Polyethylene (UHMWPE), and positive control 
Latex Rubber. After 24 hours, fibroblasts were morphologically analysed, and culture 
media was replaced by the extraction one. Test samples and controls were incubated 
in triplicate (n=3). After 24, 48 and 72 h testing, the reaction of cells to extracts was 
evaluated by means of light microscopy and compared to the positive control and 
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negative control. A score for confluency of monolayer, degree of floating cells and 
changes in cellular morphology was calculated based on the scores posted on Table 
1. In the end of the test, cell number was measured and the percentage of cell 
growth inhibition determined. By means of combining the different quantitative and 
qualitative parameters scores, the obtained cytotoxic index defines if samples fail or 
pass the cytotoxicity test (used scores can be seen in Table 2). 
Table 1. Quantitative and qualitative scores used in the cytotoxicity tests. 
 
Table 2. Different cytotoxicity indexes used to classify the reactivity of tested 
samples. 
 
 
 
 
 
 
 
Cytotoxic Response Reactivity Pass/Fail 
0-1 None Pass 
1-3 Slight Pass 
3-5 Mild Retest 
5-7 Moderate Fail 
7-8 Severe Fail 
Score 
Confluency  
(%) 
Floating cells 
(%) 
Change of cellular 
morphology 
Inhibition of cell 
growth 
 (%) 
0 100 0 No changes during test period 0-10 
1 90-100 0-5 Slight changes, few cells affected 10-30 
2 60-90 5-10 
Mild changes, some 
cells round/spindle 
shaped 
30-50 
3 30-60 10-20 
Moderate changes, 
many cells 
round/spindle 
50-70 
4 0-30 > 20 
Severe changes, 
about all cells show 
morphological 
changes 
70-100 
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2.2.2. Chitosan fiber meshes: 
Scanning Electron Microscopy 
The mesh structure of chitosan fibers was analysis by Scanning Electron Microscopy 
(Leica Cambridge S360) again after coating with gold. 
Mechanical Properties 
Short-time swelling, creep and dynamic mechanical analysis (DMA) experiments 
were carried out in a DMA7e Perkin-Elmer apparatus, in the compression mode, 
using parallel plates with 10 mm diameter. The analysed samples, with cylindrical 
shape, were typically 2 mm high. All experiments were performed while the samples 
were immersed in an isotonic saline solution. In order to implement such runs, a 
metallic cylindrical vessel was fitted into the inner part of the furnace of the 
apparatus. The vessel was filled with isotonic saline solution. The calibration of the 
force was performed with the top plate immersed, in order to take into account the 
impulsion effect of the solution. Before the runs have been carrying out on the 
samples, the temperature of the bath was stabilised at 37 ºC, using the own 
temperature sensor of the apparatus. 
The short-time monitoring of the swelling of the studied mesh was carried out 
using the thermal mechanical analysis (TMA) mode of the Perkin-Elmer dynamic 
mechanical analysis (DMA) apparatus. Briefly, the temperature of the dry sample is 
kept at 37 ºC in an external furnace, near the DMA equipment. The sample is quickly 
positioned between the plates and the furnace with the bath is immediately raised up. 
The height of the sample starts to be recorded less than 10 seconds after the sample 
contacts with the liquid. During the experiment a small stress of 10 Pa is imposed to 
the sample by the top plate, in order to maintain the contact between the sample and 
the plates. 
In the creep experiments, previously swelled samples are positioned between the 
plates and immersed until the temperature equilibrates at 37ºC. The creep stress was 
0.1 MPa. A program of creep/recovery was used, where the strain, ε, was measured 
against time. 
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DMA experiments were performed in the immersed samples (with equilibrated water 
content) at 37 ºC. The real (storage modulus), E’, and the imaginary (loss modulus), 
E”, of the complex modulus, E*=E’+iE” (with i=(-1)1/2), were recorded against 
frequency, that varied between 0.5 and 10 Hz. A static stress of 36 kPa and a 
dynamic stress of 30 kPa were used in such experiments. 
Swelling Tests 
The swelling ratios of the samples were calculated using the same experimental set-
up and method that was described above. 
Cytotoxicity and Biocompatibility: Direct Contact Test with Osteoblast-like Cells 
Cytotoxicity assay was performed for chitosan fiber meshes by following the same 
methodology as described for chitosan fibers in part 2.2.1. 
In order to study cell morphology, attachment and proliferation onto the chitosan fiber 
meshes scaffolds a human osteoblasts SaOs-2 cell line was selected. Former 
described culture conditions were also used for osteoblast-like cells. Cells cultured in 
DME Media (Sigma), enriched with 10% FBS (Biochrome) and 1% 
antibiotic/antimicotic solution (Sigma) were seeded directly over samples in a 
concentration of 3.3 x 104 cell/ml. Incubation was performed at 37 ºC (5% CO2, 100% 
humidity) for 24 hours and 7 days. Tissue culture grade polystyrene (TCPS) discs 
were used as control and replicates were always prepared. After each incubation 
period, samples were washed with Phosphate Buffer Saline (PBS, Sigma) solution 
and fixed in gluteraldehyde 2.5% (v/v). For Scanning Electronic Microscopy (SEM) 
observation, samples were previously dehydrated in crescent alcohol concentrations 
(50%, 70%, 90% and 100%), air-dried and sputter coated with gold. 
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3. Results and discussion 
3.1. Chitosan fibers  
Scanning Electron Microscopy 
 
 
 
 
 
 
 
 
Figure 1. SEM micrographs of chitosan fibers; A) x360, B) x3000. 
 
Figure 1.A and B present SEM images of the developed chitosan fibers. As it can be 
seen here in, chitosan fibers have been oriented in one direction due to the stretching 
process. Additionally, the images show that the fibers have a smooth and uniform 
striated surface even though using drying elements and rolling up the fiber on 
cylindrical support following a methanol drying bath may damage a fiber surface. For 
instance, Knaul et al. [15] have reported the effects of different drying elements on 
chitosan fiber surfaces.  
Mechanical Properties 
With regard to tensile tests maximum strain at break, and tensile strength of fibers 
were found 8.5± 2.3% and 204.9± 9.7 MPa, respectively. 
Swelling Tests 
Figure 2 shows the swelling behaviour of produced fibers. As it can be seen in the 
graph, the fibers showed a rapid swelling in the first 30 minutes, and then they 
gradually tend to equilibrium that is achieved in about 120 min.  
A B 
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Figure 2. Swelling ratio vs. time for chitosan fibers. 
Bioactivity Tests 
Figure 3.A, B, C present SEM micrographs of chitosan fibers before (Figure 
3.A) and after a bioactivity test for 30 days (Figure B, C). In Figure 3.A it is possible 
to observe the typical oriented morphology of the fiber. Similar morphology was 
observed in the first days of immersion in SBF. However, after 14 days of immersion, 
a number of nucleus started to form on the surface of the fibers, that by EDS analysis 
were found to correspond to the formation a calcium phosphate (Ca-P) (Data not 
shown). This nucleus have grown with increasing immersion times and after 30 days 
a compact and well-defined Ca-P layer could be observed, as presented in Figures 
3.B and 3.C For higher magnifications (Figure 3.C) this layer tended to the typical so-
called cauliflower like morphology of Ca-P films.  
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Figure 3. Sem micrographs of chitosan fibers; A) before, B) after 30 days of 
immersion in SBF (x1000), C) after 30days of immersion in SBF (x3000). 
A commercial polyamide fiber was used as a control and for this case no Ca-P 
film could be observed even after 30 days of immersion in SBF (Figure 4). This 
clearly indicates the bioactive of the developed fibers, confirming what has been 
observed by authors such as Muzzarelli in-vivo [25].  
 
 
 
 
 
 
 
Figure 4. SEM micrograph of commercial available polyamide fibers after 30 days 
immersion in SBF (x1000). 
A 
B C 
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This result is supported by EDS and ICP analysis (Figure 5 and 6, 
respectively). Ca and P elements in the formed layers can be clearly seen in EDS 
spectra. In addition, ICP results showed that there was a decreasing of Ca and P 
concentration in the SBF solution after 14 days leading to the precipitation and 
growth of the Ca-P layer that was observed by SEM. 
 
 
 
 
 
 
 
Figure 5 – EDS spectra of the Ca-P coatings on the surface of chitosan fibers (after 
30 days in SBF). 
 
 
 
 
 
 
Figure 6 – Evolution of the Ca and P elemental concentrations in the SBF as a 
function of immersion time of chitosan fibers in SBF. 
Cytotoxicity Test 
Regarding the in vitro study of the cytotoxic effect of chitosan fibers; results indicate 
that the material passed the test with a cytotoxic index of 0 (see Table 3). This 
means that as for tissue culture polystyrene surfaces and UHMWPE, when cell 
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culture media was replaced by extracts of materials in study good fibroblast 
proliferation and no cell morphology modifications were observed. This is not typically 
at all of biodegradable polymers. 
Table 3. Results comparing fibroblasts cytotoxic response and reactivity to chitosan 
materials and controls. 
 
3.2. Chitosan fiber meshes  
Scanning Electron Microscopy 
SEM images of fiber meshes are presented in Figure 7.A, B, C. As it can be seen in 
the micrograhps, the chitosan fibers could be formed into mesh structures having an 
average pore size in range of 100-500 µm. In addition, it was possible to see that 
fibers have sticked to each other. This structure gives them good mechanical 
strength as well as it will enable cell ingrowth, as required for tissue engineering 
scaffolding applications. 
 
 
 
Sample Total Cytotoxic 
Response 
Reactivity Pass/Fail 
Chitosan fiber 0 None Pass 
Chitosan fiber 
mesh scaffolds 
0 None Pass 
UHMWPE 0 None Pass 
TCPS 0 None Pass 
Latex 8 Severe Fail 
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Figure 7 – SEM micrographs of the structure of the developed chitosan fibers 
meshes; A) x33.4, B) x50, C) x250 
Mechanical Properties 
Swelling experiments are usually carried out by means of measuring the sample’s 
weight after different periods of immersion. It is then very difficult to access the 
swelling data during short-time immersion periods, which would be rather relevant for 
materials having a fast swelling rate. The studied chitosan meshes are among such 
systems, where the equilibration of water content occurs mostly in the first hour after 
immersion. The innovative procedure described here in permits to follow this process 
by continuously monitoring the height of the samples immediately after the moment 
they are immersed. Obviously, considering an isotropic swelling, the height of the 
sample is easily correlated with the increase of volume 
 
 
 
A B 
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Figure 8 – Evolution of the strain of a dry chitosan mesh after it was immersed at 37 
ºC (symbols). The solid line corresponds to the best fit of the data according to Eq. 
(2). 
 
The sample’s strain (ε=(h-h0)/h0, where h and h0 are the measured and initial 
heights of the sample) is measured against time. The results obtained with an initially 
dry sample with h0=2.351 mm are shown in Figure 8. The increase of the strain is 
faster in the first 20 minutes and the limit strain seems to be less than 30%. 
The data in Figure 8 was fitted according to the stretched exponential function: 
 
[ ]))/(exp(1)( β∞ τ−−ε=ε tt  
 
where ε∞ is the limit swelling strain, τ is a characteristic swelling time and β is an 
exponent parameter that measures the deviation from a first-order swelling kinetics 
(β=1). This function appears in this context as an empirical model that may be useful 
to characterise the strain at equilibrium and the swelling rate. This equation has been 
often used to follow relaxational processes, i.e., the isothermal evolution to the 
equilibrium when a system is subjected to an external perturbation (see, for example, 
ref. [29]); in that case the model has physical significance. The results in Figure 8 
were fitted using a Levenberg-Marquard algorithm and the adjusted parameters 
were: ε∞= 29,4±0.08%, τ= 9.8±0.1 min and β=0.54±0.003. 
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The meshes may be subjected to static loads if used in different biomedical 
applications. In polymer-based materials an applied static stress usually results in a 
continuous, long term deformation under the applied stress, called creep. Such 
phenomenon may be relevant in the clinical use of the studied meshes, being 
associated with changes on the mechanical performance of the material and in 
variations in the dimensions of the implant. In this work creep/recovery of the 
immersed chitosan mesh was studied in simulated in-vitro conditions. 
The “instantaneous” increase of the strain is mainly associated with the expulsion of 
water within the mesh and thus is weakly assigned with the changes of geometry of 
the chitosan fibres, but rather is to the quantity of water initially in equilibrium and to 
the original cellular geometry of the sample. Please note that the initial strain value 
(≈35%) is higher than the plateau in the swelling experiments (≈30%, as suggested 
by Figure 8). The excess strain (≈5%) is then basically due to the deformation of the 
mesh geometry of the chitosan sample. 
After the initial deformation a clear delayed response is observed in the creep 
experiment (see inset graphics in Figure 9). The approximately linear relationship 
found in the log time graphics may be in accordance with the power-law for the time 
dependence found in the viscoelastic creep response found in another system [30]. 
Therefore, it is possible to assign this delayed creep to the viscoelastic properties of 
the chitosan fibres. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9 – Creep (60 min) followed by a recovery stage (60 min) and, finally, a 
second short creep run performed at 37 ºC in the immersed chitosan mesh. The inset 
graphics shows the viscoelastic component of the first creep run, in a log time scale. 
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The removing of the strain results in a quick decrease of strain that occurs 
with a similar time-scale of the swelling experiment (τ ≈ 10 min). Therefore, most of 
the strain recovery is related with the swelling of the mesh. After 1 h of recovery, it is 
found that the strain is far to converge to 0. This may be an indication that part of the 
mesh structure was irreversibly transformed during the creep state, leading to a more 
compact cellular arrangement. 
After this creep/recovery experiment the sample was again subjected to the 
same creep stress. The strain appears to respond similarly to the first creep 
exposition, being an indication that neither apparent complex memory effects nor 
drastic structural occurs in the sample. 
 The rheological behaviour of the immersed mesh was also characterised by 
DMA. Both storage and loss moduli (E’ and E”) were measured at 37 ºC in the 
frequency range 0.5-10 Hz, which are typical frequencies found in physiological 
stress-variation situations (blood pumping rate, masticatory frequency, time for 
patient movements…). The results are shown in Figure 10. It is to be noticed that the 
values may change if the experiment is carried out at different stresses, due to the 
variation of the water content in equilibrium inside the mesh. Please also note that E’ 
and E” may be transformed into other viscoelastic parameters [31], such as 
compliance, D*=D’-iD”=1/E*, shear complex modulus, G*=G’+iG”==E*/[2(1+ν*)], 
where ν* is the complex Poisson’s ratio, shear compliance, J*=J’-iJ”=1/G*, or the real 
and imaginary components of the dynamic viscosity, η’=G”/ω and  η”=G’/ω. 
The storage modulus increases with increasing frequency, being E’ typically 
above 1 MPa. The loss modulus shows the inverse tendency. This results in a 
decrease of the loss factor, tan δ=E”/E’ with increasing frequency (inset graphics in 
Figure 10). This parameter measures the fraction of the imposed mechanical stress 
that is dissipated in the form of heat. As tan δ is typically above 0.15 for f<1 Hz, one 
may conclude that the damping capability of the system is significant, which may be 
important for some biomedical application that require dissipation of mechanical 
energy. It was found that living cells behaves as soft glassy materials existing close 
to a glass transition, implying that cytoskeletal proteins may regulate cell mechanical 
properties [32]. This kind of evidences leads one to speculate on the existence of 
some advantages upon biological functions when the materials of the implant that will 
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be in contact with living tissues, also present a viscoelastic character, as is the case 
for the studied chitosan mesh. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 – Storage and loss moduli (E’ and E”) as a function of frequency (f) at 37 
ºC of the immersed chitosan mesh. The inset graphics shows the frequency 
dependence of the loss factor. 
 
Swelling Tests 
 
 
 
 
 
 
 
 
 
Figure 11 – Swelling ratio vs. time for the developed 3D chitosan fiber meshes. 
 
Figure 11 shows the swelling behaviour of chitosan fiber meshes. In this 
figure, it is possible to observe the typical swelling behaviour of chitosan scaffolds [7]. 
Samples reach the equilibrium water uptake ratio, which is around 170% (w/w), after 
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about 3h in NaCl solution. Although fiber meshes were swelled up to high ratio, they 
preserved their physical integrity upon incubation in aqueous solution. This property 
of chitosan fiber meshes may enable for easy handling of the scaffold material in 
practical clinical applications. This result has been confirmed by DMA tests. 
Cytotoxicity and Biocompatibility: Direct Contact Test with Osteoblast-like Cells 
Cytotoxicity test results for chitosan fiber mesh scaffolds can be seen in Table 3. 
They showed no cytotoxic effect, and behaviour very similar to tissue culture and 
UHMWPE surfaces 
In order to observe cell morphology and proliferation of an osteoblast cell line 
over chitosan fiber mesh scaffold surfaces SaOs-2 cells were directly cultured and 
incubated for 1 and 7 days. By means of observing Figures 12.A and B it is possible 
to verify that scaffolds allowed for very significant cell proliferation from day 1 to day 
7, respectively. After 7 days, it was clearly seen that cells have been attaching to the 
scaffolds and bridging each other by means of filapodia structures which is typical for 
osteoblast-like cells (Figure 13) [33]. Furthermore, a detailed analysis of osteoblastic-
like cells morphology confirmed short-term cytotoxic results performed with 
fibroblasts, and allowed for observing extensive lamellipodium structure formation. 
 
 
 
 
 
 
 
 
Figure 12 – Osteoblast-like cells A)adhering to chitosan based fibres after 1 day of 
culture, B) proliferating over chitosan based fibres after 7 days of culture. 
 
 
 
A B 
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4. Conclusions 
In this paper attention has been focused on the preparation and properties of 
chitosan fiber and fiber meshes for potential use in tissue engineering applications. In 
the present study, chitosan fibers could be produced by a wet spinning technique. A 
subsequent drying treatment with methanol was used to improve the mechanical 
strength of fibers. Mechanical tests showed that the fibers had enough tensile 
strength to be used to produce scaffolds with good mechanical performance. 
Unexpectedly, the developed fibers showed a bioactive behaviour, which is also very 
important for biomaterials aimed to be used for instances in bone tissue engineering 
scaffolding. Fibers could also be formed into 3D structure aimed to be used as tissue 
engineering scaffolds. One could observe that mesh structure of the scaffold was 
suitable for cell ingrowth. This was confirmed by the results obtained on the in-vitro 
cell culture studies. Both types of samples extracts were comparable to UHMWPE 
clearly passing the test. In addition, osteoblasts growing over scaffold surfaces 
presented adequate morphology and good proliferation, proofing that the developed 
scaffolds might be used for bone tissue engineering applications.  
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The most exciting phrase to hear in science, the one that heralds 
new discoveries, is not "Eureka!" (I found it) but "That's funny..." 
    Isaac Asimov 
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CHAPTER IV 
MULTICHANNEL MOULD PROCESSING OF 3D STRUCTURES FROM 
MICROPOROUS CORALLINE HYDROXYAPATITE GRANULES AND 
CHITOSAN SUPPORT MATERIALS FOR GUIDED TISSUE 
REGENARATION/ENGINEERING 
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Abstract 
A 3D composite material was produced from microporous coralline origin 
hydroxyapatite (HA) microgranules, chitosan fibers and chitosan membrane. 
Cylindrical HA microgranules were oriented along channel direction within 
multichannel mould space and aligned particles were supported with fibers and 
a chitosan membrane. The positive replica of mould channels was clasp fixed to 
produce thicker scaffolds. Light microphotographs of the developed complex 
structure showed good adhesion between the HA particles, the fibers and the 
supporting membrane. The composite material showed 88 % (w/w) swelling in 
one hour and preserved the complex structure of the original material upon 
long-term incubation in physiological medium. MEM extract test of HA chitosan 
complex showed no cell growth inhibition and cell viability assay (MTS) 
indicated over 90 % cell viability.  
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1. Introduction 
The new and rapidly developing tissue engineering field is requiring novel 
processing methods and designs of scaffold and membranes for guided tissue 
regeneration. The scaffolds have been fabricated using conventional techniques 
such as fiber bonding, solvent casting, particulate leaching, membrane 
lamination and melt molding [1-4]. The disadvantage of the above technologies 
includes the intensive fabrication process, the limitation to thin structures, and 
residual particles in the polymer matrix, irregularly shaped pores, and 
insufficient interconnectivity. Recently, rapid protyping technologies such as 
fused deposition modelling, laminated object manufacturing, three dimensional 
printing and 3D plotting have also been applied to process biodegradable and 
bioresorbable materials with controllable and reproducible porosity and well-
defined 3D microstructures  [5-8].  
Marine skelatal material is usually made of CaCO3 in the crystalline form 
of calcite and aragonite and silicated SiO2 materials combined with Mg(OH)2. 
Organisms from different species of corals and hydrocorals have a wide variety 
of skeletal architectures and crystalline structures [9]. Coralline carbonate 
derivatives, mostly coralline hydroxyapatite, are currently being used mostly as 
bone filler or nonweight-bearing areas and orbital implants [10].  The internal 
structure of some coral species is very similar to porous structure of bone and 
replica of porous calcium carbonate can be converted to highly biocompatible 
and osteogenic tricalcium phoshate and/or hydroyapatite by a hydrothermal 
process  [11, 12]. 
Chitin and chitosan are biologically renewable, biodegradable, 
biocompatible, non-toxic and biofunctional [13]. The use of chitosan together 
with bioceramics such as calcium phosphate as a scaffold material for tissue 
engineering applications has been reported previously by a number of 
researchers [14-16]. The incorporation of bioceramics has been shown to 
increase osteoconductivity and improved mechanical strength greatly  [17, 18]. 
Chitosan fibers, which can be easily extended into three-dimensional 
structures of woven, knitted and nonwoven are widely used in a variety of 
biomedical applications, including sutures, wound dressing, and artificial hair 
[19, 20]. This interest is mainly derived from the fact that chitosan is a natural 
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polymer that shows well-known wound acceleration ability and a biological 
aptitude to stimulate cell proliferation. Depending on the processing conditions, 
chitosan fibers can present good mechanical properties. Several authors have 
described the improving the mechanical strength of fibers from chitosan [21-23]. 
Adequate mechanical properties can make chitosan based materials adequate 
for the developing of tissue engineering scaffolds that can be used for bone or 
cartilage regeneration.   
The aim this study is the development of a composite material from 
coralline origin hydroxyapatite (HA) particles and chitosan fibers for use in 
tissue engineering or in guided tissue regeneration. By orienting the cylindrical 
coral particles (microchannels run parallel along the particle length) in one 
direction, an anisotropic material similar to biologic structure of bone can be 
produced. The bone forming cells osteocytes are known to be arranged in 
concentric layers called lamellae. In turn, lamellae surrounds central 
microscopic channels known as haversian canals, through which run capillaries 
and nerves. Haversian canals and surrounding lamellar structure are oriented 
parallel to bone structure. It is believed that a scaffold structure mimicking these 
arrangements can provide a guided bone ingrowth and correct vascularization 
of biomaterial inside the body. 
Since coralline origin HA granules are prone to damage from mechanical 
stirring or harsh handling procedure, a new processing method was suggested 
in order to blend cylinder shaped coralline HA particles with chitosan fibers. In 
this method, semi-cylinder parallel channels (1 mm in width and deep) were 
prepared in a mould for holding and orienting the particles in one direction. This 
composite material was reinforced with chitosan fibers along and right angle to 
channels and finally, a membrane was used to cover the material in the mould. 
After obtaining a replica of mould channels over the membrane, thicker 
scaffolds can be produced by physical clamp fixing of subsequent replicas of 
coralline HA to each other. 
2. Materials&Methods 
Chitosan (deacetylation degree 87 %), acetic acid, and sodium hydroxide were 
obtained from Sigma Chemical Co. (St. Louis, USA). Methanol was obtained 
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from Merck Chemical Co. (Germany). Sodium sulphate was obtained from 
Aldrich Chemical Co. All the other chemicals used were of analytical grade. 
2.1. Preparation of coralline origin HA reinforced composite material 
2.1. 1. Chitosan fiber preparation  
Chitosan fibers were produced as previously reported [24]. In brief, chitosan 
was dissolved in aq. 2 % (v/v) acetic acid solution in 5 % (w/v) concentration by 
stirring magnetically at room temperature overnight. Methanol was added to 
dilute the viscous solution for easy injection until reaching 3 % (w/v) final 
concentration. Glycerol was used as a plasticizer (2.5 % (w/w)). After filtration 
with a cloth filter, solution was placed in an ultrasonic bath to remove the air 
bubbles. The solution was allowed to remain at room temperature overnight for 
aging. The clear solution was injected into a coagulation bath at 40 °C, (30 % 
1N Na2SO4, 10 % 1N NaOH and 60 % distilled water). The formed fibers were 
kept in this coagulation medium for one day and then washed several times with 
distilled water. They were suspended in aqueous 30 % methanol for 4-5 h and 
then in aqueous 50 % methanol overnight. The chitosan filaments were wound 
on the cylindrical support and the fibers were dried at room for one day.  
2.1.2. Chitosan membrane preparation 
Chitosan membranes were made by a simple solvent casting technique. The 
chitosan was dissolved in aqueous acetic acid solution (1 % (w/v)), and then 
was casted onto a plastic petri dishes in a ratio of 0.25g/cm2. Membranes were 
then allowed to dry slowly in an incubator at 37 °C for 3 days.  
2.1.3. Assembly of coralline origin HA granules, chitosan fibers, and 
membrane 
A chitosan-coralline origin HA slurry was obtained by careful mixing chitosan 
solution (3 %, (w/v)) with prewetted HA microgranules in 1/1 ratio (w/w). The 
slurry was then placed into channel spaces by means of a gentle smear 
process (Figure 1). 
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TCP/HA 
particles 
chitosan 
fibers 
mold 
Over the coralline origin HA filled spaces, chitosan fibers were aligned as one 
set parallel and another set right angle to channel direction to produce a chess 
like pattern (Figure 2). Finally, a chitosan membrane was placed over the 
coralline origin HA particles and the fiber network. In order to provide good 
adhesion between membrane and wet particles, a weight was applied over the 
membrane and let to act overnight. The assembly with the mould was placed to 
an oven at 37 oC to dry the material. Special care was given to peel off the 
composite material from the mould. Released material was stored in desicator 
until further assembly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Shematic representation of the preparation method of coralline origin 
HA-chitosan fiber composite using a multichannel mould (A); Principle of 
production of thicker scaffolds by clasp fixing of TCP/HA replica complexes (B, 
C). 
 
 
(A) 
(B) 
(C) 
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2.2.Cytotoxicity assays 
The cytotoxicity of leachables of the tested material was evaluated by using cell 
culture methods, namely short MEM (minimum essential medium) extraction 
test (72 hours), according to ISO/EN 109935 guidelines [25]. 
2.2.1. Cell culture 
A cell line of mouse long fibroblasts (L929) was selected for all cytotoxicity 
assays. Cells were grown in Dulbecco’s modified eagle medium (DMEM, 
Sigma), supplemented with 10 % of Foetal Bovine Serum (Biochrome) and 1 % 
of antibiotics/antimicotics solution (Sigma) until they reach confluency. Twenty-
four hours before the cytotoxicity tests start, cells were trypsinized and seeded 
(n= 3 per tested condition) on 24 and 96 well plates using a density of 7x104 
cells/cm2. 
2.2.2. MEM extraction test (72 hours) 
The materials (n= 3) were incubated in 10 ml of complete culture medium (2.5 
cm2/ml) (1) for 24 hours at 37 ºC under constant agitation. In the end of the 24 
hours the extraction fluids were filtered (45 µm of pore size). 
Morphological evaluation 
For morphological evaluation, culture medium present in the 24 well plates was 
replaced by 2 ml of extraction fluid and incubated for 72 hours at 37 ºC in a 
humidified atmosphere containing 5 % of CO2. After 72 hours the reaction of the 
cells to the extracts was evaluated by means of light microscopy and compared 
to the negative control (cells incubated with standard culture medium) and 
positive control (latex rubber). A score for confluency of the monolayer, degree 
of floating cells and change of cellular morphology was then calculated based 
on the values posted on Table 1. Cells were also trypsinized, the percentage of 
growth inhibition was determined through trypan blue exclusion test and a score 
was obtained after correction for the value of positive and negative controls. 
The scores were then combined (four parameters have equal weight) resulting 
in a final cytotoxic response index ranging from 0 to 8 (Table 2). 
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Score 
Confluency  
(%) 
Floating cells 
(%) 
Change of cellular 
morphology 
Inhibition of cell 
growth 
 (%) 
0 100 0 No changes during test period 0-10 
1 90-100 0-5 Slight changes, few cells affected 10-30 
2 60-90 5-10 
Mild changes, some 
cells round/spindle 
shaped 
30-50 
3 30-60 10-20 
Moderate changes, 
many cells 
round/spindle 
50-70 
4 0-30 > 20 
Severe changes, 
about all cells show 
morphological 
changes 
70-100 
 
Table 1. Quantitative and qualitative scores used in the cytotoxicty tests. 
 
Table 2. Cytotoxicity index 
 
 
 
 
 
Cell viability assay 
After 24 hours of cell seeding culture medium was replaced by 200 µl of 
extraction fluid and incubated for 72 hours at 37 ºC in a humidified atmosphere 
containing 5 % of CO2. After 72 hours cell viability was assessed by using Cell 
Titer 96® One solution Cell proliferation Assay kit (Promega, USA). This test is 
based on the bioreduction of the substrate, (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazolium) (MTS), into a brown 
formazan product by NADPH or NADP produced by dehydrogenase enzymes in 
Cytotoxic Response Reactivity Pass/Fail 
0-1 None Pass 
1-3 Slight Pass 
3-5 Mild Retest 
5-7 Moderate Fail 
7-8 Severe Fail 
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metabolically active cells  [26, 27]. For the assay to occur extraction fluids were 
removed and 100 µl of a mixture of culture medium without FBS and MTS in 5:1 
ratio were added into each well. Cells were then incubated for three hours at 37 
ºC in a humidified atmosphere containing 5 % of CO2, in the end of which 
optical density was read at 490 nm in a plate reader (Molecular Devices, USA). 
Results are plotted as percentage of negative control. 
2.3. Swelling test 
In order to test the swelling behaviour, the scaffold was cut into five small 
pieces and each piece was immersed in 0.154 M NaCl aqueous isotonic saline 
solution (pH 7.4).  The samples were taken out from solution at various time 
intervals being weighted with an analytical balance. The experiment was 
continued until reaching of an equilibrium value. 
 The swelling ratio of the samples was calculated according to the 
following equation: 
 
% S = (mw – mi) / mi  x 100   (1) 
 
where % S is the percentage of swelling, mw is the weight of the wet sample 
after immersion in the NaCl solution. Average values were used to determine 
the swelling ratio of scaffold for each of the time points. 
3. Results and discussion 
3.1. Coralline origin HA/chitosan composite material preparation 
Light transmission microscopy analysis of the composite material showed that 
most of coralline origin HA cylinder bodies were aligned along channel direction. 
Chitosan microfibers are seen to be running along coralline origin HA granules 
and making chess structure between coralline origin HA replica and chitosan 
membrane (Figure 2.B). Chitosan membrane was observed to hold both 
granules and fibers securely. The strength of composite materials can be 
increased greatly with the incorporation of fibers. In this respect, the coralline 
origin HA filled channels were supported by parallel chitosan fibers. A chess-like 
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structure was produced, so that the load can be distributed evenly over the 
complex. 
 
 
 
 
 
 
 
 
 
Figure 2. Light transmission microphotographs of HA granules (white cylinder 
bodies) and chitosan fibers (indicated by arrows) over chitosan membrane:  
(A) Front view of complex and (B) back view of complex. 
The parallel distribution of coralline origin HA particles is especially 
important because, fine microchannel architecture of cylindrical structures align 
in longitudinal direction of ceramic structure. By that way, highly oriented 
channel networks can be created through the composite material. This pattern 
would mimic the haversian network of natural bone and as a result, a correct 
remodelling of biomaterial by infiltration of bone tissue and extensive 
vascularization at implantation site can be expected. This will be analysed in 
future in-vivo studies. 
3.2. Cytotoxicity assays 
With regard to short-term MEM extract test there was no cell growth inhibition 
detected after the trypan blue exclusion test (0.00 + 0.00). Moreover cells 
revealed similar morphologies and proliferation patterns when compared with 
the negative control, obtaining a score of 1 in the cytotoxicity index (Table 2) 
showing in this sense that these materials were non-toxic. This type of result is 
not typical at all for biodegradable polymers.  
Regarding cell viability assay (MTS test), cells produced large amounts 
of the brown formazan product, which indicates a normal metabolism (Figure 3). 
L929 cells incubated with composite extracts showed a good incorporation and 
1 mm 1 mm 
A B 
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metabolization of MTS, displaying only a slight inhibition of the metabolism 
when compared to negative control.   
 
 
 
 
 
 
 
 
 
 
Figure 3. Cell viability of L929 cells after incubation with test and control 
extracts over a period of 72h. Results based on optical measurements. 
 
As a result of the cytotoxicity experiments it can be said that the 
chitosan/coralline origin HA scaffolds are non-toxic and hence can be used for 
further studies within the biomaterials/tissue engineering field. 
3.3. Swelling test 
 
 
 
 
 
 
 
 
 
 
Figure 4. Swelling curve of coralline HA-chitosan composite in physiological 
saline (pH 7.4). 
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Figure 4 shows that the composite material was swelled up to 88 % and no 
further swelling was observed afterwards. Upon long-term incubation of scaffold 
material in a physiological saline solution, no physical alteration or deformation 
in coralline origin HA replica or fiber alignment was detected. Chitosan material 
is known to swell in aqueous solutions and sometimes this property can be 
used to secure biomaterial inside the implantation space [28], taking advantage 
of a press–fitting mechanism. The developed composite materials maintain their 
integrity when immersed in physiological media, even though they showed a 
brief swelling. Consequently, it can be expected that in implantation site it will 
show no further change in structure due to swelling. 
4. Conclusions 
A 3D composite of coralline origin HA microgranules was obtained by using a 
multichannel mould processing and chitosan as reinforcing material. The 
composite material showed parallel orientation of cylindrical coralline origin HA 
bodies along channel direction and good adhesion of particles to chitosan fibers 
and the outer chitosan membrane. MEM extraction test indicated no cell growth 
inhibition as determined by the trypan blue exclusion method. MTS test with the 
composite showed more than 90 % cell viability compare to negative controls. 
The cytotoxicity assays confirmed that the composite material is non-toxic. The 
swelling test in physiological medium indicated 88 % (w/w) swelling in one hour 
and afterwards no further change was observed. Long-term incubation of the 
composite in aqueous medium showed no change in integrity of the 
constituents of the composite material. Consequently the developed complex 
architectures presents a range of properties that might allow for their use in 
guided tissue regeneration and as tissue engineering scaffolds. 
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I am among those who think that science has a great beauty. A 
scientist is a child placed before a natural phenomena which 
impress him like a fairy tale 
        Marie Curie 
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CHAPTER V  
FORMATION OF BONE-LIKE APATITE LAYER ON CHITOSAN FIBER MESH 
SCAFFOLDS BY A BIOMIMETIC SPRAYING PROCESS  
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Abstract 
Bone-like apatite coating of polymeric substrates by means of biomimetic 
process is a possible way to enhance the bone bonding ability of the materials. 
The created apatite layer is believed to have an ability to provide a favorable 
environment for osteoblasts or osteoprogenitor cells.  
The purpose of this study is to obtain bone-like apatite layer onto chitosan 
fiber mesh tissue engineering scaffolds, by means of using a simple biomimetic 
coating process and to determine the influence of this coating on osteoblastic cell 
responses. Chitosan fiber mesh scaffolds produced by a previously described 
wet spinning methodology were initially wet with a Bioglass®-water suspension 
by means of a spraying methodology and then immersed in a simulated body 
fluid (SBF) mimicking physiological conditions for one week. The formation of 
apatite layer was observed morphologically by scanning electron microscopy 
(SEM). As a result of the use of the novel spraying methodology, a fine coating 
could also be observed penetrating into the pores, that is clearly within the bulk 
of the scaffolds. Fourier Transform Infrared spectroscopy (FTIR-ATR), Electron 
Dispersive Spectroscopy (EDS) and X-ray diffraction (XRD) analysis also 
confirmed the presence of apatite-like layer. A human osteoblast-like cell line 
(SaOs-2) was used for the direct cell contact assays. After two weeks of culture, 
samples were observed under the SEM. When compared to the control samples 
(unmodified chitosan fiber mesh scaffolds) the cell population was found to be 
higher in the Ca-P biomimetic coated scaffolds, which indicates that the levels of 
cell proliferation on this kind of scaffolds could be enhanced. Furthermore, it was 
also observed that the cells seeded in the Ca-P coated scaffolds have a more 
spread and flat morphology, which reveals an improvement on the cell adhesion 
patterns, phenomena that are always important in processes such as 
osteoconduction. 
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1. Introduction 
Bone is a complex, dynamic and highly vascular tissue with a large amount of 
extracellular matrix. In nanoscale, bone matrix consists of highly organized 
collagen fibers surrounded by apatite crystals [1]. Due to this very specialized 
structure, repair or replacement of damaged or traumatized bone still remains as 
a serious problem in surgery. For many years, autografts and allografts have 
been used for bone repair. However, there are many limitations and 
complications in the use of autogratfs and allografts, including limited supply, 
donor site morbidity and transfer of diseases.      
Engineering of bone tissue is a new approach to recreate complexity, 
stability, and biologic function of bone tissue. The most common strategy for the 
tissue engineering of bone is to use a scaffold combined with osteoblast or the 
cells that can mature/differentiate into osteoblasts and regulating factors that 
promote cell attachment, differentiation and mineralized bone formation [2]. To 
serve as a scaffold for bone tissue engineering, the material should be 
biocompatible, biodegradable, and porous with an interconnective pore structure 
in order to allow nutrients and metabolites to permeate. Furthermore, it must also 
be osteoconductive, so that osteoblasts and osteoprogenitor cells can attach and 
migrate in the scaffold.    
Calcium phosphate ceramics and bioactive glasses have been proposed 
to be used as a scaffold for bone tissue engineering due to their excellent 
osteoconductivity [3, 4]. It has been shown that they can bind to bone trough an 
apatite layer at the interface or bind directly to bone [5]. However, they can not 
serve alone as a scaffold because of their brittleness and low resistance against 
impact loading.  
Biodegradable polymers have been proposed as possible alternatives and 
received much attention as bone replacement materials [6-8]. They can be easily 
processed into 3-D porous structures with a proper degradation rate and 
mechanical strength. However, most of them are not show bioactivity without any 
surface modification. To overcome this problem, the surface of the material can 
be coated with HA or apatite. A number of methods, such as plasma spraying [9], 
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ion sputtering [10], laser deposition [11], sol-gel deposition [12], dip coating 
sintering [13], have been used for apatite coating of the material surfaces. 
However, these processes need very high temperatures or very high/low pH that 
can not be applied to the polymeric materials. In addition, the apatite formed by 
these processes is usually highly crystalline and has different crystal structure 
than that in natural bone apatite. Another drawback in these processes is the 
difficulties in obtaining a homogenous and a thin layer of coating on the surface 
of the material.  
Biomimetic coating using simulated body fluid (SBF) has been developed 
by Kokubo and co-workers as an alternative to the methods discussed above 
[14]. They have reported that the formed apatite, so-called bone-like apatite, is 
more similar to natural bone with a low crystallinity and nano-cyrstal size which is 
also an important issue in its degradation. Moreover, the conditions that are used 
in this process are very mild and allow applying a variety of polymeric and non-
polymeric surfaces [15, 16]. For instance, Reis et al. [17-19] adapted and used 
this methodology for starch-based biodegradable polymers. Regarding the 
mechanism, it has been shown that the functional groups on the polymer surface, 
such as Si-OH, Ti-OH and carboxyl or carboxylate, are the responsible for the 
apatite nucleation in SBF. Once the material with a functional surface immersed 
in SBF, which is already supersaturated with ions that constitute apatite, apatite 
nuclei starts to form and grow into a dense and uniform bone-like apatite layer 
[15]. One way to introduce functional Si-OH group on the polymeric surfaces is to 
face the polymer with Bioglass® particles before immersion in SBF [20].  
The objective of the present study is to obtain bone-like apatite layer on chitosan 
fiber mesh scaffolds by using the biomimetic approach.  We developed a new 
methodology based on a simple spraying process in order to have a 
homogeneous coating on these complex structures. Moreover, we also tested 
the scaffolds with human osteoblast-like cell line (SaOs-2) to determine the 
influence of bone-like apatite coating on cell adhesion and viability.  
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2. Materials&Methods 
Chitosan (deacetylation degree 87 %), was obtained from Aldrich Chemical Co.  
Bioglass® with particle size of 5µm was kindly supplied by US Biomaterials Corp. 
(Florida, USA). All the other chemicals used were of analytical grade.  
2.1. Production of Chitosan Fiber Mesh Scaffolds 
Chitosan fibers were produced as previously reported [21]. In brief, chitosan was 
dissolved in aq. 2% (v/v) acetic acid solution in 5% (w/v) concentration at room 
temperature overnight. Methanol was added to dilute the viscous solution for 
easy injection until reaching 3% (w/v) final concentration. Glycerol was used as a 
plasticizer (2.5% (w/w)). After filtration with a cloth filter, the solution was placed 
in an ultrasonic bath to remove the air bubbles. The clear solution was injected 
into a coagulation bath (30% 1N Na2SO4, 10% 1N NaOH and distilled water). 
The formed fibers were kept in this coagulation medium for one day and then 
washed several times with distilled water. They were then suspended in an 
aqueous 50% methanol solution for 1h and subsequently in 100% methanol for 
3h. The fibers were then put in a plastic cylindrical mould and dried at 60°C 
overnight.  
2.2. Biomimetic Coating 
A simple methodology was developed for the biomimetic coating experiments. 
The method is basically based on spraying a Bioglass®/water suspension on the 
surface of the scaffolds. This spraying methodology allows for the coating of the 
bulk of the scaffold. Briefly, a certain amount of Bioglass® was suspended in 
ultra-pure water. Produced scaffolds could then be wet with this Bioglass®-water 
suspension by using this simple methodology. After drying for a certain time 
under air flow, each sample was immersed in 40ml of simulated body fluid (SBF) 
(x1) (see Figure 1).  
The ion concentrations of SBF were approximately equal to those of human 
blood plasma.  The tubes were put in an incubator at 37°C for 7 days. The 
 96
Bioglass® particles 
suspended in water
Air flow
SBF (1X)
37°C, 7 days
Sample wet with
Bioglass®/water suspension
 
solution and the tubes were renewed next day. After the first day of immersion, 
renewal was every 2 days for the solution. In the end of the immersion period, 
samples were washed with distilled water and dried at room temperature. 
 
 
 
 
 
Figure 1. Shematic representation of a novel biomimetic Ca-P coating process 
using a simple spray. 
 
2.3. Characterization of Ca-P Coated Scaffolds 
In order to analyze the morphology of the Ca-P layer formed on the scaffolds, the 
samples were mounted onto brass stubs, sputter coated with gold and analyzed 
under a Scanning Electron Microscope (SEM) at an accelerating voltage 15kV. 
Electron Dispersive Spectroscopy (EDS) was also used to determine the 
presence of Ca and P in bioactive layers. To evaluate the changes on the 
chemical structure of sample surface, Fourier Transform Infrared Spectroscopy 
(FTIR-ATR) was used. Thin Film X-ray diffraction (TF-XRD) was used for 
identifying the crystalline phases present, and characterizing the 
crystalline/amorphous nature of the formed Ca-P bioactive layers. 
2.4. Cell Culture Studies with Osteoblasts 
A human osteoblasts SaOs-2 cell line was selected to study cell morphology, 
attachment and proliferation onto Ca-P coated chitosan fiber meshes scaffolds. 
Cells cultured in DME Media (Sigma), enriched with 10% FBS (Biochrome) and 
1% antibiotic/antimicotic solution (Sigma) were seeded directly over samples in a 
concentration of 2x106 cells/scaffold. Incubation was performed at 37 ºC (5% 
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CO2, 100% humidity) for 3 weeks. Uncoated samples were used as a control. 
After each incubation period, samples were washed with Phosphate Buffer 
Saline (PBS, Sigma) solution and fixed in gluteraldehyde 2.5% (v/v). For 
Scanning Electronic Microscopy (SEM) observation, samples were previously 
dehydrated in increasing alcohol concentrations (50%, 70%, 90% and 100%), air-
dried and sputter coated with gold.  
Cell viability  
A MTS assay was carried out to determine the cell viability after 3 weeks of 
culture by using Cell Titer 96® Aqueous One Solution Cell proliferation Assay kit 
(Promega, USA). This test is based on the bioreduction of the substrate, (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4-sulfophenyl)-2H 
tetrazolium) (MTS), into a brown formazan product by NADPH or NADP 
produced by dehydrogenase enzymes in metabolically active cells. According to 
the standard procedure, the triplicates of samples were placed in a new plate and 
fresh medium was added to each well. MTS reagent in 5/1 ratio was added to 
each well and then incubated for three hours at 37 ºC in a humidified atmosphere 
containing 5% of CO2.  A 100µl of incubated medium was transferred to 96-well 
plate culture plate and the optical density was read at 490nm in a micro-plate 
reader (Synergy HT, Bio-tek). 
Alkaline Phosphatase (ALP) Activity 
In order to determine the amount of alkaline phosphatase (ALP) produced by the 
cells seeded on the scaffolds, scaffolds/ cells constructs were washed, freeze-
thawed and sonicated after 3 weeks of culture. p-Nitrophenyl phosphate (pNPP) 
was added to the supernatant in the ratio of 1/3 and incubated at 37°C for 1 h. 
The enzyme reaction was then stopped by a solution containing 2 M NaOH and 
0.2 mM EDTA in distilled water. The absorbance of p-nitrophenol (pNP) formed 
was determined at 405 nm with a reference filter at 620 nm. A standard curve 
was made using pNP values ranging from 0 to 600 µmol/ml. The results were 
expressed as µmol of pNP produced/ml/h. 
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3. Results&Discussion 
3.1. Biomimetic Coating 
The scaffolds used in this study were porous chitosan fiber meshes of a 
cylindrical shape with a diameter of 1cm (Figure 2).  
 
 
 
 
 
Figure 2. Chitosan fiber mesh scaffolds produced by wet spinning 
 The structure is made of randomly oriented fibers with an average 
diameter of 100µm and these fibers form a highly interconnected nest-like 
structure as it can be seen from SEM micrographs (see Figure 3.A and B). As we 
have reported before [21], these scaffolds have a very high water uptake ability, 
which can of course provide better adhesion of Bioglass® particles on the 
surface of the fiber during the biomimetic coating process. However the coating 
of biodegradable scaffolds with biomimetic Ca-P layers is rather difficult and not 
many examples of this can be found on the literature [22, 23]. 
 
  
 
 
 
Figure 3. SEM micrographs of chitosan fiber mesh scaffolds; A) x15, B) x200 
A B 
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SEM micrographs of Ca-P coated chitosan fiber mesh scaffolds were given in 
Figure 4.  
 
 
 
 
 
 
 
 
 
Figure 4. SEM micrographs of the developed coated scaffolds, exhibiting a fine 
and homogenous Ca-P layer onto chitosan fiber meshes surfaces; A) x100, B) 
x300, C) 500, D) x5000 
 After Bioglass® spraying to the samples, a fine and homogenous Ca-P 
layer was observed on their surface after 7 days soaking in SBF solution. Kokubo 
et al. [24, 25] proposed the mechanism of bone-like apatite formation on 
polymeric surfaces when CaO-SiO2 glass particles are used as a nucleation-
inducing agent. According to this mechanism, silicate ions released from the 
glass particles are attached on the polymer surface and Si-OH groups in the 
silicate ions induce the apatite nucleation on the surface. At the same time, the 
release of calcium ions from glass particles increases the ionic activity product of 
SBF with respect to apatite and accelerates the apatite nucleation. Finally, the 
apatite nuclei formed on the surface grow spontaneously by consuming Ca and P 
A B 
C D 
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ions from the fluid. Using this approach, many flat polymeric surfaces have been 
coated with bone-like apatite by rolling the samples in Bioglass®/water 
suspension [26]. However, the rolling process is not suitable for more complex 
surfaces due to the non-homogenous distribution of Bioglass® particles. 
Therefore, we developed a simple spraying method which allowed a 
homogenous distribution of glass particles on the scaffold surface as well as 
inside the structure. As a result of this method, a homogenous bone-like apatite 
layer was observed on the individual fibers. Moreover, it was also possible to see 
the typical cauliflower morphology of bone-like apatite layer in SEM micrographs 
with a higher magnification (Figure 4.D).  
 The EDS spectra of the coated samples confirmed the formation of apatite 
layer by showing the Ca and P elements (Figure 5). The typical Ca-P ratio was 
around 1.6 ±0.10 which is similar to natural bone apatite.  
 
 
 
 
 
 
 
 
 
Figure 5. EDS spectra of Ca-P coated chitosan fiber mesh scaffolds. 
 
Figure 6 shows FTIR spectra of control (uncoated chitosan fiber meshes) 
and biomimetic Ca-P coated chitosan fiber meshes. Uncoated samples 
presented the characteristic absorption bands of chitosan which are a wide band 
associated with –OH group at around 3400cm-1 and a band associated with 
glycosidic linkage at around 1050cm-1. After Ca-P coating of the surface, the 
characteristic band attributed to –OH tend to disappear while a sharp band 
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appeared at 1030cm-1 which is a characteristic P-O stretching band. The 
decrease in the intensity of –OH stretching group might be due to the increase in 
the carbonate substitution as has been reported by the others [27, 28]. It has 
been suggested that when the carbonate substitution increase, carbonate ions 
replace with hydroxyl ions [28]. These results demonstrated that the surfaces of 
the chitosan fibers were completely coated by a carbonated apatite layer. 
 
 
 
 
 
 
 
 
 
 
Figure 6. FTIR spectra of Ca-P coated sample and uncoated sample. 
 
 
 
 
 
 
 
 
 
 
Figure 7. Thin-film XRD patterns of the chitosan fiber meshes immersed in SBF 
for 7 days. 
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Thin-film XRD of the samples immersed in SBF for 7 days is presented in 
Figure 7. The main diffraction peak at 2θ=32° is a contribution of (211), (300) and 
(202) planes of apatite. Another main diffraction peak at 2θ=26° indicated the 
(002) lattice plane of apatite crystals. Other diffraction peak of apatite appeared 
around at 2θ=40° as it was marked in Figure 7. The broad peak at around 2θ=20° 
was due to the chitosan. The intensity of this peak decreased after coating which 
confirms once again the apatite layer on the surface of fibers.  
3.2. Cell Culture Studies with Osteoblasts 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Human osteoblast like cells seeded on A) Ca-P coated (x2000), B) Ca-
P coated (x3000) and C) uncoated (x2000) chitosan fiber mesh scaffolds after 2 
weeks of culture. 
 
 
 
 
A B 
C 
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Figure 9. Human osteoblast like cells (SaOs-2) seeded on A) Ca-P coated 
(x1000), B) Ca-P coated (x4000) and C) uncoated (x1000) chitosan fiber mesh 
scaffolds after 3 weeks of culture. 
 
Figure 8 and 9 exhibit the SEM micrographs of osteoblasts seeded on the 
surface of Ca-P coated and uncoated samples after 2 and 3 weeks of culture, 
respectively. The cells were observed to be able to attach and to proliferate in 
both surfaces. However, they seemed to be more spread and presented a 
different morphology when the surface was pre-coated with a Ca-P layer. This is 
a result of the changes in the surface chemistry of the scaffolds. Several 
investigators have reported that the surface chemistry and the topography can 
directly affect the osteoblast response and determine cell attachment and 
alignment [29-31]. Depending on the surface composition and the topography, 
protein, ligands and integrins can adsorb to the surface in different structures and 
adhesion kinetics [32]. Due to the different interaction between the adhesion 
ligands adsorbed to different surfaces and the adhesion receptors of the cells, 
cells can generate different adhesion signals. These adhesion signals influence 
A B 
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further cell attachment and morphology. In the present study, it was not possible 
to evaluate the effect of surface topography because of the irregular surface 
structure of the chitosan fibers. However, we can say that the surface chemistry 
has a clear clear influence on cell attachment and morphology. The difference on 
the cell spreading behaviour could also be observed clearly with a longer 
culturing time. The osteoblasts started to form a complete layer on the surface of 
fibers after 3 weeks of culture (Figure 9. B).  
The Ca-P coating also influenced the long-term cell viability on the 
scaffolds. Figure 10 shows the MTS results after 3 weeks of culture. MTS is an 
indirect assay to determine the metabolic activity and number of the cells. As it 
can be seen, osteoblasts seeded on the Ca-P coated scaffolds showed higher 
O.D. value than control samples which means metabolic activity and number of 
cells were higher in the Ca-P coated samples. This can be related to the 
enhanced cell attachment on the Ca-P coated samples. In fact, it has been 
reported that initial cell attachment affects further proliferation of the cells [33].  
 
 
 
 
 
 
 
 
 
Figure 10. Cell viability and proliferation of human osteoblast like cells 
determined by MTS after 3 weeks of culture. Error bars represent means ± SD 
for n=3.   
 
ALP is a well-known enzyme used as a marker of the osteogenic 
phenotype, which catalyzes the hydrolysis of phosphate esters at an alkaline pH 
[34]. It has been also demonstrated that it plays an important role in bone matrix 
mineralization process. Figure 11 presents the ALP activity of the cells cultured 
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on the coated and control scaffolds. ALP activity of the cells seeded on the Ca-P 
scaffolds were found significantly higher than that on control. One possible 
reason for that can be the release of the Ca2+ ions from the coating to the culture 
medium. Matsuoka et al. [35] showed that ALP activity and osteogenic 
differentiation of osteoblastic cells increased if there is an increase of Ca 
concentration in culture medium by release from the apatite. However, further 
studies are still needed to understand the details of mechanism of the cellular 
response to Ca-P coating that is described herein.  
 
 
 
 
 
 
Figure 11. The ALP activity of human osteoblast like cells seeded on Ca-P 
coated scaffolds and control (uncoated scaffolds). Error bars represent means ± 
SD for n=3 
4. Conclusions 
A novel and simple biomimetic approach was described for the preparation of 
bone-like apatite coated chitosan scaffolds. Fiber mesh type scaffolds could be 
prepared from chitosan by a wet spinning method. A homogenous Ca-P coating 
was produced on the surface and the bulk of chitosan scaffolds by means of 
using the proposed methodology. After 7 days of immersion in the SBF solution, 
a fine and homogenous bone-like apatite layer was observed on the surface of 
chitosan fibers. Furthermore, osteoblasts adhered on Ca-P coated samples 
showed a more spread and distinct morphology. Higher cell numbers were 
observed on the caoted scaffolds as compared to the uncoated samples. On the 
basis of these results, Ca-P coated scaffolds obtained by the proposed 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
 
 
 
 
 
 
p-
ny
tro
ph
en
ol
 (µ
m
ol
/m
l/h
)x
 5
x1
0-
1 Ca-P coated
uncoated
  
p-
ny
tro
ph
en
ol
 (µ
m
ol
/m
l/h
)x
 5
x1
0-
1
 
 106
biomimetic process can be useful to be used as a bone tissue engineering 
scaffolds.   
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Your theory is crazy, but it's not crazy enough to be true.  
              Niels Bohr 
 
 
  111
CHAPTER VI 
A NEW ROUTE TO PRODUCE STARCH-BASED FIBER MESH SCAFFOLDS 
BY WET SPINNING AND SUBSEQUENT SURFACE MODIFICATION AS A 
WAY TO IMPROVE CELL ATTACHMENT AND PROLIFERATION  
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Abstract 
This study proposes a new route for producing fiber mesh scaffolds from a 
starch-polycaprolactone blend. It was demonstrated that the scaffolds with 77% 
porosity could be obtained by a simple wet spinning technique based on 
solution/precipitation of a polymeric blend. In order to enhance the cell 
attachment and proliferation, Ar plasma treatment was applied to the scaffolds. 
It was observed that the surface morphology and chemical composition were 
significantly changed due to the etching and functionalization of the fiber 
surfaces. XPS analyses showed an increase of the oxygen content of the fiber 
surfaces after plasma treatment (untreated scaffolds O/C:0.26 and plasma 
treated scaffolds O/C:0.32). Both untreated and treated scaffolds were 
examined using a SaOs-2 human osteoblast-like cell line during 2 weeks of 
culture. The cell seeded on wet-spun SPCL fiber mesh scaffolds showed high 
viability and alkaline phosphatase enzyme activity, being those values were 
even higher for the cells seeded on the plasma treated scaffolds.  
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1. Introduction 
Tissue engineering offers a promising new approach to create biological 
alternatives for regeneration of different tissues. It involves the use of tissue-
specific cells seeded in a scaffold which can guide the cell growth and tissue 
formation in three dimensions. To bring about the desired biological response, a 
scaffold should possess a number of characteristics such as three dimensional 
highly porous and interconnective structure, large surface area, adequate pore 
size, suitable surface chemistry and mechanical properties, etc. [1] 
Biodegradable polymeric fiber structures can provide a large surface 
area and a relatively large porosity which can be optimized for specific 
applications. Besides these, many tissues, such as nerve, muscle, tendon, 
ligament, blood vessel, bone, and teeth, have tubular or fibrous bundle 
architectures and anisotropic properties. Therefore, fiber-based structures find a 
number of applications in tissue engineering, including soft tissue repair [2], 
vascular prostheses [3], bone [4, 5] and cartilage scaffolds [6], among others.  
There are three main techniques to produce fibers to be used in 
biomedical applications: melt spinning, dry spinning and wet spinning. Melt 
spinning is based on the extrusion of polymeric melt while the spinning process 
starts from polymeric solution in the case of dry and wet spinning. Most of the 
synthetic polyester fibers used in tissue engineering are produced by a 
conventional melt spinning technique [7, 8]. However, excessively high 
processing temperatures may result in monomer formation during extrusion 
process. The excess monomer can catalyze the hydrolysis of the material. The 
wet spinning technique is an alternative way to produce biodegradable 
polyester fibers for the use in tissue engineering [9-12]. The fiber properties can 
be tailored depending on the spinning rate, the concentration of the polymer 
solution and coagulation bath. A highly viscous solution and high spinning rate 
allow fiber precipitation at the bottom of the coagulation bath. This approach 
could be used to form scaffolds during the processing. 
In design of a tissue engineering scaffold, surface physicochemistry is 
one of the most important issues to be considered. The physicochemical 
properties of the surface directly influence the scaffold performance by effecting 
the cellular response and ultimately effecting the new tissue formation [13]. In 
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order to improve the cell affinity, the surface hydrophilicity, surface energy, 
surface roughness and surface charge can be modify by different methods, 
including mechanical treatments, wet chemical treatments and plasma 
treatments. Chemical treatments have been widely used to modify the 
biomaterial surfaces [14, 15]. However, the main problem of these treatments is 
the influence of the treatment on the bulk properties of the material. The surface 
of the materials can be modified by plasma tretment without altering the bulk 
properties of the material [16, 17]. By this technique, it is possible to introduce 
or graft desired functional groups and polymer chains onto the surface. The 
surface roughness which plays an important role for cell attachment can be also 
changed by plasma treatment. Therefore, plasma is a valuable method for 
improve cell affinity to the tissue engineering scaffolds.  
In the present study, we describe a new route for the production of 
starch-based fiber mesh scaffolds which allows forming of scaffolds during 
spinning. This new route also avoids polymer degradation which is the main 
problem of melt-based systems. The surface properties of the produced 
scaffolds are tailored by plasma treatment in order to enhance cell attachment 
and proliferation 
2. Materials&Methods 
2.1. Materials 
A blend of starch/poycaprolactone (SPCL) (30/70 wt %) was used to produce 
fiber mesh scaffolds. More information on these materials can be found 
elsewhere. All the reagents used were analytical grade unless specified 
otherwise.   
2.2. Wet Spinning Process 
Starch-based fiber mesh scaffolds were originally produced by wet spinning. In 
order to obtain a polymer solution with proper viscosity, SPCL was dissolved in 
chloroform at a concentration of 40% (w/v). Please note that, it was possible to 
obtain a homogenous suspension of starch particles into the solution even 
though the only the synthetic part of the blend was soluble in the chloroform. 
Methanol was used as a coagulant. The polymer solution was loaded into a 
  115
syringe and placed in a syringe pump (World Precision Instruments, UK). A 
certain amount of polymer solution was subsequently extruded into a 
coagulation bath. The fiber mesh structure was formed during the processing by 
the random movement of the coagulation bath. The formed scaffolds were then 
dried at room temperature overnight in order to remove any remaining solvents. 
After spinning, the internal architecture of the produced fiber meshes was 
characterized by micro-computed tomography (µCT) [18]. The surface 
morphology of the fibers was analyzed under a scanning electron microscope 
(SEM, Leica Cambridge S360 microscope). Specifically, three specimens were 
scanned in air using a µCT imaging system (µCT40, Scanco Medical AG, 
Bassersdorf, Switzerland) with a nominal resolution of 12 m. The 
reconstructed images were filtered using a constrained 3D Gaussian filter to 
partially suppress noise in the volumes (µ = 1.2 voxel, support = 1 voxel), and 
binarized using a global threshold. Standard 3D morphometry as developed for 
trabecular bone was used to assess structural parameters for the scaffolds. 
These parameters included porosity and scaffold surface-to-volume ratio and 
were derived from a triangulated mesh allowing for computation of surface and 
volume [19]. In addition, pore size and fiber thickness were determined using 
the distance transformation method [20]. In this method, each pore (fiber) is 
filled with a non-redundant set of maximal spheres. Mean pore (fiber) size was 
then calculated as the volume-averaged diameter of all spheres making up the 
pore (fiber).  
2. 3. Plasma Surface Treatment 
In order to improve cell attachment and proliferation, a plasma treatment was 
performed using a plasma reactor PlasmaPrep5 (Gala Instrument GmbH, 
Germany) with a chamber size of 15 cm diameter and 31 cm length (5L) and 
with a fully automated process control. In order to maximize the surface area to 
be exposed to the plasma, the samples were wired (necklace like) with a 
distance of 1 cm between them. The wire was fixed to a metal support which 
was placed into the chamber. The chamber was flushed with argon five times 
prior to treatment. A radio frequency (RF) source was used and a power of 30 
W was applied for 15 minutes. Argon was used as a working gas and the 
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pressure in the reactor was controlled (0.18 mbar) by adjusting its flow rate. The 
samples were kept 24 hours after being removed from the reactor and then 
characterized. 
X-ray Photoelectron Spectroscopy (XPS) 
X-ray photoelectron spectroscopy (XPS) was used to quantitatively determine 
the surface composition of the scaffolds. The XPS analysis were performed 
using an 250 iXL ESCA instrument (VG Scientific) equipped with two X-Ray 
sources: a source with Al Ka1,2 monochromatized radiation at 1486.92 eV and 
another one (Dual) equipped with two anodes: Mg and Al. 
The nonconductive nature of the samples required the use of an electron 
flood gun to minimize surface charging. Charge compensation at the surface 
was performed by using both a low energy flood gun (electrons in the range 0 to 
14 eV) and an electrically grounded stain steel screen placed directly on the 
sample surface.  
 The first attempt to measure the samples was the use of the 
monochromatic X-ray source. However, this was impossible due to the high 
roughness of the samples which caused problems to build up the charge. 
Generally, charge neutralization for 3D surfaces is more difficult because of the 
“holes” on the surface. The best choice for these cases is Mg source which 
helps to neutralize the surface charge. Therefore, the measurements were 
carried out using non-monochromatic Mg-Kα radiation (hν=1253.6 eV). 
Photoelectrons were collected from a take off angle of 90º relative to the sample 
surface. The measurements were performed in the constant analyzer energy 
mode (CAE) with a 100 eV pass energy for survey spectra and 20eV pass 
energy for high resolution spectra. C1s high resolution scans were taken before 
and after experiments in order to check out the efficiency of charge 
compensation. 
 Charge referencing was done by setting the lower binding energy C1s 
hydrocarbon (CHx) peak at 285.0 eV.  
 The atomic composition of the samples was determined from the survey 
spectra using the standard Scofield photoemission cross sections. The 
chemical functional group identification was obtained from the high-resolution 
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peak analysis of C1s envelopes. The spectra fitting were performed using the 
“Chi-squared” algorithm to determine the goodness of a peak fit.  
2. 4. Cell Culture Studies 
A human osteoblast-like cell line (SaOs-2) was used to test the cell attachment 
and proliferation on the scaffolds. A 1ml of cell suspension containing 3x105 
cells in a culture medium (DMEM low glucose supplemented with 10% Fetal 
Bovine Serum and 1% antibiotics/antimicotics) were dropped onto scaffolds 
(n=3).  The cells on scaffolds were then allowed to grow for 2 weeks at 37°C in 
humidified atmosphere containing 5% CO2 with medium changes every 2-3 
days. 
Morphological Analysis 
For the morphological examination, cell/scaffold constructs were rinsed with 
Phosphate Buffer Saline (PBS, Sigma, USA) and then fixed in 2.5% 
glutaraldehyde. The samples were dehydrated through graded series of ethanol 
and dried before mounting onto brass stubs, sputter coated with gold. Finally, 
the samples were analyzed under a scanning electron microscope (SEM) at an 
acceleration voltage of 15kV. 
Cell Proliferation-DNA Assay 
Cell proliferation was evaluated by quantifying DNA content using the 
PicoGreen dsDNA kit (Molecular Probes, USA). PicoGreen dsDNA Quantitation 
Reagent is an ultra-sensitive fluorescent nucleic acid stain for quantitative 
analysis of double-stranded DNA (dsDNA) in solution. 
For the assay, the scaffold/cell constructs (n=3) were rinsed with PBS 
and incubated with sterile ultra pure water at 37°C for 1h before putting at -
80°C. The samples were then thawed and put in an ultrasonic bath for 15 min. 
An aliquot of each sample was transferred to the 96-well plate. A certain ratio of 
Tris-EDTA buffer and PicoGreen reagent prepared in the same buffer was 
added to the each well. The fluorescence was read at 485nm and 528nm 
excitation and emission, respectively. The DNA amount of each samples was 
then calculated using a standard curve.  
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Alkaline Phosphatase (ALP) Activity 
Alkaline phosphatase (ALP) activity from the scaffolds/cells constructs (n=3) 
was quantified by the specific conversion of p-nitrophenyl phosphate (pNPP) 
into p-nitrophenol (pNP). To perform the assay, the seeded scaffolds were 
rinsed with PBS and transferred individually into eppendorf containing sterile 
ultra pure water. They were then frozen at -80oC and defrosted at room 
temperature before starting the assay. A buffer solution containing 0.2% w/v p-
nitrophenyl phosphate was added to the samples in a ratio of 1:3. The enzyme 
reaction was carried out at 37°C for 1 h and then stopped by a solution 
containing 2 M NaOH and 0.2 mM EDTA in distilled water. The absorbance of 
p-nitrophenol formed was determined at 405 nm with a reference filter at 620 
nm. A standard curve was made using pNP values ranging from 0 to 600 
µmol/ml. The results were expressed as µmol of pNP produced/ml/h.  
Statistical Analysis 
All the quantitative results were obtained from triplicate samples. Data were 
expressed as a mean ±SD. For statistical analysis, a two-tailed Student's t-test 
was used. Differences were considered to be significant at p< 0.05.  
3. Results and Discussion 
3.1. Morphology of the scaffolds 
 
 
 
 
 
 
 
 
 
Figure 1. Morphology of the wet-spun SPCL fiber mesh scaffolds analysed by; 
A) µCT, showing thin section of sample, B) SEM  
 
 
1mm
 
A B 
  119
Figure 1.A and B present respectively the µCT and SEM images of SPCL 
fiber mesh scaffolds produced by wet spinning. It can be clearly seen that, the 
SPCL fibers were randomly formed into a 3D structure. The porosity of the 
scaffolds, determined by µCT, was 77%. µCT morphometry showed that fiber 
diameter was 100µm; mean pore size was 250µm, which is in the range of ideal 
pore size for bone regeneration [21]. The scaffolds have a high surface to 
volume ratio: the specific scaffold surface was 29 mm2/mm3, similar to that of 
native bone [20]. Moreover, µCT showed that wet-spinning was a very 
reproducible procedure; the coefficient of variation (CV) for fiber thickness was 
4.2%; for the other parameters, CV was 1.2% or below. 
Previous studies have reported that 2D polymer surfaces could be easily 
modified by different plasma techniques [22-24]. However, it becomes more 
complicated in the case of 3D porous polymeric structure due to the pore 
structures and low interconnectivity which do not allow the penetration of 
plasma exposition in the interior part of the structure because of the shadow 
effect. In the present study, the wet-spun scaffolds produced presented a highly 
porous and interconnected structure that can overcome this problem of plasma 
surface modification. In the case of wet-spun scaffolds, the treatment is very 
similar to treatment of a single fiber. As a result, the surface exposed to the 
plasma is much higher, which allows for a more uniform and effective surface 
treatment. 
3.2. Plasma Treatment 
 
 
 
 
 
 
Figure 2. The surface of the SPCL fiber mesh scaffolds; A) before (x3000) and  
B) after Ar plasma treatment (x3000). 
A B 
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Due to phase inversion during precipitation, the surface of the fibers 
exibited a non-smooth morphology (Figure 2.A). After plasma treatment, a 
significant difference on the fiber surfaces was observed (Figure 2.B). It is well 
known that the surface roughness typically tends to increase after a plasma 
treatment due to the so-called etching process [25]. When the plasma is 
composed of an inorganic gas such as argon, helium, hydrogen, nitrogen, and 
oxygen, it leads to the etching reactions on the topmost layer of the polymer 
surface [26]. This etching is a result of stripping off the topmost layer of the 
polymer because of the weight loss of the polymer during the plasma exposure. 
However, the SPCL fiber surfaces showed a denser and smaller nano-size 
roughness after plasma treatment. Since SPCL has a very low glass transition 
temperature (-60°C), it can be explained by melting and etching that 
consecutively occured on the surface during the plasma process.  
X-ray photoelectron spectroscopy (XPS) analysis was performed in order 
to obtain more detailed information for the chemical structures and groups 
presented on the surface before and after the performed modification. The 
results obtained are summarized in Table 1.  
 
Table 1. XPS data for wet spun SPCL scaffolds before and after modification 
 
 C% O% O:C/C:O ratio 
Theoretical PCL 69.2 30.8 0.45/2.25 
Theoretical SPCL 62.7 37.3 0.59/1.68 
Fiber mesh, 
untreated 
76.9 20.4 0.26/3.77 
Fiber mesh 
modified 
69.7 22.1 0.32/3.15 
 
As it can be seen from the table the measured oxygen content on the 
surface is lower than the theoretical one calculated for PCL. The difference 
between the bulk and surface composition of the material is not a surprise. It 
has been reported [27, 28] that in polymeric systems, the composition near to 
the surface can be markedly different from the bulk. In fact, due the high 
complexity of blend chemistry, different components may predominate at the 
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surface, depending on the blend composition, crystallinity of the components, 
complexity and degree of miscibility of the system, processing conditions and 
also the nature of surrounding environment [27-29]. However, after plasma 
modification the oxygen content on the surface increase and an O/C ratio of 
0.32 was measured (compared to 0.26 for the untreated material). Oxidation is 
not the only process which is taking place on the surface during the plasma 
treatment. As can be seen from the table the percentage of carbon was also 
changed after the treatment; it reduced from 76.9 to 69.7 confirming the 
presence of some etching. 
More detailed analyze of C1s core level spectra of SPCL fiber mesh 
samples (Figure 3) showed that they contain three main peaks – at 285 eV, 
which was assigned to the main carbon backbone, at 286.4 eV for −C−O− and 
at about 288.8eV for carboxyl bonded carbons. This is not unexpected since the 
main component of the blend poly(ε-caprolactone) has all of those bonds 
present in its structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. C1s core level spectra for wet-spun SPCL fiber meshes A) before and 
B) after Ar plasma treatment 
 
The intensity of the peaks at 286.4 eV and 288.8 eV increased after 
treatment as it can be seen from Figure 3. The created active species on the 
surface by Ar plasma are very reactive and can recombine with the oxygen from 
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the air. As a result surface functionalization with different oxygen containing 
groups occurs on the surface and this is the reason for the observed differences 
in the C1s core level spectra. It should be noted that the occurred surface 
oxidation is not as powerful as the one in which oxygen plasma is employed; in 
the latter case much more hydrophilic surfaces are produced which do not 
promote protein adsorption and consequently do not favour cell adhesion. 
3.3. Cell Culture  
Morphological Analysis 
The morphology and the shape of the osteoblast seeded onto both untreated 
and plasma treated fiber meshes showed a clear difference after different time 
of culturing (Figure 4, 5, and 6). It was observed that the cells were able to grow 
and making a film on the treated surface while they were in spindle-like shape 
with cytoplasmic extension on the untreated surface after 3 days of culture 
(Figure 4).  
 
 
 
 
 
 
 
 
Figure 4. SEM micrographs of osteoblast-like cells seeded on SPCL fiber mesh 
scaffolds after 3 days of culture; A) untreated, B) Ar plasma treated scaffold 
 
This was more evident after 7 days of culture (Figure 5.A and B). Both scaffolds 
were completely covered by cells, which indicate the ability of the scaffolds for 
osteoblast cell attachment and proliferation.  
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A B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.B. SEM micrographs of osteoblast-like cells seeded on A) untreated 
and B) Ar plasma treated SPCL fiber mesh scaffolds after 7 days of culture. 
(Picture at right shows the cells on the surface with higher magnification, 
(x1000)) 
 
However, the osteoblasts seeded on the treated fiber meshes were able to 
bridge between the fibers after 14 days of culture (Figure 6.A).  
 
 
 
 
 
Figure 6. SEM micrographs of osteoblast-like cells seeded on SPCL fiber mesh 
scaffolds after 3 days of culture; A) untreated, B) Ar plasma treated scaffold 
 
A 
B 
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Cell Viability 
Besides the cell morphology, changing the surface chemistry and topography 
also influenced the metabolic activity of the cells. As it was discussed above, 
the oxygen content of the fiber surfaces significantly increased after plasma 
treatment due to degradation and functionalization of the fiber surfaces. It is 
known that osteoblasts are attachment-dependent cell [30]. They can only 
produce and mineralize their extracellular matrix if they attach in a proper 
surface that allows specific cell-surface interaction. They also can recognize the 
changes in the surface topography if it is above 0.5 µm [31]. Therefore, DNA 
amount was significantly different between untreated and treated scaffolds after 
3 and 7 days of culture (p=0.045 and p=0.015 for 3 and 7 days, respectively) 
while it was not significant after 14 days (Figure 7). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Cell viability and proliferation of human osteoblast like cells 
determined by DNA. Error bars represent means ± SD for n=3.   
 
This can be explained by the effect of plasma treatment in the initial 
stage of culture. By plasma treatment, it is possible to increase the serum 
protein adsorption on the surfaces which would be resulted in an increase of 
initial cell attachment. Once they reached confluency, the rate of cellular death 
and proliferation becomes equal and hence the proliferation stops. This fact can 
explain the decrease in the difference between untreated and treated samples 
after 14 days of culture.  
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ALP activity 
Alkaline phosphatase is an enzyme which is used as an early marker for 
osteoblast differentiation. Although its exact role is not very clear, it is known 
that it plays an important role in bone matrix mineralization process [30]. 
Regarding the present experiments, ALP activity of the cells cultured onto the 
SPCL fiber meshes increased with the culture period (Figure 8). The enzyme 
activity of the cells was found to be even higher if the scaffolds were treated by 
plasma. On the other hand, the differences in the enzymatic activity between 
the cells seeded on untreated and treated scaffolds decreased after 14 days of 
culture. It has been reported that the deposition of extracellular matrix occurs 
before the mineralization starts [32]. This latest stage of cell differentiation 
precedes mineralization and thereby ALP enzyme activity which is associated 
with calcification tends to decrease [33, 34]. This phenomenon can explain the 
ALP results from the present study indicating that the cells cultured on 
untreated and treated scaffolds might be in different stage of differentiation. 
 
 
 
 
 
 
 
Figure 8. The ALP activity of human osteoblast like cells seeded on untreated 
and Ar plasma treated wet-spun SPCL fiber meshes. Error bars represent 
means ± SD for n=3. 
4. Conclusions 
A new route was described to produce starch-based fiber mesh scaffolds. The 
results of this study indicated that a simple wet-spinning technique could be 
used to obtain highly porous fiber mesh scaffolds from a biodegradable starch-
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polycaprolactone blend. The scaffolds could be formed, in a very reproducible 
manner, during the process by means of optimizing the processing conditions. 
Furthermore, the developed scaffolds were able to support osteoblast-like cell 
attachment and proliferation. As a second step, the scaffolds surfaces were 
modified by using Ar plasma. After plasma treatment, the surface morphology 
and surface chemical composition of the fibers were significantly changed. 
Osteoblast-like cells were able to recognize these physical and chemical 
changes on the surface and they showed higher cell viability and ALP enzyme 
activity on the treated scaffolds. 
As a final conclusion, these results suggested that starch-based fiber mesh 
scaffolds can be easily processed by a wet spinning technique into adequate 
scaffolds. Subjecting these scaffolds to Ar plasma can enhance their suitability 
for tissue engineering applications. 
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A straight line may be the shortest distance between two points, 
but it is by no means the most interesting.                                                             
                      Dr. Who 
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CHAPTER VII 
NANO- AND MICRO-FIBER COMBINED SCAFFOLDS:  
A NEW ARCHITECTURE FOR BONE TISSUE ENGINEERING 
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Abstract 
One possible interesting way of designing a scaffold for bone tissue engineering 
is to base it on trying to mimic the biophysical structure of natural extracellular 
matrix (ECM). This work was developed in order to produce scaffolds for 
supporting bone cells. Nano and micro fiber combined scaffolds were originally 
produced from starch based biomaterials by means of a fiber bonding and a 
electrospinning, two step methodology. The cell culture studies with SaOs-2 
human osteoblast-like cell line and rat bone marrow stromal cells demonstrated 
that presence of nanofibers influenced cell shape and cytoskeletal organization 
of the cells on the nano/micro combined scaffolds. Moreover, cell viability and 
Alkaline Phosphatase (ALP) activity for both cell types was found to be higher in 
nano/micro combined scaffolds than in control scaffolds based on fiber meshes 
without nanofibers.   
Consequently, the developed structures are believed have a great potential on 
the 3D organization and guidance of cells that is provided for engineering of 3-
dimensional bone tissues. 
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1. Introduction 
Bone tissue engineering has become a rapidly expanding research area since it 
offers a new and promising approach for bone repair and regeneration. Several 
requirements have been considered for engineering bone, including choosing a 
cell type that matures/differentiates into bone cells with the proper form and 
phenotype, regulating the growth factors and designing a so-called ideal scaffold 
[1]. The requirements for the design and production of an ideal scaffold are also 
very complex and not yet fully understood. An ideal scaffold must be 
biocompatible both in bulk and degraded form, exhibit a porous, interconnected, 
and permeable structure to permit the ingress of cells and nutrients, and should 
exhibit the appropriate surface structure and chemistry for cell adhesion and 
proliferation. The processing techniques used to obtain polymeric scaffolds 
include solvent casting and particulate leaching, gas foaming, freeze drying, 
rapid prototyping, thermally induce phase separating, fiber bonding, melt molding 
and electrospinning, as reviewed elsewhere [2]. Several techniques aim to 
produce a scaffold which can mimic in some way the architecture of the natural 
extracellular matrix (ECM).  
Natural extracellular matrix (ECM) is composed of various protein fibrils 
and fibers interwoven within a hydrated network of glycosaminoglycan chains [3]. 
This network structure serves as a scaffold which can support tensile and 
compressive stresses by the fibrils and hydrated networks. Besides providing an 
appropriate microenvironment for cells, ECM is responsible for transmitting 
signals to cell membrane receptors that reach nucleus via intracellular signaling 
cascades. Therefore, the fibrillar and porous structure of ECM have a great 
influence on cell functionality, mainly on cell adhesion and migration. 
In last few years, the electrospining processes have attracted a great deal 
of attention as a way to try to mimic the structure of natural ECM by means of 
producing fibers down to 3nm [4]. This process is based on the generation of an 
electrical field between a polymeric solution (or a polymer melt) placed in a 
capillary tube with a pipette or needle of small diameter and a metal collector. 
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When the electrical field reaches its critical value, repulsive electrostatic force 
overcomes the surface tension of the polymeric solution and a charged jet is 
produced. This charged polymeric jet then undergoes a stretching process which 
is accompanied by the rapid solvent evaporation and results the formation of long 
and thin fibers [5]. Electrospining has been used to fabricate nanofibrous 
structures from a number of both natural synthetic polymers, such as collagen 
[6], chitosan [7], chitin [8], silk fibroin [9] and polyethyleneoxide [10], poly(DL-
lactide-co-glycolide) [11], poly(L-lactide) [12], and polycaprolactone [13], among 
many others. The produced nanofibrous polymeric networks have been proposed 
for engineering of many different tissues. For instance, Li et al. [14] reported that 
electrospun poly(ε-caprolactone) membranes could promote chondrocyte 
proliferation and provide  maintenance of chondrogenic phenotype. In another 
study, polyurethane and gelatin have been used to design a mesoscopically 
ordered structure for using as an artificial graft [15]. Recently, it has been shown 
that nanofibrous PCL mats could be used as a scaffold to support differentiation 
of human mesenchymal stem cell cultured in specific differentiation media [16]. 
Silk fibroin based nanofibrous matrices have also been tested with human bone 
marrow stromal cells and proposed as a scaffold for bone tissue engineering 
[17].        
Though there are many studies that have been proposing nanofibrous 
polymeric mats for tissue engineering, they have a limitation for 3D applications 
due to their pore size which is smaller than a cellular diameter and can not allow 
cell migration within the structure. Furthermore, the small size of the fibers tends 
not to maximize the points of cell attachment which is a negative effect on the 
expression of several factors and on cell spreading and differentiation. 
In the present study, we have developed a novel structure which 
combines polymeric micro and nanofibers in the same construct that is aimed to 
serve as a scaffold and mimic the physical structure of ECM for bone tissue 
regeneration, but simultaneously still providing the macro support that cells do 
require.  
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2. Materials&Methods 
2.1. Materials 
Starch-based scaffolds with a 70% porosity were prepared from a blend of 
starch/poycaprolactone (SPCL) (30/70 wt%) by a fiber bonding process as 
described elsewhere [18]. All the reagents used were analytical grade unless 
specified otherwise.  
2.2. Electrospinning Process 
Electrospinning was used to obtain nanofibers onto SPCL fiber mesh scaffolds. 
The aim was to impregnate, as much as possible, the micro-fiber scaffolds with 
electrospun nanofibers. The solution used in the electrospinning experiments 
was prepared by dissolving 1g of SPCL in 7 ml chloroform. After dissolution was 
completed, 3 ml of dimethylformamide (DMF) which has a high dielectric 
constant was added to the solution to enhance electrospinning of the solution.  
The polymer solution was then electrospun to the both side of the SPCL 
fiber mesh scaffolds. Briefly, a polymer solution was placed in a simple capillary 
glass tube vertically. A special designed collector was used to move samples 
through the electrospun polymeric jets. A 15kV voltage was provided by a high 
power supply at a distance of 10cm between a collector and a capillary tube for 
10s. 
Morphological Analysis  
The developed structures were analyzed by optical microscopy (Olympus, MIC-
D). To observe more detail in morphology of the nanofibers on the scaffolds, a 
scanning electron microscope (SEM) (Leica Cambridge S360 microscope) was 
also used.  
2.3. Cell Culture 
The developed structures were tested with two different cell type, a human 
osteoblast-like osteosarcoma SaOs-2 cell line and rat bone marrow stromal cells. 
 136
In both experiment sets SPCL fiber mesh scaffolds without electrospun 
nanofibers were used as controls.  
In the cell culture experiments with a human osteoblast-like SaOs-2 cell 
line, cells were seeded onto the scaffold using a density of 3x105 cells/scaffolds 
and allowed to grow for two weeks, with medium (DMEM low glucose 
supplemented with 10% Foetal Bovine Serum, 1% antibiotics/antimicotics 
changes every 2 days.  
Rat bone marrow stromal cells (RBMSC) were obtained from the femoras 
and tibias of 4 weeks-old male Wistar  rats (Charles River, Spain) as described 
elsewhere [19]. Briefly, femurs and tibias were aseptically excised, cleaned of 
soft tissue, and washed in α-MEM (Life Technologies, Grand Island, NY) 
containing 10 times more amount of normal antibiotics concentration in order to 
avoid contamination during the harvest. Then, the epiphyses were cut off, and 
the diaphyses flushed with 5 ml of complete medium [α-MEM (minimal essential 
medium); Eagle, Sigma, St. Louis, MO], supplemented with 10 % FBS (foetal 
bovine serum; Biochrome), 50 µg/mL ascorbic acid (Sigma), 50 µg/mL 
gentamycin, 1% antibiotics/antimicotics, 10 mM β-glycerophosphate (Sigma), 
and 10-8M dexamethasone (Sigma)]. Cells were cultured at 37 ºC in a humidified 
atmosphere containing 5 % of CO2. 
The confluent cell monolayers were detached using trypsin/EDTA (0.25% 
tyripsin/0.02% EDTA, Sigma) and resuspended in complete medium. A 50µl of 
cell suspension containing 3x105 cells were pippeted onto the each scaffold. 
Cell/scaffold constructs were incubated at 37C for 2h to allow RBMSC to diffuse 
into and adhere to the scaffolds before adding 1 ml of culture medium to each 
well.  The cells on the scaffolds were then allowed to grown for 2 weeks at 37°C 
in a humidified atmosphere containing 5% of CO2 with medium changes every 2-
3 days. 
Morphological Analysis 
After 7 and 14 days of culture, cell/scaffold constructs were fixed in 2.5% 
glutaraldehyde, dehydrated through graded series of ethanol and dried. The 
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samples were mounted onto brass stubs, sputter coated with cold and analyzed 
under a Scanning Electron Microscope (SEM) at an accelerating voltage 15kV.  
Cell proliferation Assay 
After 7 and 14 days of culture, cell viability was assessed by using Cell Titer 96® 
Aqueous One Solution Cell proliferation Assay kit (Promega, USA). This test is 
based on the bioreduction of the substrate, (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazolium) (MTS), into a brown 
formazan product by NADPH or NADP produced by dehydrogenase enzymes in 
metabolically active cells. For this assay, culture medium was removed, samples 
were washed with PBS before the addition of serum free medium plus Cell Titer 
96® Aqueous One Solution (5/1 ratio). The samples were then incubated for three 
hours at 37 ºC in a humidified atmosphere containing 5 % of CO2. A 100 µl of 
incubated medium was transferred to 96-well plate culture plate and the optical 
density was read at 490 nm in a micro-plate reader (Synergy HT, Bio-tek). 
Alkaline Phosphatase (ALP) Activity 
Alkaline phosphatase (ALP) activity from the scaffolds/ cells constructs was 
quantified by the specific conversion of p-nitrophenyl phosphate (pNPP) into p-
nitrophenol (pNP). The enzyme reaction was carried out at 37°C for 1 h and then 
stopped by a solution containing 2 M NaOH and 0.2 mM EDTA in distilled water. 
The absorbance of p-nitrophenol formed was determined at 405 nm with a 
reference filter at 620 nm. A standard curve was made using pNP values ranging 
from 0 to 600 µmol/ml. The results were expressed as µmol of pNP 
produced/ml/h. Please note that ALP activity was determined in weekly collected 
supernatant and lysed cell for SAOS-2 and RBMSC, respectively. 
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3. Results&Discussion 
3.1. Nano- and micro fiber combined scaffolds  
Figure 1.A presents the images of the newly designed combined nano/micro fiber 
structures. As it can be seen, nanofibers could be randomly electrospun on the 
microfibers and they present the structure that looks like a nanobridge between 
the microfibers which is very similar to the architecture of ECM [20]. The average 
diameter of produced SPCL nanofiber was measured to be around 400nm 
(Figure 1.B). Moreover, nanofibers presented a fine morphology without 
presence of beads which is refered as a common problem of electropsun fibers 
[4]. These results also confirmed that the processing parameters were 
successfully optimized in order to produce fine nanofibers from SPCL. 
 
 
 
 
 
Figure 1. Microscopic images of the scaffolds. Figure B presents a detailed view 
of nanofibers as observed by SEM. 
3.2. Cell Culture  
Morphological Analysis 
Regarding cell culture studies with SaOs-2 and RBMSC, cell responses in both 
cases were clearly different to the nano/micro fiber combined scaffolds when 
directly compared with the control fiber mesh scaffolds. It was observed that 
there were significant differences, mainly those related with cell shape and 
morphology, which could indicate that the patterned layered by the nanofibers 
A 
B 
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was leading to a different cytoskeleton rearrangement on the seeded cells. SEM 
images showed that cells had covered microfibers and started to fill the spaces 
between the latter using for that purpose the previously laid down nanofibers 
after 7 days of culture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Human osteoblast like cells (SAOS-2) seeded on nano- and micro-fiber 
combined scaffolds and control (scaffolds without nanofibers); A) after 7 days, B), 
C) and D) after 14 days of culture. 
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Figure 3. Human osteoblast like cells on control scaffolds after 14 days of culture 
 
Figure 2 shows confluent growth on combined scaffolds and control by the SaOs-
2 osteoblast-like cell line. As it can be observed the cell population growing on 
the combined scaffolds presented a different organization being able to bridge 
between microfibers. The presence of nanofibers also led to the changes in cell 
morphology (Figure 2.C and D). Cells along the nanofibers showed very 
stretched morhologhy. This fact can be particular useful as this cytoskeletal 
rearrangement could affect gene expression, as described by a report of Curtis 
and Wilkonson [21]. It has been claimed that when the cells stretch themselves, 
the receptors are also stretched and activated. This results on the expression of 
different genes than those observed in unstretched cells. This particular 
hypothesis will be further confirmed in forthcoming (already ongoing) studies. A 
similar cell response was observed in the study with RBMSC (Figure 4). After 14 
days of culture, the scaffolds were covered by cells which used nanofibers to 
bridge between microfibers (Figure 4.B and C). 
It is known that human cells can attach and organize themselves well 
around the fibers diameter smaller than those of the cells [22]. This approach 
might explain the behavior of the cells on the developed combined scaffolds. This 
cell organization could provide better and faster colonization of the scaffolds with 
cells which is of main importance for tissue engineering approaches. 
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Figure 4. Rat bone marrow stromal cells (RBMSC) seeded on nano- and micro-
fiber combined scaffolds and control (scaffolds without nanofibers); A) after 7 
days, B) and C) after 14 days of culture. D) Rat bone marrow stromal cells on 
control scaffolds after 7 days of culture  
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Cell viability 
The effect of nano/micro fiber combination on cell viability and proliferation of 
both cell types was tested using a MTS assay. The MTS assay is based on a 
reduction reaction which reduced MTS reagent to brown formazan product when 
incubated with viable cells. Thus, the absorbance of formazan indirectly reflected 
the metabolic activity of cells, which is also associated with cell number.  
 
 
 
 
 
 
 
 
 
 
Figure 5. Cell viability and proliferation of human osteoblast like cells determined 
by MTS. Error bars represent means ± SD for n=3.   
 
 
 
 
 
 
 
 
 
 
Figure 6. Cell viability and proliferation of rat bone marrow stromal cells 
determined by MTS. Error bars represent means ± SD for n=3. 
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Figure 5 and 6 present the MTS results of cell culture studies with SAOS-2 and 
BMSC, respectively. After 7 and 14 days of culturing O.D. values were found to 
be considerably different for combined scaffolds in both studies. These results 
indicate that both cell types seeded on combined scaffolds showed increasing 
metabolic activity and growth rates when directly compared with the control. This 
fact is closely related with the previously deposited nanofiber mesh. While 
reducing large void spaces between the pores the mesh is creating additional 
structures where cells can adhere from the very beginning, avoiding at the same 
time that the cell suspension drops through the pores until it reaches the bottom 
of the wells. This particular phenomena shows the validity of the proposed 
methodology for increasing the cell seeding and culturing conditions during the 
development of bone tissue engineered constructs. 
ALP Activity 
ALP is a well-known enzyme used as a marker of the osteogenic phenotype, 
which catalyzes the hydrolysis of phosphate esters at an alkaline pH [23]. The 
skeletal isoform of ALP is a glycoprotein found on the cell membrane of 
osteoblasts [24]. It has been also demonstrated that it plays an important role in 
bone matrix mineralization process.  
Figure 7 and 8 shows the ALP activity of SaOs-2 and RBMSC cultured on 
the combined scaffolds and control scaffolds. In both cases, the enzyme activity 
of scaffolds with nano fibers was higher than that of control in the end of first 
week. In the case of RBMSC, the differences in enzyme activity became even 
higher after a second week of culture. This is probably related with the different 
proliferation rates of the cells seeded on the different scaffolds and at the same 
time with a probable more induced osteogenic phenotype. The latter hypothesis 
might be related with the cytoskeleton rearrangement caused by the nanofibers. 
However further studies are needed to evaluate the influence of these structures 
on the differentiation of osteogenic cells. 
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Figure 7. The ALP activity of  human osteoblast like cells seeded on SPCL nano- 
and micro-fiber combined scaffolds and control (scaffolds without nanofibers). 
Error bars represent means ± SD for n=3. 
 
 
 
 
 
 
 
Figure 8. The ALP activity of rat bone marrow stromal cells seeded on SPCL 
nano- and micro-fiber combined scaffolds and control (scaffolds without 
nanofibers). Error bars represent means ± SD for n=3. 
4. Conclusions 
An electrospinning technique was used to produce nanofibers on SPCL fiber 
meshes in order to combine nano- and microfibers in the same 3D scaffold 
architecture. It was clearly demonstrated that cell response changed completely 
with the addition of nanofibers on the fiber meshes. Osteoblasts were organized 
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to bridge between microfibers and this resulted in scaffolds completely filled with 
cells after two weeks of culture. Moreover, the presence of nanofibers had an 
influence in cell morphology which was observed to be much more streched and 
spread. The scaffolds without nanofibers did not show this kind of organization 
and the morphology of cells remained normal, and forming a continuous cell 
monolayer over microfibers. Furthermore, cells seeeded on combined scaffolds 
showed higher viability and ALP activity than that on control. 
The results from this study indicate that nano- and micro-fiber scaffolds can 
provide an ideal structure for cell deposition and organization. Their unique 
architecture which supports and guides the cells makes them a suitable 
candidate for bone tissue engineering applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 146
References 
1. Gomes, M.E. and R.L. Reis, Tissue engineering: Key elements and some 
trends. Macromolecular Bioscience, 2004. 4(8): p. 737-742. 
2. Liu, X.H. and P.X. Ma, Polymeric scaffolds for bone tissue engineering. 
Annals of Biomedical Engineering, 2004. 32(3): p. 477-486. 
3. Lutolf, M.P. and J.A. Hubbell, Synthetic biomaterials as instructive 
extracellular microenvironments for morphogenesis in tissue engineering. 
Nature Biotechnology, 2005. 23(1): p. 47-55. 
4. Huang, Z.M., et al., A review on polymer nanofibers by electrospinning 
and their applications in nanocomposites. Composites Science and 
Technology, 2003. 63(15): p. 2223-2253. 
5. Li, D., Y.L. Wang, and Y.N. Xia, Electrospinning nanofibers as uniaxially 
aligned arrays and layer-by-layer stacked films. Advanced Materials, 
2004. 16(4): p. 361-366. 
6. Matthews, J.A., et al., Electrospinning of collagen nanofibers. 
Biomacromolecules, 2002. 3(2): p. 232-238. 
7. Ohkawa, K., et al., Electrospinning of chitosan. Macromolecular Rapid 
Communications, 2004. 25(18): p. 1600-1605. 
8. Min, B.M., et al., Chitin and chitosan nanofibers: electrospinning of chitin 
and deacetylation of chitin nanofibers. Polymer, 2004. 45(21): p. 7137-
7142. 
9. Jin, H.J., et al., Electrospinning Bombyx mori silk with poly(ethylene 
oxide). Biomacromolecules, 2002. 3(6): p. 1233-1239. 
10. Son, W.K., et al., The effects of solution properties and polyelectrolyte on 
electrospinning of ultrafine poly(ethylene oxide) fibers. Polymer, 2004. 
45(9): p. 2959-2966. 
11. Li, W.J., et al., Electrospun nanofibrous structure: A novel scaffold for 
tissue engineering. Journal of Biomedical Materials Research, 2002. 
60(4): p. 613-621. 
 147
12. Yang, F., et al., Electrospinning of nano/micro scale poly(L-lactic acid) 
aligned fibers and their potential in neural tissue engineering. 
Biomaterials, 2005. 26(15): p. 2603-2610. 
13. Yoshimoto, H., et al., A biodegradable nanofiber scaffold by 
electrospinning and its potential for bone tissue engineering. Biomaterials, 
2003. 24(12): p. 2077-2082. 
14. Li, W.J., et al., Biological response of chondrocytes cultured in three-
dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. Journal of 
Biomedical Materials Research Part A, 2003. 67A(4): p. 1105-1114. 
15. Kidoaki, S., I.K. Kwon, and T. Matsuda, Mesoscopic spatial designs of 
nano- and microfiber meshes for tissue-engineering matrix and scaffold 
based on newly devised multilayering and mixing electrospinning 
techniques. Biomaterials, 2005. 26(1): p. 37-46. 
16. Li, W.J., et al., Multilineage differentiation of human mesenchymal stem 
cells in a three-dimensional nanofibrous scaffold. Biomaterials, 2005. 
26(25): p. 5158-5166. 
17. Jin, H.J., et al., Human bone marrow stromal cell responses on 
electrospun silk fibroin mats. Biomaterials, 2004. 25(6): p. 1039-1047. 
18. Gomes, M.E., et al., Alternative tissue engineering scaffolds based on 
starch: processing methodologies, morphology, degradation and 
mechanical properties. Materials Science & Engineering C-Biomimetic and 
Supramolecular Systems, 2002. 20(1-2): p. 19-26. 
19. Gomes, M.E., et al., Effect of flow perfusion on the osteogenic 
differentiation of bone marrow stromal cells cultured on starch-based 
three-dimensional scaffolds. Journal of Biomedical Materials Research 
Part A, 2003. 67A(1): p. 87-95. 
20. Rosso, F., et al., From cell-ECM interactions to tissue engineering. Journal 
of Cellular Physiology, 2004. 199(2): p. 174-180. 
21. Curtis, A. and C. Wilkinson, Topographical control of cells. Biomaterials, 
1997. 18(24): p. 1573-1583. 
 148
22. Laurencin, C.T., et al., Tissue engineering: Orthopedic applications. 
Annual Review of Biomedical Engineering, 1999. 1: p. 19-46. 
23. Harris, H., The Human Alkaline-Phosphatases - What We Know and What 
We Dont Know. Clinica Chimica Acta, 1990. 186(2): p. 133-150. 
24. Stigbrand, T., Present Status and Future Trends of Human Alkaline 
Phosphatases. Human Alkaline Phosphatases, ed. A.R. Liss. 1984, New 
York. 3. 
 
 
            Never express yourself more clearly than you think. 
                                    Neils Bohr 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 149
CHAPTER VIII 
GENERAL CONCLUSIONS 
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GENERAL CONCLUSIONS 
The main goal of this thesis was to be able to design adequate fiber structures 
from natural origin polymers for being used in tissue engineering applications, 
particularly in bone tissue repair approaches. The studies discussed herein can 
be divided in two main parts: 
• Development of chitosan-based fiber structures; 
• Development of starch-based fiber structures.  
Development of chitosan-based fiber structures; 
In the studies of this part, chitosan, which is a biocompatible, biodegradable and 
non-toxic natural polymer, was chosen for fiber production.  Fibers with different 
diameters were produced by means of wet spinning for use in different purposes. 
Chitosan fibers with diameter around 200µm presented an oriented surface 
morphology due to rolling up procedure during processing, which could be called 
as a kind of stretching. This property of the fibers would then provide a 
mechanical strength for the combined architecture where the chitosan fibers 
were used to reinforce the structure. These combined architectures were 
developed from coralline origin hydroxyapatite particles, chitosan membranes 
and chitosan fibers being aimed serve as a scaffold for tissue engineering or to 
be used in guided tissue regeneration by mimicking the arrangements in natural 
bone.     
Chitosan fibers with a smaller diameter were also produced, with the same 
processing procedure, and shaped into 3D randomly oriented fiber meshes. 
These fiber meshes showed to support well cell adhesion of osteoblast-like cells. 
Considering the use of these scaffolds in bone regeneration, it was important to 
have osteoconductivity in order that osteoblast and osteoprogenitor cells can 
easily attach and migrate in the scaffold. Based on this fact, the surface of 
chitosan fiber mesh scaffolds were pre-coated with a bone-like apatite layer. A 
new coating approach, using a spray, applied in these experiments due the 
 151
complex structure of chitosan fiber meshes, was herein proposed. As a result of 
coating, the osteoblast cell behaviour completely changed when they were 
cultured on the coated scaffolds.    
Development of starch-based fiber structures 
In this part, two different types of scaffolds were developed from a 
stach/polycaprolactone blend: (i) wet-spun SPCL fiber meshes and (ii) nano- and 
micro-fiber combined scaffolds.  
The wet spinning technique was also used in this part as an alternative 
route for production of SPCL fiber mesh scaffolds. By this technique, the physical 
properties (such as diameter, thickness, porosity, etc.) of the scaffolds can be 
adjusted depending on the specifications. Another important advantage of using 
this technique is that the scaffolds can be formed during processing without any 
need for a further processing step. In this part of the studies, it was possible to 
obtain the fiber mesh scaffolds with adequate porosity and the mean pore size 
which were in the proposed range for an ideal scaffold for bone tissue 
engineering. Considering the relation between cell attachment and surface 
properties of a scaffold, the ability of the scaffold surface for cell attachment 
could be enhanced by applying an Ar plasma treatment. The results from the cell 
culture studies demonstrated that the treatment worked quite effectively on 
enhancing cell attachment and proliferation.      
It is known that, the ideal scaffold should be one which closely mimics the 
natural extracellular matrix (ECM). Having this in consideration, we originally 
developed nano- and micro-fiber combined scaffolds from the same blend in the 
final study of the thesis. The basic point of this concept was to use nanofibers for 
mimicking the physical structure of natural ECM. The micro support for cells was 
provided by SPCL microfiber meshes produced by melt spinning. The presence 
of nanofibers in the structure showed great influence on cell morphology, viability 
and differentiation. In fact, cells cultured on combined scaffolds presented 
different cell organization than that on SPCL fiber meshes without nanofibers. 
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The cells tended to stretch themselves along the nanofibers and to bridge 
between microfibers. This stretched morphology led to a difference in 
differentiation rate which could be related with the different gene expression 
profiles. 
Furthermore, the presence of nanofibers seemed to be an advantage for 
increasing the cell seeding efficiency, resulting in an increase in cell viability.  
Final Remarks/Future Research 
The results obtained in the studies discussed in this thesis showed that, tissue 
engineering scaffolds with different shapes and properties can be designed by 
using fibers from natural origin polymers. One of the most promising designs 
seemed to be the one which combines the nano and microfibers in the same 
structure. By means of following the same concept, new scaffolds can be 
designed in the presence of different natural polymers such as collagen, silk 
fibroin (consists of glycosaminoglycans), which are presented in the natural 
extracellular matrix. The author of the present thesis wants to play an active role 
on taking forward these kind of approaches.  
 
 
 
 
 
 
  
